Composition Containing a Cellulose Derived Capsule With a Sunscreen

ABSTRACT

A sunscreen composition comprised of one or more sunscreen active agents encapsulated in a cellulose derived capsule wherein the composition can contain one or more additional agents. A sunscreen composition can be mixed with a bodywash, shampoo, conditioner, lotion, gel, soap, cream, hand sanitizer, spray or mousse and can be used by an individual during their normal hygiene processes, such as during a shower or bath or while applying a body product to their skin or hair.

BACKGROUND

This application is a continuation that claims priority pursuant to 35U.S.C. § 120 to U.S. Non-Provisional Ser. No. 15/264,285, filed Sep. 13,2016, a continuation that claims priority to U.S. Non-Provisional Ser.No. 14/072,926, filed Nov. 6, 2013, now U.S. Pat. No. 9,456,966, whichclaims priority pursuant to 35 U.S.C. § 119(e) to U.S Provisional PatentApplication 61/769,758, filed Feb. 27, 2013 and U.S. Provisional PatentApplication 61/722,870, filed Nov. 6, 2012, each of which is herebyincorporated by reference in its entirety.

Overexposure to ultraviolet (“UV”) radiation produced by the sun canresult in deleterious effects to individuals, including, sunburn,premature aging of skin, premature wrinkling, and for many individuals,an increase in the risk of skin cancer. To avoid these adverse effects,it is common for individuals prior to exposure to sunlight to apply asunscreen product to their skin. Such products are widely available andrelatively inexpensive. However, many individuals fail to use them on aregular basis for reasons that include, without limitation, convenienceof use and the feel of the product after application. Additionally,these products suffer from other issues such as uneven application andtheir inability to provide adequate protection due to loss of coveragesuffered from such activities as swimming, exercise that results inperspiration and dermal penetration and subsequent excretion through theurine of the active agents incorporated in the sunscreen product thatprotects an individual from the sun's harmful UV radiation (hereinafterreferred to as “sunscreen active agents”).

To provide more convenient, consistent and even sunscreen protection,several products that are used by individuals on a regular basis havebeen developed that incorporate sunscreen active agents that protect anindividual from the sun's harmful UV radiation. In the United States, itis common for individuals to bathe or shower on a regular basis, in mostinstances, every day. It is also common for those same individuals touse a body wash, shampoo, conditioner, lotion or cream while theyshower. Therefore, products have been developed that include sunscreenactive agents in bodywashes and shampoos. Other products that have beendeveloped to include sunscreen active agents are make-up, lip balm andeven hair spray products. Though the use of these products addsconvenience, they generally have not overcome some of the other issuesrelated to the use of sunscreen products.

Nevertheless, in spite of all the above attempts, there remains an unmetneed for an effective sunscreen product that provides an effective levelof sun protection, particularly a level of sun block or sunscreen thatis higher than existing formulations and remains effective even afterrinsing one or more times following application as well as having agentle or acceptable feel on the human skin, as opposed to an oily feel.The present invention addresses one or more of these needs by utilizingencapsulation technologies, milder surfactant systems, and good adhesivepolymers that provide a strong binding capability, making it moreefficient for deposition of sunscreen. The present invention addscellulose derived capsules that contain one or more sunscreen activeagents, resulting in an increase in SPF in the formulation as comparedto free sunscreen or non-encapsulated material. The cellulose derivedcapsules of the present invention also lay down on the skin surface in amanner that result in a more even distribution and spreading of thesunscreen active agent over the skin of an individual. The cellulosederived capsules of the present invention also provide a means forformulating a sunscreen active agent that can result in a greater amountof sunscreen active agent after application through such products asshampoo, body wash, conditioner, lotion, mousse, spray, hand sanitizer,cream and gel.

SUMMARY

In an aspect, the present invention discloses a sunscreen compositioncomprising a sunscreen active agent encapsulated in a cellulose derivedcapsule and one or more additional agents. In a further aspect thepresent invention discloses that a sunscreen composition is combinedwith a bodywash, shampoo, conditioner, gel, soap, hand sanitizer, cream,spray, mousse or lotion. In an aspect, the present invention disclosesthat a sunscreen active agent included in a sunscreen compositionabsorbs or blocks UV radiation from about 290 to about 420 nm. In anaspect, the present invention discloses that a sunscreen active agent isan inorganic physical blocker of UVA solar radiation, an inorganicphysical blocker of UVB solar radiation, an iron oxide or a polymer or apolyethylene.

In another aspect, the present invention discloses a sunscreencomposition, wherein the composition comprises one, two, three, four ormore sunscreen active agents. In a further aspect, the present inventiondiscloses that the SPF protection provided by a sunscreen active agentin the composition is from about 1 to 70, is from about 1 to about 50,or about 2 to about 50, or about 2 to about 40, or about 2 to about 30,or about 2 to about 20, or about 2 to about 10, or about 2 to about 5,or about 5 to about 25, or about 5 to about 20, or about 5 to about 15,or about 5 to about 10. In another aspect the present inventiondiscloses that the SPF protection provided by a sunscreen composition inthe composition is at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31,32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49,50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67,68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85,86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100 or moreand/or the SPF protection provided by a sunscreen composition in thecomposition remains above about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12,13, 14, 15, 16, 17, 18, 19, or 20, 21, 22, 23, 24, 25, 26, 27, 28, 29,30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47,48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65,66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83,84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100 ormore and/or the SPF protection provided by the composition lasts atleast about 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10,11, 12, 13, 14, 15, 16,17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70,75, 80, 85, 90, 95, 100 hours or more and/or the SPF protection providedby the composition lasts for an average of at least about about 1 day, 2days, 3 days, 4 days, 5 days, 6 days, 7 days, 8 days, 9 days, 10 days,11 days, 12 days, 13 days, 14 days, after rinsing.

In an aspect, the present invention discloses that the SPF protectionprovided by the composition increases after each additional application.In a further aspect, the present invention discloses that the SPFprotection provided by the composition increases after each additionalapplication so that after a second, third, fourth, fifth, sixth,seventh, eighth, ninth, tenth, eleventh or more washes, the SPF providedcan be above about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15,16, 17, 18, 19, or 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32,33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50,51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68,69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86,87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100 or more.

In an aspect, the present invention discloses that a sunscreencomposition includes a cationic polymer, and further, wherein thecationic polymer can be a quaternium or a polyquaternium. In a furtheraspect, the present invention discloses that a film former isdimethicone and/or petrolatum and/or a preservative is BHT and/or anadditional agent is an antioxidant, a chelating agent, a liquidhydrocarbon, a foaming agent, a skin nourishing substance, sunlesstanning actives, skin lightening actives, skin whitener, a hinderedamine light stabilizers, anti-acne actives, anti-skin wrinkling andanti-skin aging actives, vitamins, anti-inflammatory actives, anestheticactives, analgesic actives, anti-pruritic actives, anti-microbialactives (e.g. antifungals, antibacterials, and antiparasitics),anti-virals, anti-allergenics, medicinal actives (e.g., skin rash, skindisease and dermatitis medications), anti-cellulite additives, hinderedaminie light stabilizers, insect repellant actives, antioxidants, hairgrowth promoters, hair growth inhibitors, hair bleaching agents,vitamins, deodorant compounds, or more. In a further embodiment, sunlesstanning actives include, without limitation, dihydroxyacetone (DHA);glyceryl aldehyde; tyrosine and tyrosine derivatives such asmalyltyrosine, tyrosine glucosinate, and ethyl tyrosine; phospho-DOPA,indoles and derivatives. In a further embodiment, skin lighteningactives include, without limitation, EMBLICA (also an antioxidant),monobenzone (a depigmenting agent), kojic acid, arbutin, ascorbic acidand derivatives thereof (e.g., magnesium ascorbyl phosphate or sodiumascorbyl phosphate), and extracts (e.g., mulberry extract, placentalextract).

In an aspect, the present invention discloses that a composition isapplied topically and/or sprayed. In an aspect, the present inventiondiscloses that an additional agent is a surfactant and the surfactantcan be cationic, anionic, nonionic, zwitterionic, amphoteric, or anycombination thereof and/or organic or inorganic, further, wherein, asunscreen composition can include an additional agent to treat acondition suffered by an individual. In a further aspect, the presentinvention discloses that a sunscreen composition can be used to treatSeborrheic dermatitis, eczema, xerosis, infestation, dyschromia,keratosis pilaris, acne, anti-aging, sensitive skin, ephilidies, solarlentigines, photo sensitive disease, skin cancer and hx of skin cancer,melisma, auto immune, alopecia, fungal, bacterial, and viral infections,protect colored or treated hair, bromhidrosis, malodor, dandruff, woundhealing, insect repellant, pet shampoo/skin care, lindane or similarconditions.

In an aspect, the present invention discloses that a sunscreen activeagent is titanium dioxide and the titanium dioxide can have an anatase,ritile or amorphous structure and the titanium dioxide can be uncoatedor coated and can be coated with aluminum compounds, including, withoutlimitation, aluminum oxide, aluminum stearate or aluminum laurate or canbe coated with phospholipids or silicone compounds. In a further aspect,the present invention discloses that titanium dioxide can be micronizedand has a mean primary particle size ranging from about 10 nm to about50 nm or a micronized mean primary particle size of 15 nm and/or thetitanium dioxide is uncoated and if uncoated titanium dioxide can have amean particle size of around 35 nm to about 50 nm. In a further aspect,the present invention discloses that a mixture of two or more differentparticle sizes of titanium dioxide and/or comprises a mixture of coatedand uncoated titanium dioxide. In an aspect, the present inventiondiscloses that a composition comprises a sunscreen active agent isencapsulated or two or more sunscreen active agents are encapsulatedand/or a sunscreen composition comprises one or more sunscreen activeagents.

In an aspect, the present invention discloses that the ratio ofsunscreen composition to bodywash, shampoo, conditioner, lotion, gel,soap, cream, hand sanitizer, spray or mousse is about 0.2, 0.5, 0.7 1.0,1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4,2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.2, 3.5, 3.7, 4.0, 4.2, 4.5, 4.7, 5.0,6.0, 7.0, 8.0, 9.0, 10; 12, 15, or 20 parts bodywash, shampoo, lotion,conditioner, gel, soap, hand sanitizer, cream, spray or mousse tosunscreen active agent as measured w/w.

In an aspect, the present invention discloses that the pH of thesunscreen composition is from about 6 to about 8, about 6.7 to about 7.5or about 4.0 to about 10. In a further aspect, the present inventiondiscloses that the pH of the composition is at least 1, 2, 3, 4, 5, 6,7, 8, 9, 10, 11, 12, 13, or 14.

In an aspect, the present invention discloses that a cellulose derivedcapsule contains one sunscreen active agent or two or more sunscreenactive agents and further, wherein the cellulose derived capsule can beflexible and further, wherein the cellulose derived capsule has a highload rate. In an aspect, the present invention discloses that acellulose derived capsule is comprised of hydroxypropylcellulose,hydroxypropylmethylcellulose, ethylcellulose, carboxymethylcellulose orany derivatives therefrom and, wherein, the cellulose derived capsulecan have a diameter of about 400 nm to about 700 nm. In an additionalembodiment, a cellulose derived capsule has a diameter of about 400 nmto about 650 nm, about 400 nm to about 600 nm, about 400 nm to about 550nm, about 400 nm to about 500 nm, about 400 nm to about 450 nm, about200 nm to about 750 nm, about 250 nm to about 700 nm, 300 nm to about600 nm or about 300 nm to about 700 nm. In a further embodiment, 75% ormore of the cellulose derived capsules have a diameter of about 300 nmto about 600 nm. In a further embodiment, a cellulose derived capsulehas a diameter of at least 25 nm, at least 50 nm, at least 75 nm, atleast 100 nm, at least 125 nm, at least 150 nm, at least 175 nm, atleast 200 nm, at least 225 nm, at least 250 nm, at least 275 nm, atleast 300 nm, at least 325 nm, at least 350 nm, at least 375 nm, atleast 400 nm, at least 425 nm, at least 450 nm, at least 475 nm, atleast 500 nm, at least 525 nm, at least 550 nm, at least 575 nm, atleast 600 nm, at least 625 nm, at least 650 nm, at least 675 nm, atleast 700 nm, at least 725 nm, at least 750 nm, at least 775 nm, atleast 800 nm, at least 825 nm, at least 850 nm, at least 875 nm, atleast 900 nm, at least 925 nm, at least 950 nm, at least 975 nm, atleast 1000 nm or more.

In an aspect, the present invention discloses that a sunscreencomposition comprises water, a chelating agent, a moisturizing agent, apreservative, a thickening agent, a silicone containing compound, anessential oil, a structuring agent, a vitamin, a pharmaceuticalingredient, or an antioxidant, or any combination of such ingredients ormixtures of such ingredients and further, wherein the sunscreencomposition includes, without limitation, at least two, three, four,five, six, seven, eight, nine, ten, or more additional agents andfurther, wherein the additional agents can have a concentration that isfrom about 0.0001% to about 99.9% (w/v). In an aspect, the presentinvention discloses that one or more additional agents are encapsulatedor one or more additional agents are not encapsulated. In an aspect, thepresent invention discloses that one or more additional agents are notencapsulated.

In an aspect, the present invention discloses that a sunscreencomposition increases the protection of an individual to which thecomposition is applied. In a further aspect, the present inventiondiscloses that the concentration of a sunscreen active agent that is aUVA or a UVB absorber is from of about 1% to about 40%, or about 2% toabout 20%, or about 2% to about 10%, or about 5% to about 10%, or about1%, 2%, 3%, 4%, 5%, 6%, 7%, 7.4%, 7.5%, 7.6%, 8%, 9%, 10%, 11%, 12%,13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%,27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39% or 40%(w/v). In a further aspect, the present invention discloses that acellulose derived capsule is prepared so as to experience breakage inthe range of about 0, 0.1, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12,13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50,55, 60, 65, 70, 75, 80, 85, 90 or 95% to about 0.50.1, 0.5, 1, 2, 3, 4,5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23,24, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90 or 95% afterapplication or the cellulose derived capsule is prepared so as toexperience breakage in response to conditions that occur on the skin orhair and can be in response to conditions that occur on the skin or hairin a time release or controlled manner. In an additional aspect, thepresent invention discloses that an additional agent is a vitamin thatcan be encapsulated in a cellulose derived capsule or not. In a furtheraspect, the present invention discloses that an additional agent is ananti-acne active that can be encapsulated in a cellulose derived capsuleor not. In a further aspect, the present invention discloses that anadditional agent is an anti-skin wrinkling active that can beencapsulated in a cellulose derived capsule or not. In a further aspect,the present invention discloses that an additional agent is a botoxactive that can be encapsulated in a cellulose derived capsule or not.In a further aspect, the present invention discloses that an additionalagent is an anti-skin aging or anti-wrinkling active that can beencapsulated in a cellulose derived capsule or not and further, whereinanti-skin aging or anti-wrinkling additional agents can be a bicyclicaromatic compounds, compounds which have retinoid-type activity,free-radical scavengers, hydroxy or keto acids or derivatives thereof,further, wherein an anti-skin aging or anti-wrinkling additional agentsare sulfur-containing D and L amino acids and their derivatives andsalts, phospholipids (e.g., distearoyl lecithin phospholipid), fattyacids, fatty alcohols, cholesterol, plant sterols, phytic acid, lipoicacid; lysophosphatidic acid, and skin peel agents (e.g., phenol and thelike), and mixtures thereof. In a further aspect, the present inventiondiscloses that an additional agent is an anti-inflammatory active thatcan be encapsulated in a cellulose derived capsule or not. In a furtheraspect, the present invention discloses that an additional agent isanesthetic that can be encapsulated in a cellulose derived capsule ornot. In a further aspect, the present invention discloses that anadditional agent is an analgesic that can be encapsulated in a cellulosederived capsule or not. In a further aspect, the present inventiondiscloses that an additional agent is an antimicrobial or antifungalthat can be encapsulated in a cellulose derived capsule or not. In afurther aspect, the present invention discloses that an additional agentis an anti-viral that can be encapsulated in a cellulose derived capsuleor not. In a further aspect, the present invention discloses that anadditional agent treats dermatological conditions that can beencapsulated in a cellulose derived capsule or not. In a further aspect,the present invention discloses that an additional agent is ananti-cellulite active that can be encapsulated in a cellulose derivedcapsule or not. In a further aspect, the present invention disclosesthat an additional agent treats hair loss that can be encapsulated in acellulose derived capsule or not. In a further aspect, the presentinvention discloses that an additional agent is hair bleaching agentthat can be encapsulated in a cellulose derived capsule or not. In afurther aspect, the present invention discloses that an additional agentis a deoderant that can be encapsulated in a cellulose derived capsuleor not. In a further aspect, the present invention discloses that anadditional agent is an anti-oxidant active that can be encapsulated in acellulose derived capsule or not. In a further aspect, the presentinvention discloses that an additional agent is photostable antioxidantthat can be encapsulated in a cellulose derived capsule or not. In afurther aspect, the present invention discloses that an additional agentis an insect repellent that can be encapsulated in a cellulose derivedcapsule or not. In a further aspect, the present invention disclosesthat an additional agent is a polyquatermium and/or a cationic activethat can be encapsulated in a cellulose derived capsule or not. In afurther aspect, the present invention discloses that an additional agentis film barrier system that can be encapsulated in a cellulose derivedcapsule or not. In a further aspect, the present invention disclosesthat an additional agent is a film former that can be encapsulated in acellulose derived capsule or not. In a further aspect, the presentinvention discloses that an additional agent is a secondary film formerthat can be encapsulated in a cellulose derived capsule or not. In afurther aspect, the present invention discloses that an additional agentis a preservative. In a further aspect, the present invention disclosesthat an additional agent is a chelating agent that can be encapsulatedin a cellulose derived capsule or not. In a further aspect, the presentinvention discloses that an additional agent is a thickening agent orgellant that can be encapsulated in a cellulose derived capsule or not.In a further aspect, the present invention discloses that an additionalagent is fragrance, dye and/or antimicrobial that can be encapsulated ina cellulose derived capsule or not. In a further aspect, the presentinvention discloses that an additional agent is a surfactant that can beencapsulated in a cellulose derived capsule or not. In an aspect, thesurfactant results in reduced lathering or results in lathering and/orthe surfactant is an anionic surfactant, a taurate, a nonionicsurfactant, a ampohoteric lathering surfactant, a amphoteric surfactantor a cationic surfactant. In a further aspect, the present inventiondiscloses that an additional agent is a quenching agent that can beencapsulated in a cellulose derived capsule or not. In a further aspect,the present invention discloses that an additional agent is a thickeningagent or gellant that can be encapsulated in a cellulose derived capsuleor not. In a further aspect, the present invention discloses that anadditional agent is a hindered amine light stabilizers that can beencapsulated in a cellulose derived capsule or not. In a further aspect,the present invention discloses that an additional agent is a skinwhitener that can be encapsulated in a cellulose derived capsule or not.

In an aspect, the present invention discloses that the sunscreencomposition can be applied once per day, applied two, three, four ormore times per day, applied every other day or applied about 10, 8, 7,6, 5, 4, 3, 2 or 1 time per week. In a further aspect, the presentinvention discloses that a sunscreen can be applied to wet skin and/orhair or applied to dry skin and/or hair. In a further aspect, thepresent invention discloses that a sunscreen composition contains one,two or more surface-treated metal oxide pigments that block UVradiation, further, wherein the surface-treated metal oxide can block UVradiation in the wavelength range of from about 290 nm to about 400 nm.

In an aspect, the present invention discloses that a cellulose derivedcapsules containing sunscreen active agents are in the 400-450 nm range,the 400-500 nm range, the 400-550 nm range, the 400-600 nm range, the400-650 nm range. In a further aspect, the present invention disclosesthat the cellulose derived capsules contain an active coating on theexterior of the cellulose derived capsule membrane which has absorptionproperties. In a further aspect, the present invention discloses thatthe cellulose derived capsules are of different sizes. In a anotheraspect, the present invention discloses that the cellulose derivedcapsule is comprised of 0.1%-5% wt/wt of cellulosic material, 5%-20%wt/wt of cellulosic material, 20%-50% wt/wt of cellulosic material or50%-70% wt/wt of cellulosic material. In a further aspect, the presentinvention discloses that the cellulose derived capsule is comprised oftwo or more layers, further, wherein each layer can contain a differentsunscreen active agent, wherein each layer ca contain the same sunscreenactive agent, wherein each layer can contain a different sunscreenactive agent, wherein at least one layer can contain a differentsunscreen active agent than at least one other layer, wherein at leastone layer can contain a sunscreen active agent and at least one layercontains an antioxidant, wherein at least one layer can contain asunscreen active agent and at least one layer contains a vitamin,wherein at least one layer can contain a sunscreen active agent and atleast one layer contains an anti-inflammatory, wherein at least onelayer can contain a sunscreen active agent and at least one layercontains an astringent.

In an aspect, the present invention discloses that a sunscreencomposition can be comprised of a cationic surfactant, a cellulosederived capsule and a polymer, can be comprised of an anionicsurfactant, cellulose derived encapsulate, and a polymer, can becomprised of a nonionic surfactant, cellulose derived encapsulate, and apolymer, can be comprised of an amphoteric surfactant, cellulose derivedencapsulate, and a polymer, wherein the composition can be comprised ofa surfactant containing a quat group, wherein said quat group is capableof absorbing UV radiation, can be comprised of a surfactant metalcomplex to enhance reflective properties, can be comprised of more thanone surfactant, a cellulose derived capsule and a polymer, can becomprised of a cellulose derived capsule comprising ethyl cellulose anda surfactant base containing one or more polymers, can be comprised of acellulose derived capsule comprising carboxymethyl cellulose and asurfactant base containing one or more polymers.

In an aspect, the present invention discloses that a sunscreen activeagent is an organic or non-polar highly refractive sunscreen activeagent, or a sunscreen active agent is an organic sunscreen active agentand wherein, the composition contains inorganic metals. In an aspect,the present invention discloses that a sunscreen composition comprises asurfactant, a polymer and a cellulose derived capsule, further wherein,the composition is comprised of one or more different cellulose derivedcapsules, each comprised of a different cellulose derivative.

In an aspect, the present invention discloses that the inner refractiveindex of a sunscreen composition is 1.5-1.7, is 1.5-1.9, is 1.5-2.2, is1.5-2.4, is 1.5-2.6, In a further aspect, the present inventiondiscloses that the inner refractive index of a non-sunscreen activeagent in the composition is 1.5-2.7. In an additional aspect, thepresent invention discloses that the inner refractive index of a nonorganic dispersed with organic sunscreen active agent in the compositionis 1.5-2.7. In a further aspect, the present invention discloses thatthe composition contains cellulose derived capsules of different sizesand the inner refractive index of the composition is greater than 1.5.

In an aspect, the present invention discloses that the compositioncontains cellulose derived capsules, further wherein, the mixture ofcellulose derived capsules contains capsules containing differentcellulose derivatives and the inner refractive index of the compositionis greater than 1.5. In a further aspect, the present inventiondiscloses that the composition has an overall refractive index of 1.4-2.

DETAILED DESCRIPTION

The present invention encompasses compositions containing one or moresunscreen active agents capable of protecting an individual from thedeleterious effects of exposure to the sun's harmful UV radiation(hereinafter, referred to as “sunscreen active agent or sunscreen activeagents”) in a cellulose derived capsule that may be added, withoutlimitation, to a bodywash, a shampoo, a conditioner, a gel, a handsanitizer, a cream, a spray, a mouse or a lotion (hereinafter referredto as a “combination product”). In an embodiment, the invention relatesto a cellulose derived capsule that ecompasses a sunscreen composition,wherein the sunscreen composition comprises one or more sunscreen activeagents, further wherein the sunscreen composition is s solid or aliquid. In a further embodiment, the sunscreen composition also containsone or more additional agents that can include, without limitation,surfactants, polymers, antimicrobials, vitamins, antioxidants, pigments,fragrances, hindered aminie light stabilizers, skin whitener and otheradditional agents that after administration by an individual, deposit anactive agent on a substrate, for example, without limitation, anindividual's skin or hair, forming a film that reflects or absorbs tosome degree the harmful radiation from the sun or attenuates the harmfuleffect of ultraviolet radiation and with certain active agents, providesan additional benefit. The present invention provides a body wash,shampoo, conditioner, gel, hand sanitizer, cream, spray, mousse or alotion that is formulated so that it may be applied during normalhygienic activities, such as washing, moisturizing or other normalhygiene activities, such that the combination product results in theapplication of an effective level of a sunscreen active agentencapsulated in a cellulose derived capsule to the body such that thesunscreen active agent continues to provide effective solar protectioneven after rinsing or washing of an individual's body.

In an embodiment, a sunscreen active agent comprises a sunscreenadditive that absorbs or reflects some or all of the sun's ultraviolet(“UV”) radiation on the skin of an individual exposed to sunlight andthus, helps to protect an individual against overexposure to the UVradiation. Sunscreen active agents commonly contain one or more of thefollowing ingredients: an organic chemical compound that absorbs UVradiation, inorganic particulates that reflect, scatter and/or absorb UVradiation (such as titanium dioxide, zinc oxide, or a combination ofboth) and organic particulates that mostly absorb light like organicchemical compounds. In an embodiment, a sunscreen composition caninclude a surfactant metal complex to enhance the reflective property ofa sunscreen composition containing a sunscreen active agent. In afurther embodiment, a cellulose derived capsule membrane can increasethe absorption properties of a sunscreen formulation.

In an embodiment, a sunscreen active agent is combined with a bodywash,shampoo, conditioner, gel, hand sanitizer, cream, lotion, spray ormousse and can include, without limitation, a additional agent to form acombination product. In an embodiment, a bodywash includes, withoutlimitation, a lathering bodywash or a non-lathering bodywash. In anembodiment, a bodywash includes, without limitation, an emulsion ofwater and detergent base with added fragrance and is a skin cleaningagent commonly used in a shower or bath. In an embodiment, a body washincludes, without limitation, popular brands such as Fa, Palmolive, Axe,Lynx, Radox, Nivea, Johnson, Senses, Adidas, Umbro, Old Spice, ImperialLeather and right guard. In an embodiment, a bodywash contains a mildersurfactant than a shampoo. In a further embodiment, a bodywash includes,without limitation an all-in-one multifunctional, moisturizing cleanserthat both provides SPF and imparts color to the skin after application,wherein the bodywash includes, without limitation, iron oxide pigmentsas well as red petrolatum, at least one, preferably two, anioniclathering surfactants, a non-ionic lathering surfactant, surface-treatedzinc oxide pigments, an alkyl silicone and a volatile cyclic silicone.

In an embodiment, a spray includes, without limitation, an aerosolspray. In a further embodiment, a spray includes, without limitation,hair spray, body spray, for example, without limitation, those sold byAXE, spray on insect protection and spray on deodorant. In one aspect ofthe present invention, the SPF liquid cleansing composition isaerosolized. In a further embodiment, the aerosol spray includes,without limitation, a propellant. In an additional embodiment, apropellant is, without limitation is a mixture of isobutane, butane andpropane, including, without limitation A46, AP30 (11% Propane, 29%Isobutane, 60% n-butane); AP40 (22% Propane, 24% Isobutane, 54%n-butane); andAP70 (31% Propane, 23% Isobutane, 46% n-butane).

In an embodiment, a shampoo includes, without limitation, sodium laurylsulfate and/or sodium laureth sulfate with a co-surfactant, including,without limitation, cocamidopropyl betaine in water to form a thick,viscous liquid. In a further embodiment, a shampoo includes salt,including, without limitation, sodium chloride, a preservative and afragrance. In an embodiment, a shampoo is formulated to maximize thefollowing qualities, without limitation, pleasing foam, easy rinsing,minimal skin or eye irritation, feels thick and/or creamy, pleasantfragrance, low toxicity, good biodegradability, slightly acidic and noor minimal damage to hair.

In a further embodiment, a lotion includes, without limitation, a low tolow medium viscosity topical preparation intended for application tounbroken skin. In an embodiment, a lotion is an oil-in-water emulsionthat includes, without limitation, cetearyl alcohol and an emulgent toprevent separation of these two phases. In an embodiment, a lotioncontains, without limitation, fragrances, glycerol, petroleum jelly,dyes, preservatives, proteins and stabilizing agents. In an embodiment,lotions include, without limitation a skin medication such as anantibiotic, antiseptic, antifungal, corticosteroid, anti-acne agents orsoothing, smoothing, moisturizing or protective agents, including,without limitation, calamine. In an embodiment, a gel includes, withoutlimitation, a solid, jelly-like material that can have propertiesranging from soft and weak to hard and tough and include, withoutlimitation, substantially dilute cross-linked system, which exhibit noflow when in a steady-state. In an embodiment a gel includes, withoutlimitation, a hydrogel an organogel or a xerogel.

In an embodiment, a conditioner includes, without limitation, hairconditioner, which can include, without limitation, the followingingredients: moisturizers, reconstructors, acidifiers, detanglers,thermal protectors, glossers, oils, surfactants, lubricants,sequestrants, antistatic agents, preservatives and sunscreen activeagents. In an embodiment, a conditioner includes, without limitation, apack conditioner, a leave-in conditioner, an ordinary conditioner thatincludes both pack and leave-in ones and hold conditioners.

In an embodiment, a hand sanitizer includes, without limitation,isopropanol, ethanol, n-propanol or povidone-iodine. In a furtherembodiment, hand sanitizers can contain the following inactiveingredients, without limitation, a thickening agent, including withoutlimitation, polyacrylic acid for alcohol gels, humectants, includingwithout limitation, glycerin for liquid rubs, propylene glycol andessential oils derived from plants. In an embodiment, a hand sanitizeris a non-alcohol hand sanitizer, which includes without limitation, anitrogenous cationic surface-acting agent, that include, withoutlimitation, benzalkonium chloride, triclosan or povidone-iodine.

In an embodiment, a soap is a salt of a fatty acid. Soaps for cleansingare generally obtained by treating vegetable or animal oils and fatswith a strongly alkaline solution. Soaps can be in a solid form, such asa bar or in a decorative shape. Soap can also be a liquid. Othercomponents can be added to soap, without limitation, including oils,fragrances and conditioners. In a further embodiment, a soap contains asurfactant. In another embodiment, a soap does not contain a surfactant.

In an additional embodiment, a soap is a melt and pour soap. The processfor a melt and pour soap differs from the cold process, hot process orrebatching process of making soap in that no soap is made (i.e. noactual saponification occurs) in the process; a melt and pour soap baseacquired in commerce is melted in a direct heat melter or water jacketmelting pot (large double boiler) and additional items such asfragrance, essential oils, moisturizing agents, colorants, orexfoliating agents are added. While still hot, the concoction can bepoured into individual molds, tray molds, or blocks which upon coolingcan be sliced. In an embodiment, a melt and pour soap is a clearglycerin soap or a white soap made from white coconut oil.

In an embodiment, a soap is Castile soap. Castile soap is a name used inEnglish-speaking countries for olive oil based soap made in a stylesimilar to that originating in the Castile region of Spain. In anembodiment, Castile soap includes, without limitation, sodium hydroxide,potassium hydroxide and/or ash.

In an embodiment, a shampoo, bodywash, conditioner, gel, soap, cream orlotion combination product is applied by hand, washcloth, or anycleansing article such as a brush, loofah, pouf, sponge, or other to anindividual.

The sun protection factor of a sunscreen is a laboratory measure of theeffectiveness of sunscreen. What this means is that the higher the SPF,the more protection a sunscreen offers against UV-B radiation (theultraviolet radiation that causes sunburn). The SPF is the amount of UVradiation required to cause sunburn on the skin with the sunscreen on,as a multiple of the amount required without the sunscreen. SPF isdetermined by measuring the Minimal Erythemal Dose (“MED”) and isdefined as the threshold dose that produces skin erythema. The MEDindicates the amount of energy irradiating the skin and theresponsiveness of the skin to the radiation. In order to determine theMED, the reaction of the skin is recorded 24 hours after exposure to UVradiation. The minimal dose that induces any visible reddening at thatpoint is defined as one MED. Redness that occurs immediately afterexposure, however, and disappears during the following three to fivehours is mainly caused by heat and is not comparable with real UVerythema.

In an embodiment, “average SPF” is the SPF, determined as describedherein, for about 5 to about 50 subjects, or about 5 to about 20subjects, or about 5 to about 10 subjects, where the subjects preferablyhave Type II skin. The SPF of a particular sunscreen active agent isobtained by dividing the MED of skin that has been protected by anactive agent by the MED of unprotected skin. The higher the SPF, themore effective the active agent is in preventing an individual from skinerythema, which is on an individual is recognized as constituting asunburn. SPF is generally measured in numerical increments that identifyhow long an individual can be exposed to UV radiation from the sunbefore that same individual will experience 1 MED. For example,utilizing a sunscreen with an SPF of 6 will allow an individual to beexposed to the sun six times longer than an SPF of 1 before thatindividual receives 1 MED. As the SPF value of a sunscreen increases,the less chance exists for development UV erythema of the skin. In anembodiment, a sunscreen product containing an sunscreen active agent hasan SPF value ranging from about 2 to 70. Methods for measuring SPF aredescribed in, e.g., FDA monograph C.F.R. 21. A method for applying thesunscreen prior to measurement is as follows: Wet 50 cm² square area oftesting site with 10 ml of water delivered with a syringe. Apply testsample as per FDA monograph to area. Work lather on the subject for 3minutes to allow the product to absorb into the skin. Rinse area after 2additional minutes with 20 ml of water. Pat dry and allow 15 minutesbefore exposure to radiation as per FDA monograph.

Log P is a term known to those of skill in the chemical arts. It is ameasure of differential solubility of a compound in two solvents. Moreparticularly, it is a partition coefficient expressed as the log ratioof the concentrations of the solute in the solvent. A partitioncoefficient well known to persons having ordinary skill in the art isbased on the solvents Octanol and Water. In an embodiment, a sunscreenactive agent has a log P of greater than about 4.0 that blocks orabsorbs ultraviolet radiation in the wavelength range of from about 290nm to about 400 nm and is selected from the group consisting ofoctylmethoxycinnamate, octocrylene and octyl salicylate. The at leastone organic sunscreen agent having a log P of greater than about 4 thatblocks or absorbs ultraviolet radiation in the wavelength range of fromabout 290 nm to about 400 nm includes sunscreens currently approved bythe FDA and listed in the Sunscreen Drug Products for Over-The-CounterHuman Use Final Monograph published in the Fed era! Register on May 21,1999 at Volume 64, Number 98, pages 27666-27693 as well as organicsunscreen active agents approved by regulatory agencies in countriesother than the United States.

Any sunscreen active agent known in the art or apparent to the skilledartisan may be used in the invention. The term sunscreen active agent asused herein defines ultraviolet ray-blocking compounds exhibitingabsorption or blockage within the wavelength region between about 290and 420 nm. Sunscreen active agents may be classified, withoutlimitation, into five groups based upon their chemical structure:para-amino benzoates; salicylates; cinnamates; benzophenones; andmiscellaneous chemicals including menthyl anthralinate and digalloyltrioleate. Inorganic sunscreen active agents may also be used includingtitanium dioxide, zinc oxide, iron oxide and polymer particles such asthose of polyethylene and polyamides.

Specific suitable sunscreen active agents include, for example:p-aminobenzoic acid, its salts and its derivatives (ethyl, isobutyl,glyceryl esters; p-dimethylaminobenzoic acid); Anthranilates (i.e.,o-aminobenzoates; methyl, menthyl, phenyl, benzyl, phenylethyl, linalyl,terpinyl, and cyclohexenyl esters); Salicylates (amyl, phenyl, benzyl,menthyl, glyceryl, and dipropylene glycol esters); Cinnamic acidderivatives (methyl and benzyl esters, alpha-phenyl cinnamonitrile;butyl cinnamoyl pyruvate); Dihydroxycinnamic acid derivatives(umbelliferone, methylumbelliferone, methylaceto-umbelliferone);Trihydroxycinnamic acid derivatives (esculetin, methylesculetin,daphnetin, and the glucosides, esculin and daphnin); Hydrocarbons(diphenylbutadiene, stilbene); Dibenzalacetone and benzalacetophenone;Naphtholsulfonates (sodium salts of 2-naphthol-3,3-disulfonic and of2-naphthol-6,8-disulfonic acids); Dihydroxynaphthoic acid and its salts;n- and p-Hydroxybiphenyldisulfonates; Coumarin derivatives (7-hydroxy,7-methyl, 3-phenlyll); Diazoles (2-acetyl-3-bromoindazole, phenylbenzoxazole, methyl naphthoxalole, various aryl benzothiazoles); Quininesalts (bisulfate, sulfate, chloride, oleate, and tannate); quinolinederivatives (8-hydroxyquinoline salts, 2-phenylquinoline); Hydroxy- ormethoxy substituted benzophenones; Uric and vilouric acids; Tannnic acidand its derivatives (e.g., hexaethylether); (Butyl carbityl) (6-propylpiperonyl) ether; Hydroquinone; Benzophenones (Oxybenzene,Sulisobenzone, Dioxybenzone, Benzoresorcinol,2,2′,4,4′-Tetrahydroxybenzophenone,2,2′-Dihydroxy4,4′-dimethoxybenzophenone, Octabenzone;4-Isopropyhldibenzoylmethane; Butylmethoxydibenzoylmethane; Etocrylene;and 4-isopropyl-di-benzoylmethane; titanium dioxide, iron oxide, zincoxide, and mixtures thereof. Other cosmetically-acceptable sunscreensand concentrations (percent by weight of the total cosmetic sunscreencomposition) include diethanolamine methoxycinnamate (10% or less),ethyl-[bis(hydroxypropyl)]aminobenzoate (5% or less), glycerylaminobenzoate (3% or less), 4-isopropyl dibenzoylmethane (5% or less),4-methylbenzylidene camphor (6% or less), terephthalylidene dicamphorsulfonic acid (10% or less), and sulisobenzone (also calledbenzophenone-4, 10% or less). In an embodiment, sunscreen active agentsare FDA-approved or approved for use in the European Union. For example,FDA-approved sunscreen active agents may be used, singly or, preferably,in combination. See, e.g., U.S. Pat. Nos. 5,169,624; 5,543,136;5,849,273; 5,904,917; 6,224,852; 6,217,852; and Segarin et al., chapterVil, pages 189 of Cosmetics Science and Technology, and FinalOver-the-Counter Drug Products Monograph on Sunscreens (FederalRegister, 1999:64:27666 27963), all of which are incorporated herein byreference.

In an embodiment, zinc oxide is used as a sunscreen active agent and thefine particle size of the zinc oxide is in the range from 2 to 50microns. In a further embodiment, the zinc oxide is, without limitation,at least about 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17,18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35,36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50 or moremicrons. In a further embodiment, zinc oxide can, without limitation, besurface coated to facilitate dispersion.

In an embodiment, a product marketed in the United States, preferredcosmetically-acceptable sunscreen active agents and concentrations(reported as a percentage by weight of the total cosmetic sunscreencomposition, and referring to the final percentage of the sunscreenactive agent after addition to the bodywash) include: aminobenzoic acid(also called para-aminobenzoic acid and PABA; 15% or less; a UVBabsorbing organic sunscreen), avobenzone (also called butyl methoxydibenzoylmethane; 3% or less, a UVA I absorbing organic sunscreen),cinoxate (also called 2-ethoxyethyl p-methoxycinnamate; 3% or less, aUVB absorbing organic sunscreen), decamsule, dioxybenzone (also calledbenzophenone-8; 3% or less, a UVB and UVA II absorbing organicsunscreen), homosalate (15% or less, a UVB absorbing organic sunscreen),menthyl anthranilate (also called menthyl 2-aminobenzoate; 5% or less, aUVA II absorbing organic sunscreen), octocrylene (also called2-ethylhexyl-2-cyano-3,3 diphenylacrylate; 10% or less, a UVB absorbingorganic sunscreen), octyl methoxycinnamate (7.5% or less, a UVBabsorbing organic sunscreen), octyl salicylate (also called 2-ethylhexylsalicylate; 5% or less, a UVB absorbing organic sunscreen), oxybenzone(also called benzophenone-3; 6% or less, a UVB and UVA II absorbingorganic sunscreen), padimate 0 (also called octyl dimethyl PABA; 8% orless, a UVB absorbing organic sunscreen), phenylbenzimidazole sulfonicacid (water soluble; 4% or less, a UVB absorbing organic sunscreen),sulisobenzone (also called benzophenone-4; 10% or less, a UVB and UVA IIabsorbing organic sunscreen), titanium dioxide (25% or less, aninorganic physical blocker of UVA and UVB), trolamine salicylate (alsocalled triethanolamine salicylate; 12% or less, a UVB absorbing organicsunscreen), zinc oxide (25% or less, an inorganic physical blocker ofUVA and UVB) and Tineubin (a UVA absorber manufactured by BASF).

In an embodiment, in the European Union, preferredcosmetically-acceptable photoactive sunscreen active agents andconcentrations (reported as a percentage by weight of the total cosmeticsunscreen composition, and referring to the final percentage of thesunscreen active agent after addition to the bodywash) include: PABA (5%or less), camphor benzalkonium methosulfate (6% or less), homosalate(10% or less), benzophenone-3 (10% or less), phenylbenzimidazolesulfonic acid (8% or less, expressed as acid), terephthalidene dicamphorsulfonic acid (10% or less, expressed as acid), butylmethoxydibenzoylmethane (5% or less), Mexoryl XL, Neo heliopan AP,Benzophenone-9, Uvinul T 150, Uvinul A Plus, Uvasorb HEB, Parsol SLX,benzylidene camphor sulfonic acid (6% or less, expressed as acid),octocrylene (10% or less, expressed as acid), polyacrylamidomethylbenzylidene camphor (6% or less), octyl methoxycinnamate (10% or less),PEG-25 PABA (10% or less), isoamyl p-methoxycinnamate (10% or less),ethylhexyl triazone (5% or less), drometrizole trielloxane (15% orless), diethylhexyl butamido triazone (10% or less), 4-methylbenzylidenecamphor (4% or less), 3-benzylidene camphor (2% or less), ethylhexylsalicylate (5% or less), ethylhexyl dimethyl PABA (8% or less),benzophenone-4 (5%, expressed as acid), methylene bis-benztriazolyltetramethylbutylphenol (10% or less), disodium phenyl dibenzimidazoletetrasulfonate (10% or less, expressed as acid), bis-ethylhexyloxyphenolmethoxyphenol triazine (10% or less), methylene bisbenzotriazolyltetramethylbutylphenol (10% or less, also called TINOSORB M), andbisethylhexyloxyphenol methoxyphenyl triazine. (10% or less, also calledTINOSORB S).

In further embodiments, the sunscreen active agent includes, withoutlimitation, a silicone long-chain molecule with chromophores, e.g.,PARASOL SLX (DSM Nutritional Products), which contains benzyl malonatechromophores attached to specific points on a polysiloxane chain. In anadditional embodiment, a sunscreen active agent comprises a siliconelong-chain molecule with chromophores. In an embodiment, sunscreencompositions include, without limitation, octyl methoxycinnamate,octocrylene, avobenzone, titanium dioxide, and a silicone long-chainmolecule with chromophores. In an embodiment, the silicon long-chainmolecule may be used in sunscreen active agents at about 0.5 to about5%, or in a combination product comprising one or more sunscreen activeagents and a bodywash, shampoos, lotion, conditioner, gel, soap, handsanitizer, cream, or spray at a concentration of about 0.2 to about 2%(w/v).

In an embodiment, inorganic physical blockers of UVA and UVB include,without limitation, iron oxide and polymer particles such as those ofpolyethylene and polyamides. In further embodiments, a sunscreen activeagent is, without limitation, cinnamate (e.g., Octylmethoxycinnamate(ethyl hexyl methoxycinnamate), (available under the tradename PARSOLMCX), oxybenzone (e.g., benzophenone-3 (2-Hydroxy4-Methoxybenzophenone),avobenzone (4-tert-Butyl-4′-methoxydibenzoylmethane or PARSOL 1789),octyl salicylate (2-Ethylhexyl Salicylate), octocrylene (2-Ethylhexyl2-Cyano-3,3-Diphenylacrylate), methyl anthranilate, and/or titaniumdioxide, or combinations thereof.

In an embodiment, a p-methoxycinnamic acid ester first sunscreen activeagent includes, without limitation, amyl p-methoxycinnamate,2-ethylhexyl p-methoxycinnamate, 2-ethoxyethyl p-methoxycinnamate,diethanolamine p-methoxycinnamate, n-octyl p-methoxycinnamate and propylp-methoxycinnamate.

In an embodiment, a second sunscreen active agent recognized as safe andeffective by the US Food and Drug Administration includes, withoutlimitation, p-aminobenzoic acid, Cinoxate, Avobenzone, digalloyltrioleate, dioxybenzone, ethyl 4-[bis(hydroxypropyl)]aminobenzoate,glyceryl aminobenzoate, homosalate, lawsone with dihydroxyacetone,menthyl anthranilate, octocrylene ethyl 2-cyano-3,3-diphenyl acrylate,octyl salicylate, oxybenzone, Padimate O, phenylbenzimidazole sulfonicacid, red petrolatum, sulisobenzone, titanium dioxide, zinc oxide,including regular grades and grades of such fine particle size as enablethe composition to be translucent or transparent, and triethanolaminesalicylate. Additional sunscreen compounds recognized by Europeanauthorities include N,N,N-trimethyl-4-(2-oxoborn-3-ylidenemethyl)anilinium methyl sulfate, 3-imidazol-4-ylacrylic acid and itsethyl ester, 2-phenylbenzimidazole-5-sulfonic acid and its salts,ethoxylated 4-aminobenzoic acid, amyl 4-dimethylaminobenzoate,3,3,5-trimethylcyclohexyl-2-acetamidobenzoate, potassium cinnamate,4-methoxycinnamic acid salts, propyl 4-methoxycinnamate, salicylic acidsalts, amyl 4-methoxycinnamate, mexenone, sulisobenzone, 2-ethylhexyl2-(4-phenylbenzoyl)-benzoate, 5-methyl-2-phenylbenzoxazole, sodium3,4-dimethoxyphenylglyoxylate,1,3-bis(4-methoxyphenyl)propane-1,3-dione,5-(3,3-dimethyl-2-norbornylidene)-3-penten-2-one,alpha-(2-oxoborn-3-ylidene)-p-xylene-2-sulfonic acid,alpha-(2-oxoborn-3-ylidene)toluene-4-sulfonic acid and its salts,3-(4-methylbenzylidene)bornan-2-one, 3-benzylidenebornan-2-one,alpha-cyano-4-methoxycinnamic acid and its hexyl ester,1-p-cumenyl-3-phenylpropane-1,-3-dione, 4-isopropylbenzyl salicylate,cyclohexyl 4-methoxycinnamate, and1-(4-t-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione.

In an embodiment, a sunscreen active agent includes, without limitation,octyl methoxycinnamate at about 4.5 to about 9%, Octocrylene at about0.5 to about 15%, Avobenzone (e.g., PARSOL 1789) at about 2 to about 4%,and titanium dioxide at about 3 to about 9%.

In an embodiment, a sunscreen composition includes, without limitation,about 0.1 to 7.5 weight percent of octylmethoxy cinnamate, about 0.1 to6 parts weight percent of octyl salicylate, about 0.1 to 5 parts weightpercent of oxybenzone, about 1 to 10 weight percent of cationicsurfactant, and about 0.01 to 1 weight percent of a quaternizedcompound. These sunscreen compositions may further include, withoutlimitation, a film former and/or 0.01 to 1 weight percent of apreservative.

In an embodiment, a composition containing a sunscreen active agentprovides protection from the sun's UV radiation after application onaverage, by greater than an SPF of 1 and up to about SPF 70. In afurther embodiment, the average SPF provided by a composition containinga sunscreen active agent is about 1 to about 50, or about 2 to about 50,or about 2 to about 40, or about 2 to about 30, or about 2 to about 20,or about 2 to about 10, or about 2 to about 5, or about 5 to about 25,or about 5 to about 20, or about 5 to about 15, or about 5 to about 10.In an additional embodiment, the average SPF provided by a compositioncontaining a sunscreen active agent is at least 1, 2, 3, 4, 5, 6, 7, 8,9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26,27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44,45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62,63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80,81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98,99, 100 or more. In an embodiment, the average SPF is above about 2,above about 5, above about 10, above about 15. In an embodiment, theaverage SPF provided by a composition containing a sunscreen activeagent remains at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14,15, 16, 17, 18, 19, or 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31,32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49,50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67,68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85,86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100 or more, foran average of at least about 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10,11, 12,13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50,55, 60, 65, 70, 75, 80, 85, 90, 95, 100 hours or more or for an average,of at least about 1 day, 2 days, 3 days, 4 days, 5 days, 6 days, 7 days,8 days, 9 days, 10 days, 11 days, 12 days, 13 days, 14 days, afterrinsing. In an embodiment the average SPF provided by a compositioncontaining a sunscreen active agent increases with each additionalwashing after a first wash, so that after a second, third, fourth,fifth, sixth, seventh, eighth, ninth, tenth, eleventh or more washes,the SPF provided can be at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12,13, 14, 15, 16, 17, 18, 19, or 20, 21, 22, 23, 24, 25, 26, 27, 28, 29,30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47,48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65,66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83,84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100 ormore.

In an embodiment, a composition containing a sunscreen active agentprovides protection from the sun's UV radiation after application onaverage, and after rinsing, by greater than an SPF of 1 and up to aboutSPF 70. In a further embodiment, the average SPF provided by acomposition containing a sunscreen active agent after rinsing is about 1to about 50, or about 2 to about 50, or about 2 to about 40, or about 2to about 30, or about 2 to about 20, or about 2 to about 10, or about 2to about 5, or about 5 to about 25, or about 5 to about 20, or about 5to about 15, or about 5 to about 10. In an additional embodiment, theaverage SPF provided by a composition containing a sunscreen activeagent, after rinsing, is above about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29,30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47,48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65,66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83,84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100 ormore. In an embodiment, the average SPF after rinsing is above about 2,above about 5, above about 10, above about 15, In an embodiment, theaverage SPF provided by a composition containing a sunscreen activeagent, after rinsing, remains above about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10,11, 12, 13, 14, 15, 16, 17, 18, 19, or 20, 21, 22, 23, 24, 25, 26, 27,28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45,46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63,64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81,82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99,100 or more, for an average of at least about 0.5, 1, 2, 3, 4, 5, 6, 7,8, 9, 10,11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 30,35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100 hours or more orfor an average, of at least about 1 day, 2 days, 3 days, 4 days, 5 days,6 days, 7 days, 8 days, 9 days, 10 days, 11 days, 12 days, 13 days, 14days, after rinsing. In an embodiment the average SPF provided by acomposition containing a sunscreen active agent increases with eachadditional washing after a first wash, and a subsequent rinse, so thatafter a second, third, fourth, fifth, sixth, seventh, eighth, ninth,tenth, eleventh or more washes, the SPF provided can be above about 1,2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20,21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38,39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56,57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74,75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92,93, 94, 95, 96, 97, 98, 99, 100 or more.

In an embodiment, after application of a composition containing asunscreen active agent to the skin followed by rinsing, the sunscreenactive agent penetrates to an average of at least about 5 micronsbeneath the skin surface. In an embodiment, the sunscreen active agentpenetrates to an average of at least about 5, 10, 15, 20, 25, 30, 35,40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 105, 110, 115, 120,125, 130, 135, 140, 145 or 150 microns beneath the skin surface. In afurther embodiment, after application of a body wash, shampoo,conditioner, gel, soap, hand sanitizer, cream, spray, mousse and/or andlotion containing sunscreen active agent to the skin and/or hairfollowed by rinsing, the sunscreen active agent penetrates to an averageof no more than about 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65,70, 75, 80, 85, 90, 95, 100, 105, 110, 115, 120, 125, 130, 135, 140, 145or 150 microns beneath the skin surface. In an additional embodiment,after application of the body wash, shampoo, conditioner, gel, soap,hand sanitizer, cream, spray, mousse and/or and lotion containing anactive agent to the skin followed by rinsing, the active agentpenetrates to an average of about 5 to about 150, 5 to about 140, toabout 5 to about 130, 5 to about 120, 5 to about 110, 5 to about 100, 5to about 90, 5 to about 80, 5 to about 70, 5 to about 60, 5 to about 50,5 to about 40, 5 to about 30, 5 to about 20, 5 to about 10, 10 to about20, 10 to about 30, 10 to about 40, 10 to about 50, 10 to about 60, 10to about 70, 10 to about 80, 10 to about 90, 10 to about 100, 20 toabout 30, 20 to about 40, 20 to about 50, 20 to about 60, 20 to about70, 20 to about 80, 20 to about 90, 20 to about 100, 30 to about 40, 30to about 50, 30 to about 60, 30 to about 70, 30 to about 80, 30 to about90, 30 to about 100, 40 to about 50, 40 to about 60, 40 to about 70, 40to about 80, 40 to about 90, 40 to about 100, 50 to about 60, 50 toabout 70, 50 to about 80, 50 to about 90, 50 to about 100, 60 to about70, 60 to about 80, 60 to about 90, 60 to about 100, 70 to about 80, 70to about 90, 70 to about 100, 80 to about 90, 80 to about 100 or 90 toabout 100, or about 5, 10, 15, 20, 25, 30, 25, 40, 45, or 50 micronsbeneath the skin surface. Depth of penetration may be tested by tapestripping methods that are well-known in the art.

In an embodiment, a sunscreen composition containing a sunscreen activeagent contains at least one sunscreen active agent. In a furtherembodiment, a sunscreen composition containing a sunscreen active agentcontains one, two, three, four, or more different sunscreen activeagent. In an embodiment, a composition containing a sunscreen activeagent contains three different sunscreen active agents. In a furtherembodiment, a composition containing a sunscreen active agent containsfour, five or six different sunscreen active agents. The sunscreenactive agent may be an organic molecule or inorganic. The sunscreenactive agent may be a UVA absorber, a UVB absorber, a physical blocker,a physical reflector, or any combination thereof. In an embodiment, oneor more of the sunscreen active agents is encapsulated in a cellulosecapsule. In an embodiment, a composition containing a sunscreen activeagent may include, without limitation, one or more other additionalagents. In a further embodiment, the additional agents are included in asunscreen composition that contains one or more sunscreen active agents.In a further embodiment, the additional agents can be, withoutlimitation, one or more components capable of providing a positivecharge to the system to assist with attachment to a negatively chargedmolecule or surface, such as, without limitation, charged components ofskin and/or hair. In an embodiment, the cationic polymer is, withoutlimitation, a quaternium, e.g., polyquaternium. The additional agentscan be, without limitation, a film former, including, withoutlimitation, dimethicone and/or petrolatum, and/or a preservative, suchas BHT. In a further embodiment, other additional agents, that can beadded to a sunscreen formulation, but are not necessarily required,include, without limitation, preservatives, antioxidants, chelatingagents, liquid hydrocarbon (e.g., one similar to pentane), foamingagents (e.g., a cationic foaming agent), skin nourishing components,antibacterials, medicinals, and the like.

In an embodiment, the sunscreen composition containing a sunscreenactive agent is applied topically to the skin of an individual. In afurther embodiment, the sunscreen composition containing a sunscreenactive agent is applied to the hair or sprayed onto the skin or hair ofan individual. In an additional embodiment, the sunscreen compositioncontaining a sunscreen active agent that is applied topically or sprayedonto the hair or skin of an individual contains, without limitation, atleast one additional agent.

In an embodiment, the sunscreen composition containing a sunscreenactive agent is applied to an individual with an applicator, including,without limitation, with a sponge, a loofah, a toy, a cotton pad, a washcloth, a specialized wash cloth, a towel, clothing, a spray bottle, anapplicator bottle or any device or article, including a clothing articleor applicator. In a further embodiment, a toy, includes, withoutlimitation, a rubber squeeze toy, including, without limitation, arubber duck, or a plastic squeeze toy. In an embodiment, the applicatoris preloaded or can be loaded with the sunscreen composition containinga sunscreen active agent. In an embodiment, the application, includes,without limitation, an applicator bottle with a roller ball, a pushbutton, a nozzle, a turn knob or other means to to apply the sunscreencomposition to an individual. In a further embodiment, the applicatorprovides the sunscreen composition to an individual in metered, definedamounts. In an embodiment, the metering is by pushing down on a nozzlethat is part of the applicator. In a further embodiment, the applicatoris a squeezable bottle wherein the sunscreen composition can be removedfrom the bottle as an individual squeezes the bottle. In an embodiment,the sunscreen composition containing a sunscreen active agent is appliedusing a spray on applicator, including, without limitation, a spraybottle.

In an embodiment, the sunscreen composition containing a sunscreenactive agent is a powder or other dry form. In a further embodiment, thesunscreen composition containing a sunscreen active agent is applied toan individual by applying the powder or other dry form to theindividual. In a further embodiment, following application of the powderor other dry form, the sunscreen composition containing a sunscreenactive agent is rubbed, massaged, caressed onto the individual. In anembodiment, the sunscreen composition containing a sunscreen activeagent that is in the form of a powder or other dry form is stored in anapplicator. In an embodiment, the applicator is the same as theapplicator used for powder or other dry form products, including,without limitation, a baby powder bottle or other applicator that isconformed to the application of a powder or other dry form of asunscreen composition.

In an embodiment, the sunscreen active agents of the invention can be,without limitation, combined with a conventional bodywash, shampoo,lotion, spray, conditioner, gel, soap, hand sanitizer, cream, or mousse.The bodywash, shampoo, lotion, spray, conditioner, gel, soap, handsanitizer, cream, or mousse can be, without limitation, any bodywash,shampoo, lotion, spray, conditioner, gel, soap, hand sanitizer, cream ormousse known in the art or apparent to one of skill in the art, asdescribed above. In a further embodiment, the invention provides asunscreen composition containing at least one or more sunscreen activeagents in combination with one or more surfactants. The surfactant(s)may be cationic, anionic, nonionic, zwitterionic, amphoteric, or anycombination thereof. In an embodiment, the bodywash, shampoo, lotion,spray, conditioner, gel, soap, hand sanitizer, cream or mousse containsat least one sunscreen active agent that is organic or inorganic, or acombination of both. In an embodiment, sunscreen compositions include UVabsorbers, blockers (e.g., many inorganic sunscreens are UV blockers) orreflectors. UV absorbers may be a UVB or UVA absorber (e.g., UVA I orUVA II absorber). In a further embodiment, a sunscreen active agentincludes, without limitation, more than one organic sunscreen activeagent (e.g., at least one UVB absorber and at least one UVA absorber)and at least one inorganic sunscreen active agent. In an embodiment, asunscreen active agent is a physical blocker sunscreen, e.g., titaniumdioxide. In an additional embodiment, a sunscreen active agent is,without limitation, a cationic polymer and/or a film former as well asany other components described herein for sunscreen active agents.Additional ingredients may include film formers, cationic polymers,antioxidants, preservatives, and the like.

In an embodiment, a sunscreen composition is used, without limitation,to treat an individual suffering from, Seborrheic dermatitis, eczema,xerosis, infestation, dyschromia, keratosis pilaris, acne, anti-aging,sensitive skin, ephilidies, solar lentigines, photo sensitive disease,skin cancer and hx of skin cancer, melisma, auto immune, alopecia,fungal, bacterial, and viral infections, protect colored or treatedhair, bromhidrosis, malodor, dandruff, wound healing, insect repellant,pet shampoo/skin care, lindane or similar conditions.

In an embodiment, a sunscreen composition can contain as a sunscreenactive agent only titanium dioxide. Titanium dioxide, either alone or incombination with other sunscreens, can have an anatase, rutile, oramorphous structure. Titanium dioxide particles can be uncoated or canbe coated with a variety of materials including, without limitation,aluminum compounds such as aluminum oxide, aluminum stearate, aluminumlaurate and the like; phospholipids such as lecithin; siliconecompounds; and mixtures thereof. Various grades and forms of titaniumdioxide are described in CTFA Cosmetic Ingredient Dictionary, ThirdEdition (1982), pp. 318 319; U.S. Pat. No. 4,820,508 to Wortzman, issuedApr. 11, 1989; and World Patent No. WO 90/11067 to Elsom et al,published Oct. 4, 1990; these three references are incorporated byreference herein in their entirety. Suitable grades of titanium dioxidefor use in a sunscreen composition can be purchased from commercialsuppliers, including, without limitation, the MT micronized series fromTri-K Industries (Emerson, N.J.). Micronized titanium dioxides generallyhave a mean primary particle size ranging from about 10 nm to about 50nm. For example, the titanium dioxide has a mean primary particle sizeof about 15 nm and this sunscreen active agent is available under thetrade designation MT-15OW (uncoated) and MT-100T (coated with stearicacid and aluminum compounds). Uncoated titanium dioxides having meanprimary particle sizes of around 35 nm and around 50 nm are availableunder the trade designations MT-500B and MT-600B, respectively. Othercoated titanium dioxides having a mean primary particle size around 15nm include MT-100F (modified with stearic acid and iron hydroxide) andMT-100S (treated with lauric acid and aluminum hydroxide). Mixtures oftwo or more types and particle size variations of titanium dioxide canbe used in the present invention. In an embodiment the titanium dioxideis a silica-coated titanium dioxide, including, without limitation T-AVO(Eusolex).

In an embodiment, a sunscreen composition contains a zinc basedsunscreen active agent (e.g., Z-COTE™ HP 1 [registered trademark,SkinCeuticals]). Zinc sunscreen active agent can be, without limitation,a micro-fine zinc oxide coated with a form of dimethicone thattransforms the frequently granular and pasty particles of zinc oxide toa smooth formulation which is transparent and does not give theappearance of skin coated with white paint.

In a further embodiment, inorganic sunscreen active agents are, withoutlimitation, Tioveil and Spectraveil (both of the Tioxide Group). Tioveilinclude, without limitation, products which are 40% dispersions ofsurface-treated titanium dioxide in a range of cosmetic vehicles.Spectraveil include, without limitation, products which are 60%dispersions of zinc oxide in a range of cosmetic vehicles. In anembodiment, Tioveil and Spectraveil are film-formers.

In an embodiment, a sunscreen composition comprising one or moresunscreen active agents is encapsulated. In a further, embodiment, asunscreen composition comprises one or more sunscreen active agents andone or more additional agents that are encapsulated. Encapsulationincreases the stability of the sunscreen composition as well asincreases the effectiveness of the sunscreen composition to protect anindividual from deleterious effects suffered from exposure to the sun'sharmful rays. Encapsulation also can minimize their absorption of thesunscreen active agent into the dermis and its excretion in the urine.

In an embodiment, a sunscreen active agent comprises about 0.1% to about50%, or about 1% to about 30%, or about 1% to about 25%, or about 3% toabout 25%, or about 5% to about 25%, or about 10% to about 25′)/0 orabout 15% to about 25′)/0, or about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29,30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47,48, 49, 50% or more of the sunscreen composition (all percentages hereinare weight per volume percent unless otherwise specified). In anembodiment, a combination of one or more sunscreen active agents and abodywash, shampoo, lotion, mousse, conditioner, gel, soap, handsanitizer, cream, or spray, the one or more sunscreen active agentscomprise at least about 0.05, 1.5, 2.5, 7.5, 1, 2, 3, 4, 5, 6, 7, 8, 9,10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27,28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45,46, 47, 48, 49 or, or more than 50% of the sunscreen composition.

In an embodiment, a sunscreen composition absorbs at least 1, 2, 3, 4,5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23,24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41,42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59,60, 61, 62, 63, 64, 65, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78,79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96,97, 98, 99, or 100% of incident radiation at wave lengths of 290 to 320nanometers, In a further embodiment, a sunscreen composition absorbs atleast 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19,20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37,38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55,56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 67, 68, 69, 70, 71, 72, 73, 74,75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92,93, 94, 95, 96, 97, 98, 99, or 100% of incident radiation at wavelengths less than 290 or greater than 320 nanometers. In an embodiment,a sunscreen composition is combined with a bodywash, shampoo, lotion,conditioner, gel, soap, hand sanitizer, cream, spray or mousse in aratio of about one part sunscreen active agent to two parts bodywash,shampoo, lotion, conditioner, gel, soap, hand sanitizer, cream, spray ormousee measured as w/w. In a further embodiment, the ratio of sunscreencomposition to bodywash, shampoo, lotion, conditioner, gel, soap, handsanitizer, cream, spray or mousse is, without limitation, about 0.2,0.5, 0.7 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1,2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.2, 3.5, 3.7, 4.0, 4.2,4.5, 4.7, 5.0, 6.0, 7.0, 8.0, 9.0, 10; 12, 15, or 20 parts bodywash,shampoo, lotion, conditioner, gel, soap, hand sanitizer, cream, spray ormousse to sunscreen active agent as measured w/w.

In an embodiment, the sunscreen composition has a pH of about 6 to about8. In a further embodiment, the sunscreen composition has a pH of about6.7 to about 7.5. In a further embodiment, the sunscreen composition hasa pH of at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, or 14.

In an embodiment, a sunscreen composition is combined with a bodywash,shampoo, lotion, conditioner, gel, soap, hand sanitizer, cream, spray ormousse all at once, in groups, or separately. In an embodiment, asunscreen composition comprises at least two separate components thatinclude, without limitation, a first component that comprises all theingredients except an inorganic or physical blocker sunscreen, and asecond component that comprises an inorganic or physical blockersunscreen active agent. In an embodiment, a first component is added toa bodywash, shampoo, lotion, conditioner, gel, soap, hand sanitizer,cream, spray or mousse with thorough mixing, followed by a secondcomponent. In a further embodiment, all ingredients except the titaniumdioxide are mixed, then added to a bodywash, shampoo, lotion,conditioner, gel, soap, hand sanitizer, cream, spray or mousse, and thenthe titanium dioxide is added.

In an embodiment, a sunscreen composition is encapsulated in a cellulosederived capsule. In a further embodiment, a sunscreen composition isencapsulated in a cellulose derived capsule and a second sunscreencomposition is not encapsulated. In a further embodiment, a sunscreencomposition contains cellulose derived capsules comprising more than onecellulose derivative. In a further embodiment, the cellulose derivedcapsules in a sunscreen composition are of different sizes and/orcontain multiple layers. In an additional embodiment, each layer of acellulose derived capsule can contain one or more sunscreen activeagents and/or additional agents.

In an additional embodiment, one or more different sunscreencompositions are encapsulated in a cellulose derived capsule and one ormore sunscreen compositions are not encapsulated. Generally,encapsulation of a molecule, including, without limitation, a sunscreenactive agent or a additional agent involves trapping the sunscreenactive agent or additional agent in, e.g., a vesicle. In an embodiment,depending on the vesicle of choice, the vesicle may remain intactfollowing application to an individual or it may break open whenapplied. In a further embodiment, the vesicle may break open whenapplied over a period of time, wherein the period of time can becontinuous until the last vesicle breaks open or at one or more definedperiod after application to an individual. In an embodiment, thestability, durability, and/or SPF protection provided by a sunscreenactive agent in a bodywash, shampoo, conditioner, gel, soap, handsanitizer, cream, lotion, spray or mousse can be increased through theselection of a particular cellulose derived capsule that meets thedesired requirements.

In an embodiment, a cellulose derived capsule is a capsule wherein atleast a portion of the capsule is composed of a cellulose derivative. Ina further embodiment, a cellulose derived capsule includes, withoutlimitation, a capsule wherein the capsule is composed solely of acellulose derivative. In a further embodiment, a cellulose derivedcapsule includes, without limitation, one or more anionic components aspart of the capsule. In a further embodiment, a cellulose derivedcapsule includes, without limitation, one or more cationic components aspart of the capsule. In a further embodiment, a cellulose derivedcapsule includes, without limitation one or more additional ingredients,including without limitation, a lipid, a dye, a therapeutic, a protein,an antimicrobial, an antibiotic or other molecule. In an embodiment, acapsule is a microcapsule, also known as a microsphere. In an additionalembodiment, a cellulose derived capsule is flexible, can have high loadrates and can be prepared in large quantities without a high reactiontime and drying step. The preparation and purification of cellulosederived capsules are well known in the art and available for one ofskill to prepare the cellulose derived capsules of the presentinvention. In an embodiment, a celluolose derived capsule isphotostable. In a further embodiment, a cellulose derived capsule is notphotostable and without limitation, disintegrate following exposure tothe sun and release their internal contents, including, a sunscreenactive agent and any additional agents included in the sunscreencomposition.

In an embodiment, a cellulose derivative for use in a cellulose derivedcapsule includes without limitation, hydroxypropylcellulose,hydroxypropylmethylcellulose, ethylcellulose and carboxymethylcellulose,and any derivatives therefrom. In an embodiment, the cellulosederivative used in a cellulose derived capsule ishydroxypropylcellulose. In a further embodiment thehydroxyproplcellulose has a medium or low degree of polymerization ofthe hydroxypropylcellulose.

In an embodiment, a cellulose derived capsule has a diameter of about400 nm to about 700 nm. In an additional embodiment, a cellulose derivedcapsule has a diameter of about 400 nm to about 650 nm, about 400 nm toabout 600 nm, about 400 nm to about 550 nm, about 400 nm to about 500nm, about 400 nm to about 450 nm, about 200 nm to about 700 nm, about250 nm to about 650 nm, about 300 nm to about 600 nm, about 350 nm toabout 550 nm. In a further embodiment, 75% or more of the cellulosederived capsules have a diameter of about 300 nm to about 600 nm. In afurther embodiment, a cellulose derived capsule has a diameter of atleast 25 nm, at least 50 nm, at least 75 nm, at least 100 nm, at least125 nm, at least 150 nm, at least 175 nm, at least 200 nm, at least 225nm, at least 250 nm, at least 275 nm, at least 300 nm, at least 325 nm,at least 350 nm, at least 375 nm, at least 400 nm, at least 425 nm, atleast 450 nm, at least 475 nm, at least 500 nm, at least 525 nm, atleast 550 nm, at least 575 nm, at least 600 nm, at least 625 nm, atleast 650 nm, at least 675 nm, at least 700 nm, at least 725 nm, atleast 750 nm, at least 775 nm, at least 800 nm, at least 825 nm, atleast 850 nm, at least 875 nm, at least 900 nm, at least 925 nm, atleast 950 nm, at least 975 nm, at least 1000 nm or more.

In an embodiment, a sunscreen composition includes, without limitation,any one of, any combination of, or all of the following additionalingredients: water, a chelating agent, a moisturizing agent, apreservative, a thickening agent, a silicone containing compound, anessential oil, a structuring agent, a vitamin, a pharmaceuticalingredient, or an antioxidant, or any combination of such ingredients ormixtures of such ingredients. In an embodiment, the sunscreencomposition includes, without limitation, at least two, three, four,five, six, seven, eight, nine, ten, or all of these additionalingredients identified in the previous sentence. In a furtherembodiment, the amount of such ingredients can range from 0.0001% to99.9% by weight or volume of the composition, or any integer or range inbetween. In an embodiment, a sunscreen composition includes, withoutlimitation, one or more of the aforementioned additional ingredients,wherein the sunscreen active agent is encapsulated in a cellulosederived capsule and the additional ingredients are not encapsulated in acellulose derived capsule. In a further embodiment, a sunscreencomposition includes, without limitation, a sunscreen agent encapsulatedin a cellulose derived capsule and wherein one or more additionalingredients are encapsulated in a cellulose derived capsule with thesunscreen active agent or sunscreen active agents.

In an embodiment, a sunscreen composition or a sunscreen combinationproduct, wherein a sunscreen active agent is encapsulated in a cellulosederived capsule increases the SPF protection of an individual on which asunscreen composition or a sunscreen combination product is applied ascompared to a sunscreen composition or a sunscreen combination productwhere a sunscreen active agent is not encapsulated. In a furtherembodiment, a sunscreen composition or a sunscreen combination product,wherein a sunscreen active agent is encapsulated in a cellulose derivedcapsule increases the SPF protection of an individual on which asunscreen composition or a sunscreen combination product is applied ascompared to a sunscreen composition or a sunscreen combination productwhere a sunscreen active agent is not encapsulated by at least 0.1 timesgreater, 0.2 times greater, 0.3 times greater, 0.4 times greater, 0.5times greater, 0.6 times greater, 0.7 times greater, 0.8 times greater,0.9 times greater, 1 times greater, 1.25 times greater, 1.5 timesgreater, 1.75 times greater, 2 times greater, 2.25 times greater, 2.5times greater, 2.75 times greater, 3 times greater, 3.25 times greater,3.5 times greater, 3.75 times greater, 4 times greater, 4.25 timesgreater, 4.5 times greater, 4.75 times greater, 5 times greater, 5.25times greater, 5.5 times greater, 5.75 times greater, 6 times greater,6.25 times greater, 6.5 times greater, 6.75 times greater, 7 timesgreater, 7.25 times greater, 7.5 times greater, 7.75 times greater, 8times greater, 8.25 times greater, 8.5 times greater, 8.75 timesgreater, 9 times greater, 9.25 times greater, 9.5 times greater, 9.75times greater, 10 times greater, 11 times greater, 12 times greater, 13times greater, 14 times greater, 15 times greater, 16 times greater, 17times greater, 18 times greater, 19 times greater, 20 times greater, 21times greater, 22 times greater, 23 times greater, 24 times greater, 25times greater, 30 times greater, 35 times greater, 40 times greater, 45times greater, 50 times greater, 55 times greater, 60 times greater, 65times greater, 70 times greater, 75 times greater, 80 times greater, 85times greater, 90 times greater, 95 times greater, 100 times greaterthan a sunscreen agent is not encapsulated.

In an embodiment, a cellulose derived capsule encapsulated UVB absorber,for example, without limitation, octyl methoxycinnamate, is used as asunscreen active agent at a concentration that results in a finalconcentration of the UVB absorber in a shampoo, bodywash, conditioner,gel, soap, hand sanitizer, cream, lotion, spray or mousse of about 1% toabout 40%, or about 2% to about 20%, or about 2% to about 10%, or about5% to about 10%, or about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 7.4%, 7.5%, 7.6%,8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%,23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%,37%, 38%, 39% or 40%. In an embodiment the final concentration is about7.6%. In an embodiment, more than one sunscreen active agent isencapsulated in a cellulose derived encapsulate. In a furtherembodiment, the final concentration of each of the sunscreen activeagents, independently, in the final sunscreen additive, is about 1% toabout 40%, or about 2% to about 20%, or about 2% to about 10%, or about1%, 2%, 3%, 4%, 5%, 6%, 7%, 7.4%, 7.5%, 7.6%, 8%, 9%, 10%, 11%, 12%,13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%,27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39% or 40%.The sunscreen active agents may be encapsulated together or separately,or any combination thereof. In an embodiment, a sunscreen active agentis added to a bodywash, shampoo, conditioner, gel, soap, hand sanitizer,cream, lotion, spray or mousse that includes a sunscreen active agentencapsulated in a cellulose derived capsule, including withoutlimitation, a microcapsule. In a further embodiment, the shampoo,conditioner, gel, soap, hand sanitizer, cream, lotion, spray, mousse orbodywash containing an encapsulated sunscreen active agent alsocontains, without limitation, a cationic polymer. In an additionalembodiment, the shampoo, lotion, spray, mousse, bodywash or conditioner,gel, soap, hand sanitizer, cream, containing an encapsulated sunscreenactive agent can also contain, without limitation, a film former, anantioxidant, a preservative, a chelating agent, a thickener, anemollient, and/or other active and inactive ingredients.

In an embodiment, an active sunscreen agent is encapsulated in acellulosic derived capsule and wherein a sunscreen active agentincludes, without limitation an inorganic molecule. In a furtherembodiment, an inorganic sunscreen agent encapsulated in a cellulosicderived capsule includes, without limitation, titanium, zinc, metalalkoxides and more.

In an embodiment, the cellulose derived capsules, including withoutlimitation, microcapsules, may be prepared so as to experience about 0%breakage, or breakage in a range from about 0.1, 0.5, 1, 2, 3, 4, 5, 6,7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25,30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90 or 95% to about0.50.1, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17,18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75,80, 85, 90 or 95%, after application (or application and rinsing in thecase of a bodywash, shampoo or conditioner, gel, soap, hand sanitizer,cream, containing the cellulose derived capsules). In an embodiment, acellulose derived capsule is formulated so as to break open in responseto conditions that occur on the skin, so that after application thecellulose derived capsules act to release their contents in atime-release or controlled manner.

In an embodiment, additional agents that do not protect against thesun's radiation can be encapsulated in a cellulose derived capsule withor without a sunscreen active agent. In an embodiment, additional agentsthat do not provide protection from the sun's radiation are encapsulatedin a cellulose derived capsule that is added to a bodywash, shampoo,conditioner, gel, soap, hand sanitizer, cream, lotion, spray or mousse.In an additional embodiment, the cellulose derived capsule containing anadditional agent, also contains a sunscreen active agent. In anembodiment, a additional agent that does not provide protection from thesun's radiation, includes, without limitation, sunless tanning actives,skin lightening actives, anti-acne actives, anti-skin wrinkling andanti-skin aging actives, vitamins, anti-inflammatory actives, anestheticactives, analgesic actives, anti-pruritic actives, anti-microbialactives (e.g. antifungals, antibacterials, and antiparasitics),anti-virals, anti-allergenics, medicinal actives (e.g., skin rash, skindisease and dermatitis medications), anti-cellulite additives, insectrepellant actives, antioxidants, hair growth promoters, hair growthinhibitors, hair bleaching agents, vitamins, deodorant compounds, ormore. In a further embodiment, sunless tanning actives include, withoutlimitation, dihydroxyacetone (DHA); glyceryl aldehyde; tyrosine andtyrosine derivatives such as malyltyrosine, tyrosine glucosinate, andethyl tyrosine; phospho-DOPA, indoles and derivatives. In a furtherembodiment, skin lightening actives include, without limitation, EMBLICA(also an antioxidant), monobenzone (a depigmenting agent), kojic acid,arbutin, ascorbic acid and derivatives thereof (e.g., magnesium ascorbylphosphate or sodium ascorbyl phosphate), and extracts (e.g., mulberryextract, placental extract). In an additional embodiment, skinlightening agents include, without limitation, those described in WO95/34280, WO 95/07432, and WO 95/23780.

In an embodiment, vitamins include, without limitation, Vitamin A andderivatives thereof (including, for example, retinol, see anti-wrinklingactives), ascorbic acid (Vitamin C and derivatives), Vitamin B (e.g.,riboflavin, vitamin B2), biotin, Vitamin D (all forms), Vitamin E andderivatives thereof such as tocopheryl acetate, beta-carotene,panthothenic acid and more. In a further embodiment, anti-acne activesinclude, without limitation, benzoyl peroxide, erythromycin, clindamycinphosphate, 5,7-dichloro-8-hydroxyquinoline, resorcinol, resorcinolacetate, salicylic acid, azaleic acid, long chain dicarboxylic acids,sulfur, zinc, various natural agents such as those derived from greentree, and more. Other non-limiting examples of suitable anti-acneactives for use herein are described in U.S. Pat. No. 5,607,980, whichdescription is incorporated herein by reference. In an embodiment,anti-skin wrinkling actives include, without limitation, a variety ofagents, often in combination, that prevent or treat wrinkling through avariety of actions, including, without limitation, cosmetic productsthat contain hydroxy acids, retinol, retinoic, retinol palmitate, aderivative of vitamin A, (or its stronger, prescribed version Retin-Aand Renova), bicyclic aromatic compounds with retinoid-type activity,including, without limitation, those described in EP 679 630. In anembodiment, antioxidants include, without limitation, vitamin C, vitaminE and coenzyme Q-10. In a further embodiment, a additional agent caninclude, without limitation, Botox (an extremely diluted form ofbotulinum toxin).

In an embodiment, anti-skin aging or anti-wrinkling actives include,without limitation, bicyclic aromatic compounds, compounds which haveretinoid-type activity, free-radical scavengers, hydroxy or keto acidsor derivatives thereof. In a further embodiment, a “free-radicalscavenger” includes, without limitation, α-tocopherol, superoxidedismutase, ubiquinol or certain metal-chelating agents. In an additionalembodiment, hydroxy acids include, without limitation, α-hydroxy acidssuch as lactic acid and glycolic acid or β-hydroxy acids such assalicylic acid and salicylic acid derivatives such as the octanoylderivative; other hydroxy acids and keto acids include, withoutlimitation, malic, citric, mandelic, tartaric or glyceric acids or thesalts, amides or esters thereof. In a further embodiment, anti-wrinklingagents and anti-skin aging agents include, without limitation,sulfur-containing D and L amino acids and their derivatives and salts,particularly the N-acetyl derivatives, a preferred example of which isN-acetyl-L-cysteine; thiols, e.g. ethane thiol; fat-soluble vitamins,ascorbyl palmitate, ceramides, pseudoceramides (e.g., pseudoceramidesdescribed in U.S. Pat. Nos. 5,198,210; 4,778,823; 4,985,547; 5,175,321,all of which are incorporated by reference herein), phospholipids (e.g.,distearoyl lecithin phospholipid), fatty acids, fatty alcohols,cholesterol, plant sterols, phytic acid, lipoic acid; lysophosphatidicacid, and skin peel agents (e.g., phenol and the like), and mixturesthereof. In an embodiment, fatty acids and/or alcohols include, withoutlimitation, straight or branched alkyl chains containing 12 20 carbonatoms and linoleic acid. In a further embodiment, anti-wrinkle activesinclude, without limitation, those described in U.S. Pat. No. 6,217,888,which description is incorporated herein by reference.

In an embodiment, skin whitening actives include, without limitation,skin ligteners and skin bleaching. In an embodiment, skin whiteningactives include, without limitation,hydroquinone, arbutin, koiic acid,azelaic acid, vitamin c, cinnamomum subavenium, alpha hydroxyl acids(“AHA's”), niacinamide and licorice extract (including, withoutlimitation, glabridin). In an embodiment, skin whitening actives includedepigmentation agents, including topical creams that contain the organiccompound monobenzone or the chemical mequinol.

In an embodiment an an additional agent is a hindered amine lightstabilizers, also referred to as “HALS.” HALS are derivatives of2,2,6,6-tetramethyl piperidine and are extremely efficient stabilizersagainst light-induced degradation of most polymers. HALS do not absorbUV radiation, but act to inhibit degradation of the polymer. They slowdown the photochemically initiated degradation reactions, to some extentin a similar way to antioxidants. In an embodiment, a significant levelof stabilization is achieved at relatively low concentrations.

In an embodiment, sunscreen composition that is encapsulated in acellulose derived capsule are used in products exposed to the sun's UVradiation. In a further embodiment, the products include, withoutlimitation, plastics, including, without limitation, natural, syntheticor semi-synthetic organic solids that are moldable. In a furtherembodiment, a plastic includes, without limitation, thermoplastics andthermosetting plastics and include, without limitation, polyethylene,polyamides, polyethylene terephthalate, polyesters, acrylonitrilebutadiene styrene, polycarbonate, polyurethane, polypropylene, melamineformadehyde, phenolics, polyetheretherketone, polyetherimide, polylacticacid, polymethyl methacrylate, polytetrafluoroethylene,urea-formaldehyde, polystyrene, polyvinyl chloride andpolytetrafluoroethylene. In an embodiment, a plastic can bebiodegradable or not. In a further embodiment, a plastic includes vinylor other plastics used in consumer products, including withoutlimitation, automobiles, including, without limitation, seats,dashboard, molding and/or trim.

In an embodiment, sunscreen composition that is encapsulated in acellulose derived capsule are used in paints. In a further embodiment, apaint including an encapsulated sunscreen composition includes one ormore additional agents, including, without limitation, HALS.

In an embodiment, a sunscreen composition that is encapsulated in acellulose derived capsule are used in products used by the military,police or other governmental or non-governmental force. In anembodiment, a product used by the by the military, police or othergovernmental or non-governmental force includes, without limitation,sunscreen, paint, clothes, weapons, including, without limitation,weapons containing composite or other synthetic parts, and other by themilitary, police or other governmental or non-governmental forceproducts. In an embodiment, a sunscreen composition that is encapsulatedin a cellulose derived capsule used for by the military, police or othergovernmental or non-governmental force includes a reflective agentand/or an agent capable of preventing the detection of infraredradiation by an individual or equipment.

In an embodiment, cascading antioxidants include, without limitation,emblica and synovia. In an embodiment, quencher actives are used forsinglet and triplet excited electron stabilization caused from photonsof energy and to reduce or eliminate degradation. In an embodiment,quencher actives include, without limitation, electron receptors,including, without limitation, Polycrylene. In an embodiment, aninfrared reflective coating comprises an agent that reflects infraredradiation, for instance, without limitation, at a wavelength betweenabout 0.74 μm to about 300 μn. In a further embodiment, an infraredreflective coating includes, without limitation, coatings which producedifferent amounts of gloss and reflection. In a further embodiment, asunscreen composition with an infrared reflective coating is used by asoldier, police, national guard, governmental agent, including, withoutlimitation, an individual working for the Federal Bureau ofInvestigation, Alcohol, and Tobacco & Firearms, Secret Service, CentralIntelligence Agency, Department of Justice or any other governmentalagent, whether located in the United States or outside the United Statesor other individuals who requires an infrared reflective coating.

In an embodiment, anti-inflammatory actives include, without limitation,steroidal, non-steroidal, and other compounds. In a further embodiment,steroidal anti-inflammatory agents include, without limitation,corticosteroids such as hydrocortisone, hydroxyltriamcinolone,alpha-methyl dexamethasone, dexamethasone-phosphate, beclomethasonedipropionates, clobetasol valerate, desonide, desoxymethasone,desoxycorticosterone acetate, dexamethasone, dichlorisone, diflorasonediacetate, diflucortolone valerate, fluadrenolone, flucloroloneacetonide, fludrocortisone, flumethasone pivalate, fluosinoloneacetonide, fluocinonide, flucortine butylesters, fluocortolone,fluprednidene (fluprednylidene) acetate, flurandrenolone, halcinonide,hydrocortisone acetate, hydrocortisone butyrate, methylprednisolone,triamcinolone acetonide, cortisone, cortodoxone, flucetonide,fludrocortisone, difluorosone diacetate, fluradrenolone,fludrocortisone, diflurosone diacetate, fluradrenolone acetonide,medrysone, amcinafel, amcinafide, betamethasone and the balance of itsesters, chloroprednisone, chlorprednisone acetate, clocortelone,clescinolone, dichlorisone, diflurprednate, flucloronide, flunisolide,fluoromethalone, fluperolone, fluprednisolone, hydrocortisone valerate,hydrocortisone cyclopentylpropionate, hydrocortamate, meprednisone,paramethasone, prednisolone, prednisone, beclomethasone dipropionate,triamcinolone, and mixtures thereof may be used. In an additionalembodiment, a steroidal anti-inflammatory for use is hydrocortisone.

In an embodiment, nonsteroidal anti-inflammatory agents include, withoutlimitation, oxicams (e.g., piroxicam, isoxicam, tenoxicam, sudoxicam,CP-14,304); salicylates (e.g., aspirin, disalcid, benorylate, trilisate,safapryn, solprin, diflunisal, fendosal); acetic acid derivatives (e.g.,diclofenac, fenclofenac, indomethacin, sulindac, tolmetin, isoxepac,furofenac, tiopinac, zidometacin, acematacin, fentiazac, zomepirac,clindanac, oxepinac, felbinac, ketorolac); fenamates (e.g., mefenamic,meclofenamic, flufenamic, niflumic, tolfenamic acids); propionic acidderivatives (e,g., ibuprofen, naproxen, benoxaprofen, flurbiprofen,ketoprofen, fenoprofen, fenbufen, indopropfen, pirprofen, carprofen,oxaprozin, pranoprofen, miroprofen, tioxaprofen, suprofen, alminoprofen,tiaprofenic); pyrazoles (e.g., phenylbutazone, oxyphenbutazone,feprazone, azapropazone, trimethazone); and combinations thereof as wellas any dermatologically acceptable salts or esters of thereof. COX-2inhibitors are also suitable for use herein, and include, but are notlimited to, AZD 3582 (Astrazeneca and NicOx), Celecoxib (PharmaciaCorp.) (4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide), Meloxicam (Boehringer Ingelheim Pharmaceuticals)(4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2GW-406381(Glaxosmithkline), Etoricoxib (Merck & Co.), Rofecoxib (MERCK & Co.)(4-[4-(methylsulfonyl) phenyl]-3-phenyl-2(5H)-furanone), Lumiracoxib(Novartis Pharma AG), Valdecoxib (Pharmacia Corp.)(4-(5-methyl-3-phenyl-4-isox-azolyl) benzenesulfonamide), and Etodolac(Wyeth Ayerst Laboratories) ((±)1,8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-b]acid).

In a further embodiment, anti-inflammatory or other skin active agentsinclude, without limitation, candelilla wax, bisabolol (e.g., alphabisabolol), aloe vera, plant sterols (e.g., phytosterol), Manjistha(extracted from plants in the genus Rubia, particularly RubiaCordifolia), and Guggal (extracted from plants in the genus Commiphora,particularly Commiphora Mukul), kola extract, chamomile, red cloverextract, sea whip extract, anise oil, garlic oil, ginger extract,vasoconstrictors such as phenylephrine hydrochloride, compounds of theLicorice (the plant genus/species Glycyrrhiza glabra) family, includingglycyrrhetic acid, glycyrrhizic acid, and derivatives thereof (e.g.,salts and esters). Suitable salts of the foregoing compounds includemetal and ammonium salts. Suitable esters include C₂-C₂₄ saturated orunsaturated esters of the acids, preferably C₁₀-C₂₄, more preferablyC₁₆-C₂₄. Specific non-limiting examples of the foregoing include oilsoluble licorice extract, the glycyrrhizic and glycyrrhetic acidsthemselves, mono ammonium glycyrrhizinate, monopotassiumglycyrrhizinate, dipotassium glycyrrhizinate, 1-beta-glycyrrhetic acid,stearyl glycyrrhetinate, and 3-stearyloxy-glycyrrhetinic acid, disodium3-succinyloxy-beta-glycyrrhetinate, and combinations thereof.

In an embodiment, anesthetic actives include, without limitation,butamben picrate, lidocaine, xylocalne, benzocaine, bupivacaine,chlorprocaine, dibucaine, etidocaine, mepivacaine, tetracaine,dyclonine, hexylcaine, procaine, cocaine, ketamine, pramoxine, phenol,and pharmaceutically acceptable salts thereof.

In an embodiment, analgesic actives include, without limitation,dyclonine hydrochloride, aloe vera, fentanyl, capsaicin, and the like.In an embodiment, anti-pruritic actives include, without limitation,alclometasone dipropionate, betamethasone valerate, and isopropylmyristate MSD. In an embodiment, anti-microbial actives include, withoutlimitation, antifungal, antibacterial, and antiseptic compounds.Antifungal compounds include, but are not limited to, compounds such asimidazole antifungals. Specific antifungals include butocouazolenitrate, miconazole, econazole, ketoconazole, oxiconizole, haloprogin,clotrimazole, and butenafine HCl, naftifine, terbinafine, ciclopirox,and tolnaftate. Antibacterial and antiseptic compounds includephenol-TEA complex, mupirocin, triclosan, chlorocresol, chlorbutol,iodine, clindamycin, CAE (Anjinomoto Co., Inc., containingDL-pyrrolidone Carboxylic acid salt of L-Cocoyl Arginine Ethyl Ester),povidone-iodine, polymyxin b sulfate-bacitracin, zinc-neomycinsulfate-hydrocortisone, chloramphenicol, methylbenzethonium chloride,and erythromycin and antiseptics (e.g., benzalkonium chloride,benzethonium chloride, chlorhexidine gluconate, mafenide acetate,nitrofurazone, nitromersol, antimicrobial deodorant compounds,antiparasitics, including, without limitation, lindane and the like maybe included in compositions of the invention.

In a further embodiment, antimicrobial and antifungal actives include,without limitation, β-lactam drugs, quinolone drugs, ciprofloxacin,norfloxacin, tetracycline, amikacin, 2,4,4′-trichloro-2′-hydroxydiphenyl ether, 3,4,4′-trichlorocarbanilide, phenoxyethanol, phenoxypropanol, phenoxyisopropanol, doxycycline, capreomycin, chlorhexidine,chlortetracycline, oxytetracycline, ethambutol, hexamidine isethionate,metronidazole, pentamidine, gentamicin, kanamycin, lineomycin,methacycline, methenamine, minocycline, neomycin, netilmicin,paromomycin, streptomycin, tobramycin, miconazole, tetracyclinehydrochloride, erythromycin, zinc erythromycin, erythromycin estolate,erythromycin stearate, amikacin sulfate, doxycycline hydrochloride,capreomycin sulfate, chlorhexidine gluconate, chlorhexidinehydrochloride, chlortetracycline hydrochloride, oxytetracyclinehydrochloride, clindamycin hydrochloride, ethambutol hydrochloride,metronidazole hydrochloride, pentamidine hydrochloride, gentamicinsulfate, kanamycin sulfate, lineomycin hydrochloride, methacyclinehydrochloride, methenamine hippurate, methenamine mandelate, minocyclinehydrochloride, neomycin sulfate, netilmicin sulfate, paromomycinsulfate, streptomycin sulfate, tobramycin sulfate, miconazolehydrochloride, amanfadine hydrochloride, amanfadine sulfate, octopirox,parachlorometa xylenol, nystatin, tolnaftate, zinc pyrithione andclotrimazole.

In an embodiment, anti-viral agents include, without limitatin, metalsalts (e.g., silver nitrate, copper sulfate, iron chloride, etc.) andorganic acids (e.g., malic acid, salicylic acid, succinic acid, benzoicacid, etc.). In particular compositions which contain additionalsuitable anti-viral agents include those described in copending U.S.patent application Ser. No. 09/421,084 (Beerse et al.); Ser. No.09/421,131 (Biedermann et al.); Ser. No. 09/420,646 (Morgan et al.); andSer. No. 09/421,179 (Page et al.), which were each filed on Oct. 19,1999.

In an embodiment, anti-allergenics include, without limitation,antihistamines. In a further embodiment, antihistamines are, withoutlimitation, H₁ or H₂ antagonists or other types of histamine releaseinhibitors. In an additional embodiment, H₁ antagonists are sedating ornon-sedating, including, without limitation, diphenhydramine (Benadryl),chlorpheniramine, tripelennamine, promethazine, clemastine, doxylamine,benadryl and more. In a further embodiment, H₁-non-sedatingantihistamines include, without limitation, astemizole, terfenadine,loratadine etc. Examples of H₂ antagonists include cimetadine,famotidine, nizatidine, and ranitidine. In an additional embodiment,histamine-release-inhibitors include, without limitation, cromolyn.

In a further embodiment, an active is a medicinal for treatment ofdermatological conditions such as psoriasis, acne, eczema, and otherskin conditions due to disease, pathology, accident, and the like andinclude, without limitation, burn relief ointments, such aso-amino-p-toluenesulfonamide monoacetate; dermatitis relief agents, suchas the active steroid amcinonide, diflorasone diacetate, andhydrocortisone; diaper rash relief agents, such as methylbenzethoniumchloride and the like; herpes treatment drugs, such asO-[(2-hydroxyethoxy)methyl]guanine; psoriasis, seborrhea and scabicideagents, such as shale oil and derivatives thereof, elubiol,ketoconazole, coal tar and petroleum distillates, salicylic acid, zincpyrithione, selenium sulfide, hydrocortisone, sulfur, menthol, psoralen,pramoxine hydrochloride anthralin, and methoxsalen; steroids, such as2-(acetyloxy)-9-fluoro-1′,2′,3′,4′-tetrahydro-11-hydroxypregna-1,4-dieno[1 6,17-b]naphthalene-3,20-dione and21-chloro-9-fluoro-1′,2′,3′,4′-tetrahydro-11b-hydroxypregna-1,4-dieno[16z, 17-b]naphthalene-3,20-dione, and othersincluding those that are antiinflammatories. In an additionalembodiment, medicinals include, without limitation, those useful in thetreatment of exposure to poison oak, poison ivy, poison sumac, and thelike. These include camphor, menthol, benzocaine, butamben picrate,dibucaine, dibucaine hydrochloride, dimethisoquin hydrochloride,dyclonine hydrochloride, lidocaine, metacresol, lidocaine hydrochloride,pramoxine hydrochloride, tetracaine, tetracaine hydrochloride, benzylalcohol, camphorated metacresol, juniper tar, phenol, phenolate sodium,resorcinol, diphenhydramine hydrochloride, tripelennamine hydrochloride,hydrocortisone, a corticosteroid, and hydrocortisone acetate. In anembodiment, other medication capable of topical administration can beincorporated in a composition of the present invention in an amountsufficient to perform its intended function.

In an embodiment, anticellulite actives include, without limitation,isobutylmethylxanthine, caffeine, theophylline, theobromine,aminophylline, yohimbine, and mixtures thereof. In an embodiment,examples of actives suitable for treating hair loss include, withoutlimitation, potassium channel openers or peripheral vasodilators such asminoxidil, diazoxide, and compounds such asN*-cyano-N-(tert-pentyl)-N′-3-pyridinyl-guanidine (“P-1075”) asdisclosed in U.S. Pat. No. 5,244,664, which is incorporated herein byreference; vitamins, such as vitamin E and vitamin C, and derivativesthereof such as vitamin E acetate and vitamin C palmitate; hormones,such as erythropoietin, prostaglandins, such as prostaglandin El andprostaglandin F2-alpha; fatty acids, such as oleic acid; diruretics suchas spironolactone; heat shock proteins (“HSP”), such as HSP 27 and HSP72; calcium channel blockers, such as verapamil HCL, nifedipine, anddiltiazemamiloride; immunosuppressant drugs, such as cyclosporin andFk-506; 5 alpha-reductase inhibitors such as finasteride; growth factorssuch as, EGF, IGF and FGF; transforming growth factor beta; tumornecrosis factor; non-steroidal anti-inflammatory agents such asbenoxaprofen; retinoids such as tretinoin; cytokines, such as IL-6, IL-1alpha, and IL-1 beta; cell adhesion molecules such as ICAM;glucorcorticoids such as betametasone; botanical extracts such as aloe,clove, ginseng, rehmannia, swertia, sweet orange, zanthoxylum, Serenoarepens (saw palmetto), Hypoxis rooperi, stinging nettle, pumpkin seeds,and rye pollen; other botanical extracts including sandlewood, red beetroot, chrysanthemum, rosemary, burdock root and other hair growthpromoter activators which are disclosed in DE 4330597 which isincorporated by reference in its entirety herein; homeopathic agentssuch as Kalium Phosphoricum D2, Azadirachta indica D2, and Joborandi DI;genes for cytokines, growth factors, and male-pattered baldness;antifungals such as ketoconazole and elubiol; antibiotics such asstreptomycin; proteins inhibitors such as cycloheximide; acetazolamide;benoxaprofen; cortisone; diltiazem; hexachlorobenzene; hydantoin;nifedipine; penicillamine; phenothaiazines; pinacidil; psoralens,verapamil; zidovudine; alpha-glucosylated rutin having at least one ofthe following rutins: quercetin, isoquercitrin, hespeddin, naringin, andmethylhesperidin, and flavonoids and transglycosidated derivativesthereof which are all disclosed in JP 7002677, which is incorporated byreference in its entirety herein; and mixtures thereof. Preferred hairloss treatment agents include minoxidil,6-(I-piperdinyl)-2,4-pyrimidinediamine-3-oxide,N′-cyano-N-(tert-pentyl)-1V-3-pyridinyl-guanidine, finasteride,retinoids and derivatives thereof, ketoconazole, elubiol or mixturesthereof.

In an embodiment, actives suitable for use in inhibiting hair growthinclude, without limitation, serine proteases such as trypsin; vitaminssuch as alpha-tocophenol (vitamin E) and derivatives thereof such astocophenol acetate and tocophenol palmitate; antineoplastic agents, suchas doxorubicin, cyclophosphamide, chlormethine, methotrexate,fluorouracil, vincristine, daunorubicin, bleomycin and hydroxycarbamide;anticoagulants, such as heparin, heparinoids, coumaerins, detran andindandiones; antithyroid drugs, such as iodine, thiouracils andcarbimazole; lithium and lithium carbonate; interferons, such asinterferon alpha, interferon alpha-2a and interferon alpha-2b;retinoids, such as retinol (vitamin A), isotretinoin: glucocorticoidssuch as betamethasone, and dexamethosone; antihyperlipidaemic drugs,such as triparanol and clofibrate; thallium; mercury; albendazole;allopurinol; amiodarone; amphetamines; androgens; bromocriptine;butyrophenones; carbamazepine; cholestyramine; cimetidine; clofibrate;danazol; desipramine; dixyrazine; ethambutol; etionamide; fluoxetine;gentamicin, gold salts; hydantoins; ibuprofen; impramine;immunoglobulins; indandiones; indomethacin; intraconazole; levadopa;maprotiline; methysergide; metoprolol; metyrapone; nadolol; nicotinicacid; potassium thiocyanate; propranolol; pyridostimine; salicylates;sulfasalazine; terfenadine; thiamphenicol; thiouracils; trimethadione;troparanol; valproic acid; and mixtures thereof. Preferred hair growthinhibitory agents include serine proteases, retinol, isotretinoin,betamethoisone, alpha-tocophenol and derivatives thereof, or mixturesthereof.

In an embodiment, hair bleaching agents include, without limitation,perborate or persulfate salts.

In an embodiment, a sunscreen composition protects against UV radiationgiven off by man made devices. In a further embodiment, a sunscreencomposition protects against UV radiation given off by fluorescent lightbulbs, wherein the protective coating applied to a fluorescent lightbulb has gaps through which UV radiation is emitted.

In an embodiment, deodorant compounds include, without limitation,astringent salts and bioactive compounds. In an additional embodiment,astringent salts include, without limitation, organic and inorganicsalts of aluminum, zirconium, zinc, and mixtures thereof. In anadditional embodiment, anions of the astringent salt include, withoutlimitaiton, sulfate, chloride, chlorohydroxide, alum, formate, lactate,benzyl sulfonate or phenyl sulfonate. In an embodiment, antiperspirantastringent salts include, without limitation, aluminum halides, aluminumhydroxyhalides, zirconyl oxyhalides, zirconyl hydroxyhalides, andmixtures thereof. In a further embodiment, aluminum salts include,without limitation, aluminum chloride and the aluminum hydroxyhalideshaving the general formula Al₂(OH)_(x)Q_(y)XH₂O, wherein Q is chlorine,bromine or iodine; x is about 2 to about 5; x+y is about 6, wherein xand y are not necessarily integers; and X is about 1 to about 6. In afurther embodiment, zirconium compounds include, without limitation,zirconium oxy salts and zirconium hydroxy salts, also referred to aszirconyl salts and zirconyl hydroxy salts, and represented by thegeneral empirical formula ZrO(OH)₂2-nz L_(z), wherein z varies fromabout 0.9 to about 2 and is not necessarily an integer; n is the valenceof L; 2-nz is greater than or equal to 0; and L is selected, withoutlimitation, from the group consisting of halides, nitrate, sulfamate,sulfate, and mixtures thereof.

In an embodiment, deodorant compounds include, without limitation,aluminum bromohydrate, potassium alum, sodium aluminum chlorohydroxylactate, aluminum sulfate, aluminum chlorohydrate, aluminum-zirconiumtetrachlorohydrate, an aluminum-zirconium polychlorohydrate complexedwith glycine, aluminum-zirconium trichlorohydrate, aluminum-zirconiumoctachlorohydrate, aluminum sesquichlorohydrate, aluminumsesquichlorohydrex PG, aluminum chlorohydrex PEG, aluminum zirconiumoctachlorohydrex glycine complex, aluminum zirconium pentachlorohydrexglycine complex, aluminum zirconium tetrachlorohydrex glycine complex,aluminum zirconium trichlorohydrex glycine complex, aluminumchlorohydrex PG, zirconium chlorohydrate, aluminum dichlorohydrate,aluminum dichlorohydrex PEG, aluminum dichlorohydrex PG, aluminumsesquichlorohydrex PG, aluminum chloride, aluminum zirconiumpentachlorohydrate, numerous other useful antiperspirant compoundslisted in the CTFA Handbook at p. 56, incorporated herein by reference,and mixtures thereof.

In an embodiment, the deodorant compound includes, without limitiation,a bacteriostatic quaternary ammonium compound, such as, for example,without limitation, cetyl trimethyl ammonium bromide, cetyl pyridiniumchloride, benzethonium chloride,diisobutylbenzoxyethoxyethyldimethylbenzyl ammonium chloride, sodiumN-lauryl sarcosine, sodium N-polymethyl sarcosine, lauroyl sarcosine,N-myristolyl glycine, potassium N-lauroyl sarcosine, and stearyltrimethyl ammonium chloride; or a bioactive compound; or a carbonate orbicarbonate salt, such as, for example, the alkali metal carbonates andbicarbonates, and the ammonium and tetralkylammonium carbonates andbicarbonates. In a further embodiment, deodorant compounds include,without limitation, chlorophyllin copper complex, aluminum chloride,aluminum chloride hexahydrate, and methylbenzethonium chloride.

In an embodiment, antioxidants include, without limitation, propyl,octyl and dodecyl esters of gallic acid, butylated hydroxyanisole (BHA,usually purchased as a mixture of ortho and meta isomers), butylatedhydroxytoluene (BHT), nordihydroguaiaretic acid, Vitamin A, ascorbicacid and its salts, ascorbyl esters of fatty acids, ascorbic acidderivatives (e.g., magnesium ascorbyl phosphate, sodium ascorbylphosphate, ascorbyl sorbate), tocopherol, tocopherol acetate, otheresters of tocopherol, tocotrienols and their esters, and6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (commerciallyavailable under the tradename TROLOX). Other suitable antioxidantsinclude uric acid and its salts and alkyl esters, sorbic acid and itssalts, lipoic acid, amines (e.g., N,N-diethylhydroxylamine,amino-guanidine), sulfhydryl compounds (e.g., glutathione, N-acetylcysteine), dihydroxy fumaric acid and its salts, lycine pidolate,arginine pilolate, nordihydroguaiaretic acid, bioflavonoids, curcumin,lysine, methionine, proline, superoxide dismutase, silymarin, teaextracts, grape skin/seed extracts, melanin, and rosemary extracts maybe used.

In a further embodiment, antioxidants include, without limitation,photostable antioxidants, including, without limitation, a photostableantioxidant marketed under the tradename EMBLICA by EMD Chemicals. In anembodiment, antioxidants, including, without limitation, photostableantioxidants (e.g., EMBLICA), are included in a sunscreen composition atabout 0.05 to about 5% (w/v), or about 0.05 to about 2%(w/v), or about0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1.0%, 1.1%, 1.2%,1.3%, 1.4%, 1.5%, 1.6%, 1.7%, 1.8%, 1.9%, 2%, 2.25%, 2.5%, 2.75%, 3%,3.25%, 3.5%, 3.75%, 4%, 4.25%, 4.5%, 4.75%, or 5% (w/v), or in abodywash, shampoo, conditioner, gel, soap, hand sanitizer, cream,lotion, spray or mousse with or without a sunscreen active agent atabout 0.02 to about 2%(w/v), or about 0.02 to about 1cY0(w/v), or about0.01%, 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.07%, 0.08%, 0.09%, 0.1%,0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1%, 1.1%, 1.2%, 1.3%,1.4%, 1.5%, 1.6%, 1.7%, 1.8%, 1.9%, 2% or more.

In an embodiment, insect repellants include, without limitation,N,N-Diethyl-m-toluamide, frequently called “DEET” and available in theform of a concentrate containing at least about 95 percent DEET,dimethyl phthalate, ethyl hexanediol, indalone,di-n-propylisocinchoronat-e, bicycloheptene, dicarboximide andtetrahydrofuraldehyde. In a further embodiment, plant-derived materialswith insect repellent activity include, without limitation, citronellaoil and other sources of citronella (including lemon grass oil),limonene, rosemary oil and eucalyptus oil. Choice of an insect repellentwill frequently be influenced by the odor of the repellent. In a furtherembodiment, DEET is used at high concentrations, including, withoutlimitation, up to about 15% or more, while plant-derived substances aretypically used in much lower amounts, such as 0.1% or less.

In an embodiment, skin care agents include, without limitation, thosefound in the CTFA Cosmetic Ingredient Handbook, Seventh Edition, 1997and the Eighth Edition, 2000 and Remington's Pharmaceutical Sciences,20th Ed., Lippincott Williams & Witkins, Baltimore, Md. (2000)(hereinafter Remington's), U.S. Pharmacopeia and National Formulary, TheUnited States Pharmacopeial Convention, Inc., Rockville, Md. andPhysician's Desk Reference, Medical Economics Co., Inc., Oradell, N.J.all of which are incorporated herein by reference.

In an embodiment, the invention provides cellulose derived capsules,including, without limitation, microcapsules, that act as a protectivebarrier on the skin when used either alone, or as an additive in abodywash, shampoo, conditioner, gel, soap, hand sanitizer, cream,lotion, spray and mousse. In these embodiments, the cellulose derivedcapsules, including, without limitation, microcapsules, may be usedwithout any additional active ingredients (i.e., empty), providing aphysical barrier, or they may be used with additional encapsulatedsunscreen active agents and additional agents that enhance their barrierfunction. In an embodiment, the cellulose derived capsules, including,without limitation, microcapsules, contain one or more agents thatabsorb radiation, such as graphite, lead, tungsten, and others known inthe art, or agents that reflect radiation such as ceramic beads. In anembodiment, because the cellulose derived capsules, including, withoutlimitation, microcapsules, are designed so as to experience minimal orno breakage when applied to the skin, as well as to experience minimalpenetration of the skin, it is possible to use even toxic substances(e.g., lead) that provide a screening effect. The cellulose derivedcapsules, including, without limitation, microcapsules, are eventuallyremoved from the skin through repeated washing and/or normal sloughingof the external skin cell layers. Especially for agents used forone-time or very few exposures, such as can occur for personnel engagedin combating or containing terrorist attacks or in warfare, theinvention provides a means to deliver a last line of defense on the skinof personnel where the active used in the microcapsules may be one thatis not appropriate for long-term use, but that is appropriate for alimited number of applications in order to protect the wearer from agreater risk (e.g., cellulose derived capsules, including, withoutlimitation, microcapsules, encapsulating lead to protect against aradiation attack).

In an embodiment, the cellulose derived capsules, including, withoutlimitation, microcapsules, is prepared so to experience no or minimalbreakage when applied to the skin, either as is or in the form of abodywash, shampoo, conditioner, gel, soap, hand sanitizer, cream,lotion, spray or mousse. In a further embodiment, the cellulose derivedcapsules, including, without limitation, microcapsules, is prepared soto experience various degrees of breakage, on average, when applied asis or in a bodywash, shampoo, conditioner, gel, soap, hand sanitizer,cream, spray or mousse. In an embodiment, the cellulose derivedcapsules, including, without limitation, microcapsules, is prepared soas to experience about 0% breakage, or breakage in a range from about0.1, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18,19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36,37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54,55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72,73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90,91, 92, 93, 94, 95, 96, 97, 98 or 99% after application (or applicationand rinsing in the case of a bodywash, shampoo, conditioner, gel, soap,hand sanitizer, cream, and possibly with a lotion, spray or moussecontaining the the cellulose derived capsules, including, withoutlimitation, microcapsules,). In a further embodiment, the the cellulosederived capsules, including, without limitation, microcapsules, areformulated so as to break open in response to conditions that occur onthe skin, so that after application the the cellulose derived capsules,including, without limitation, microcapsules, act to release theircontents in a time-release or controlled manner. In an embodiment, skinor hair conditions can vary with the user's environment, the variationof which can trigger breakage of microcapsules, include pH, temperature,friction, exposure to light or air, pressure, and the like.

In an embodiment the sunscreen composition, includes, withoutlimitation, a cationic component, including, without limitation,cationic polymers. In an embodiment, cationic components, including,without limitation, cationic polymers, include, without limitation,those described in U.S. Pat. Nos. 6,224,852; 3,816,616; 4,272,515;4,298,494; 4,080,310; 4,048,301; 4,009,256; and 3,186,911, thoseavailable commercially including, without limitation, from Union CarbideCorp. under the trademark POLYMER JR., from Celanese-Stein Hall underthe trademark JAGUAR, from GAF Corporation under the tradename Gafquatmand from Merck & Co., Inc under the trademark MERQUAT by. In a furtherembodiment, a cationic component includes, without limitation, Merquat100, a highly charged cationic dimethyldiallylammonium chloridehomopolymer, and MERQUAT™ 550, a highly charged cationic copolymerprepared with dimethyldiallylammonium chloride and acrylamide. Thesematerials are designated in the CTFA dictionary as Quaternium40 andQuaternium-41, respectively.

In an embodiment, the sunscreen composition includes, withoutlimitation, polyquaterniums. In a further embodiment, the sunscreencomposition includes, without limitation, quaternized material in powderform, including, but not limited to, the polyquaterniums. In anadditional embodiment, polyquaterniums include, but are not limited to,polyquaternium-4, -7, -11, -22, -37, -44, -5, and -64 and CELQUAT L-200for polyquaternium-4. Useful in some embodiments of the invention is adry cationic component, such as sold under the tradename CAE (AnjinomotoCo., Inc.), containing DL-pyrrolidone Carboxylic acid salt of L-CocoylArginine Ethyl Ester, which is a cationic agent useful for binding toproteins and providing an antimicrobial effect. In an embodiment, asunscreen composition includes, without limitation, a cationiccomponent, including, without limitation, a cationic polymer thatcomprises about 0.1 to about 20%, or about 0.1 to about 10%, or about0.5 to about 10%, or about 1 to about 10%, or about 0.5 to about 5%, orabout 0.5 to about 3% or about 1 to about 5%, or about 1 to about 3%, orabout 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1% or 1%,2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%,18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 35%,40%, 45%, 50%, 55%, 60%, 65% or more of the total sunscreen composition.In an additional embodiment, the cationic component is polyquaternium-4.In another embodiment, the polyquaternium-4 is present at about 1% (w/v)of the sunscreen composition.

In an embodiment, a bodywash, shampoo, conditioner, gel, soap, handsanitizer, cream, lotion, spray or mousse combined with a sunscreencomposition includes, without limitation, a cationic component,including, without limitation, a cationic polymer that comprises about0.1 to about 20%, or about 0.1 to about 10%, or about 0.5 to about 10%,or about 1 to about 10%, or about 0.5 to about 5%, or about 0.5 to about3% or about 1 to about 5%, or about 1 to about 3%, or about 0.1%, 0.2%,0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1% or 1%, 2%, 3%, 4%, 5%, 6%,7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%,22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 35%, 40%, 45%, 50%, 55%,60%, 65% or more of the total sunscreen composition. In an additionalembodiment, the cationic component is polyquaternium-4. In anotherembodiment, the polyquaternium-4 is present at about 1% (w/v) of thesunscreen composition. In an embodiment, a bodywash, shampoo,conditioner, gel, soap, hand sanitizer, cream, lotion, spray or moussecombined with a sunscreen composition includes, without limitation, acationic component, including, without limitation, a cationic polymerthat comprises about 0.03 to about 7%, or about 0.03 to about 4%, orabout 0.2 to about 4%, or about 0.3 to about 4%, or about 0.2 to about2%, or about 0.3 to about 4%, or about 0.3 to about 1%, or about 0.3 or0.4% of the total composition. In some embodiments, the cationiccomponent is polyquaternium-4; in some embodiments the polyquaternium-4is present at about 0.33% (w/v) of the total combined composition.

In an embodiment, a sunscreen composition includes, without limitation,a film barrier system, typically a hydrophobic layer that serves tomaintain the residual sunscreen after rinse. In an embodiment, a filmbarrier system includes, without limitation, petrolatum, siliconderivatives, polymers, including, without limitation, those withcarboxylic ends. In a further embodiment, a film former includes,without limitation, emollient esters, lanolin derivatives (e.g.,acetylated lanolins), and superfatted oils. In an additional embodiment,a film former includes, without limitation, MOISTUREGUARD™, whichcontains petrolatum, dimethicone, stearamidopropyl dimethylaminestearate, and tocopheryl acetate, available from Engelhard.

In an embodiment, a sunscreen composition includes, without limitation,an acrylic co-polymer as a film former. An additional embodiment, asunscreen composition includes, without limitation, a liquid acryliccopolymer formulation, including, without limitation, DERMACRYL,marketed by National Starch and Chemical. Acrylic co-polymers may beincluded in sunscreen additives at about 0.1 to about 5%, or about 0.2to about 3%, or about 0.2%, 0.3%, 0.4%, or 0.5%, or insunscreen/bodywashes at about 0.05 to about 2%, or about 0.1 to about1%, or about 0.05%, 0.1%, 0.2%, 0.3%, 0.4%, or 0.5% or about 0.1%, 0.2%,0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1% or 1%, 2%, 3%, 4%, 5%, 6%,7%, 8%, 9%, 10% or more.

In an embodiment, a secondary film former can be included in a sunscreencomposition and include, without limitation, keratin or other proteinderivative in an amino acid complex such as cysteine. In an embodiment,a film former is present in a sunscreen composition in the range ofabout 0.1 to about 25%, or about 1 to about 10%; or about 2 to about 6%;or about 3, 4, or 5% or about about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%,0.7%, 0.8%, 0.9%, 1% or 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%,12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%,26%, 27%, 28%, 29%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65% or more. Inan additional embodiment, a film former, including, without limitation,MoistureGuard is used at a concentration of about 4.2%. In a furtherembodiment, a film former is used at a 4.2% concentration.

In an embodiment, an agent can have more than one function. For example,without limitation, inorganic blockers such as Tioveil and Spectraveil(both of the Tioxide Group), can act as film-formers and otheradvantageous uses here. In addition, many emollients may also perform afilm former function in that they provide a barrier on the skin. Thus,in a further embodiment, a sunscreen composition includes, withoutlimitation, water-insoluble emollients that include, without limitation,fatty acids such as oleic and stearic; fatty alcohols such as cetyl, andhexadecyl (ENJAY); esters such as diisopropyl adipate, benzoic acidesters of C₉-C₁₅ alcohols, and isononyl iso-nonanoate; alkanes such asmineral oil; silicones; such as dimethyl polysiloxane and ethers such aspolyoxypropylene butyl ethers and polyoxypropylene cetyl ethers. In anembodiment, a water-insoluble emollient is used at a concentration fromabout 2% to about 15% by weight, 4% to about 10% or about about 0.1%,0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1% or 1%, 2%, 3%, 4%,5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%,20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 35%, 40%, 45%,50%, 55%, 60%, 65% or more (w/v) of the composition. In a furtherembodiment film formers include, without limitation, polythylenes,including, without limitation, those available from New PhaseTechnologies as PERFORMALENE 400, a polyethylene having a molecularweight of 400 or polyethylene 2000 (molecular weight of 2000), which isavailable from New Phase Technologies as PERFORMALENE 2000. In anadditional embodiment, a suitable film former/waterproofing agentincludes, without limitation, synthetic wax, also available from NewPhase Technologies as PERFORMA V-825 octadecene/MA copolymer or any filmformer chemistry known in the art. In an embodiment, film formersinclude, without limitation, acacia gum, cellulose derivatives, guarderivatives and all those set forth on pages 68 69 of the C.T.F.A.Cosmetic Ingredient Handbook, First Edition, 1988, which is herebyincorporated by reference. Such film formers include acrylamidescopolymer, acrylamide/sodium aciylate copolymer, acrylate/acrylamidecopolymer, acrylate/ammonium methacrylate copolymer, acrylatescopolymer, acrylates/diacetoneacrylamide copolymer, acrylic/acrylatecopolymer, ad ipic acid/dimethylaminohydroxypropyl diethlenetnaminecopolymer, adipic acid/epoxypropyl/diethlenetriamine copolymer, albumen,allyl stearate/VA copolymer, aminoethylacrylate phosphate/acrylatecopolymer, ammonium acrylates copolymer, ammonium alginate, ammoniumvinyl acetate/acrylates copolymer, AMP acrylates/diacetoneacrylamidecopolymer, balsam canada, balsam oregon, balsam peru, balsam tolu,benzoi acid/phthalic anhydride/pentaerythritol/neopentyl glycol/palmiticacid copolymer, benzoin extract, butadiene/acrylonitrile copolymer,butylated urea-formaldehyde resin, butyl benzoic acid/phthalic anhydridetrimethylolethane copolymer, butyl ester of ethylene maleic anhydridecopolymer, butyl ester of PVM/MA copolymer, calcium carrageenean,calcium/sodium PVM/MA copolymer, carboxymethyl hydroxyethyl cellulose,cellulose gum, collodion, copal, corn starch/aciylainide/sodium acrylatecopolymer, damar, diethylene glycolamine/epichlorohydrin/piperazinecopolymer, DMJ-IF, dodecanedoic acid/cetearyl alcoholglycol copolymer,ethylcellulose, ethylene/acrylate copolymer, ethylene/maleic anhydridecopolymer, ethylene/vinyl acetate copolymer, ethyl ester of PVM/fvIAcopolymer, flexible collodian, gum benzoin, gutta percha, hydroxybutylmethylceflu lose, hydroxyethylcellulose, hydroxyethyl ethyl cellulose,hydroxypropylceilulose, hydroxypropyl guar, hydroxypropylmethylcellulose, isopropyl ester of PVM/MA copolymer, maltodextrin,melamine/formaldehyde resin, methacryloyl ethyl betainelmethacrylatescopolymer, nitrocellulose,octylacrylamide/acrylates/butylaminoethylmethaciylate copolymer,octylacrylamide/acrylates copolymer, phthalic anhydride/glycerin/gycidyldecanoate copolymer, phthalic/trimellitic/glycols copolymer,polyacrylamide, polyaciylamidomethylpropane sulfone acid, polyacrylicacid, polybutylene terephthalate, polychlorotrifluoroethylene,polyethylacrylate, polyethylene, polyethylene terephthalate,polyisobutene, Polyquaternium-1, Polyquaternium-2, Polyquaternium-4,Polyquaternium-5, Polyquaternium-6, Polyquaternium-7, Polyquaternium-8,Polyquaternium-9, Polyquaternium-10, Polyquaternium-11,Polyquaternium-12, Polyquaternium-13, Polyquaternium-14,Polyquaternium-15, polystyrene, polyvinyl acetate, polyvinyl alcohol,polyvinyl butyral, polyvinyl imidazolinium acetate, polyvinyl laurate,polyvinyl methyl ether, potassium carrageenan, PVM/MA copolymer, PVP,PVP/dimethylaminoethymethacrylate copolymer, PVP/eicosene copolymer,PVP/ethyl methacrylate/methacrylic acid copolyerm, PVP/hexadecenecopolymer, PVP/VA copolymer, PVP/vinyl acetate/itaconic acid copolymer,rosin, serum albumin, shellac, sodium acrylate/vinyl alcohol, copolymer,sodium carrageen, sodium polymethacrylate, sodium polystyrene sulfonate,starch/acrylates/acrylamide copolymer, starch diethylaminoethyl ether,steaxyvinyl ether/maleic anhydride copolymer,styrene/acrylate/acrylonitrile copolymer, styrene/acrylate/ammoniummethacrylate copolymer, styrene/maleic anhydride copolymer, styrene/PVPcopolymer, sucrose benzoate/sucrose acetate isobutyrate/butyl benzylphthalate copolymer, sucrose benzoate/sucrose acetate isobutyrate/butylbenzyl phthalate/methyl methaciylate copolymer, sucrose benzoate/sucroseacetate isobutyrate copolymer, toluenesulfonamide/formaldehyde resin,tragacath gum, vinyl acetate/crotonates copolymer, vinylacetate/crotonic acid copolymer, vinyl acetate/crotonicacid/methacryloxybenzophenon-1 copolymer, vinyl acetate/crotonicaid/vinyl neodecanoate copolymer, zein and those set forth in U.S. Pat.Nos. 6,838,419; 6,838,088; 6,780,422; 6,531,118; and 5,916,541, all ofwhich are incorporated herein by reference.

In an embodiment, a sunscreen composition includes, without limitation,a wide variety of additional components selected so as to avoid anyundesirable reaction with the primary components (e.g., one or more ofthe sunscreen active agents) of the composition. The CTFA CosmeticIngredient Handbook, Seventh Edition, 1997 and the Eighth Edition, 2000(incorporated by reference herein), provide a broad source of possiblecosmetic and pharmaceutical ingredients typically used in skin carecompositions. In an embodiment, additional components include, withoutlimitation, one or more of the following: Absorbents, abrasives,anticaking agents, antifoaming agents, binders, biological additives,buffering agents, bulking agents, chelating agents/sequestrants (e.g.,disodium EDTA), chemical additives, colorants, cosmetic astringents,cosmetic biocides, denaturants, drug astringents, emollients (includingglycerin alovera, and Vitamins A, C, and D [hydrating agents and skinprotectants]), foam boosters, fragrance components, gums,humectants/moisturizers (including urea, guanidine, glycolic acid,polyhydroxy alcohols such as sorbitol, glycerin, hexanetriol, propyleneglycol, hexylene glycol and the like, polyethylene glycol, sugars andstarches, sugar and starch derivatives, D-panthenol, hyaluronic acid,lactamide monoethanolamine, acetamide monoethanolamine, and mixturesthereof), hydrotropes, neutralizing agents, opacifying agents andpigments, pH adjusters, plasticizers, preservatives, propellants,reducing agents, skin bleaching agents, skin protectants, solubilizingagents, and suspending agents (e.g., Carbomer 1382).

In an embodiment, the sunscreen composition includes, withoutlimitation, a preservative, including, without limitation, citric acid,tartaric acid, phosphoric acid, iminodiacetic acid, nitrilotriaceticacid, hydroxyethyleneaminodiacetic acid and ethylenediaminetetraaceticacid and salts thereof; para-hydroxybenzoates such as butyl paraben,methyl paraben and propyl paraben; imidazolines (e.g.,imidiazolinylurea), triclosan, hydantoins (e.g.,dimethyloldimethylhydantoin), isothiazolidinone compounds and mixturesthereof, KATHON CG and KATHON CGII, which containmethylchloroisothiazolinone and methylisothiazolinone (Rohm and Haas).In an embodiment, the quantity of preservative is in the range from0.001 to 2%, preferably from 0.01 to 0.2% or about 0.1%, 0.2%, 0.3%,0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1% or 1%, 2%, 3%, 4%, 5%, 6%, 7%,8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%,23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 35%, 40%, 45%, 50%, 55%, 60%,65% or more.

In an embodiment, a sunscreen composition includes, without limitation,a chelating agent. In a further embodiment, chelating agents include,without limitation, substances used to chelate or bind metallic ions,such as with a heterocyclic ring structure so that the ion is held bychemical bonds from each of the participating rings. In a furtherembodiment, chelating agents include, without limitation, ethylenediaminetetraacetic acid (EDTA), EDTA disodium, calcium disodium edetate,EDTA trisodium, EDTA tetrasodium and EDTA dipotassium. In an embodiment,one or more chelating agents is included in a sunscreen composition inamounts ranging from about 0.001 to about 0.2 weight percent, or about0.01% w/v or about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%,1% or 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%,16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%,30%, 35%, 40%, 45%, 50%, 55%, 60%, 65% or more (w/v).

In an embodiment, a sunscreen composition includes, without limitation,thickening agents or gellants to adjust the texture and viscosity of thecomposition. In an embodiment, thickening agents or gellants include,without limitation, CARBOPOL™ resins [e.g., 934, 971, 974, 980, 981] andPEMULEN™ [TR-1 and TR-2] [both CARBOPOL™ and PEMULEN™ are registeredtrademarks of BF Goodrich], Noveon AA-1, ETD resins, and ULTREZ™ resins[registered trademark, BF Goodrich] or carbomers.

In an embodiment, a sunscreen composition includes, without limitation anon-polar wax, including, without limitation, ester waxes, diesterwaxes, hydrocarbon waxes, silicone waxes and triglyceride waxes andmixtures thereof. In another embodiment, a sunscreen compositionincludes, without limitation, a liquid hydrocarbon (similar to pentane),and/or a cationic foaming agent derived from arginine and or cysteine.

In an embodiment, additional ingredients which can be present in asunscreen composition include, without limitation, fragrance, dyes,antimicrobial materials such as triclocarban, triclosan, iodophors,iodine formulations, phenolic compounds, e.g. hexachlorophene, andbisbiguanides, e.g. chlorhexidene gluconate, and the like. See, e.g.U.S. Pat. Nos. 6,827,795; 6,517,854; 6,010,817; 5,173,216; 5,719,113;5,259,984; 5,562,912; 5,629,006; 5,728,662; 5,767,163; 5,750,579;5,591,442; 5,650,143; 5,772,640; and 4,478,821.

In an embodiment, the components comprising a sunscreen composition aremixed in, without limitation, water or oil. In an embodiment, asunscreen composition or sunscreen composition combined with a bodywash,shampoo, conditioner, gel, soap, hand sanitizer, cream, lotion, spray ormousse includes, without limitation, one or more surfactants. The use ofsurfactants in bodywashes is well-known in the art. Any surfactant knownin the art and appropriate for a bodywash, shampoo, conditioner, gel,soap, hand sanitizer, cream, lotion, spray or mousse may be used. See,McCutcheon's Detergents & Emulsifiers, M.C. Publishing Co. (NorthAmerican edition 1989); Schwartz, et al., Surface Active Agents, TheirChemistry and Technology, New York, Interscience Publishers, 1949, andU.S. Pat. Nos. 6,096,697; 4,741,855; 4,788,066; 5,104,646; 5,106,609;2,658,072; 2,438,091; 2,528,378; 2,486,921; 2,486,922; 2,396,278;2,979,465; 3,179,599; 5,322,643; 5,084,212; 3,332,880; 4,122,029;4,265,878; 4,421,769; 3,929,678; 3,959,461; 4,387,090; 4,303,543; and6,224,852; and in British Patent Nos. 848,224 and 791,415. Also see CTFACosmetic Ingredient Dictionary, 4th Edition 1991, pages 509 514 forvarious long chain alkyl cationic surfactants; and Richmond, James M.,Cationic Surfactants, Marcel Dekker, Inc., New York and Basel, 1990.

In an embodiment, surfactant(s) includes, without limitation, cationic,anionic, nonionic, zwitterionic, amphoteric, or any combination ofsurfactants thereof. In a further embodiment, surfactants include,without limitation, alkyl and alkyl ether sulfates, sulfatedmonoglycerides, sulfonated olefins, alkyl aryl sulfonates, primary orsecondary alkane sulfonates, alkyl sulfosuccinates, acyl taurates, acylisethionates, alkyl glycerylether sulfonate, sulfonated methyl esters,sulfonated fatty acids, alkyl phosphates, ethoxylated alkyl phosphates,acyl glutamates, acyl sarcosinates, alkyl sulfoacetates, acylatedpeptides, alkyl ether carboxylates, acyl lactylates, anionicfluorosurfactants, and combinations thereof. Combinations of anionicsurfactants can be used effectively in the present invention. In afurther embodiment, alkyl sulfates include, without limitation, sodium,ammonium, potassium, magnesium, or TEA salts of lauryl or myristylsulfate or ammonium, sodium, magnesium, or TEA laureth-3 sulfate.

In an embodiment, a sunscreen composition has a surfactant concentrationof about 0.01% to about 10% (w/v). In a further embodiment, a sunscreencomposition has a surfactant concentration of about 3% to about 5%. In afurther embodiment, a sunscreen composition has a surfactantconcentration of at least 0.01%, at least 0.02%, at least 0.03%, atleast 0.04%, at least 0.05%, at least 0.06%, at least 0.07%, at least0.08%, at least 0.09%, at least 0.1%, at least 0.25%, at least 0.5%, atleast 0.75%, at least 1%, at least 1.25%, at least 1.5%, at least 1.75%,at least 2%, at least 2.25%, at least 2.5%, at least 2.75%, at least 3%,at least 3.25%, at least 3.5%, at least 3.75%, at least 4%, at least4.25%, at least 4.5%, at least 4.75%, at least 5%, at least 5.25%, atleast 5.5%, at least 5.75%, at least 6%, at least 6.25%, at least 6.5%,at least 6.75%, at least 7%, at least 7.25%, at least 7.5%, at least7.75%, at least 8%, at least 8.25%, at least 8.5%, at least 8.75%, atleast 9%, at least 9.25%, at least 9.5%, at least 9.75%, at least 10%,at least 11%, at least 12%, at least 13%, at least 14%, at least 15%, atleast 16%, at least 17%, at least 18%, at least 19%, at least 20%, atleast 21%, at least 22%, at least 23%, at least 24%, at least 25% (w/v).

In an embodiment, a sunscreen composition with a surfactantconcentration of about 0.01% to about 5% or about 3% to about 5% andwherein the sunscreen active agent or agents are encapsulated within acellulose derived capsule when applied to the wet skin of an individualspreads across the surface to which the sunscreen composition is appliedwith the same degree of evenness and ease as a sunscreen compositionwith a higher concentration of surfactant. In a further embodiment, asunscreen composition with a surfactant concentration of about 0.01% toabout 5% or about 3% to about 5% lathers less than a sunscreencomposition with a higher surfactant concentration. In an embodiment, asunscreen composition with a surfactant concentration of about 0.01% toabout 5% or about 3% to about 5% also includes film formers, secondarypolymers and emulsifiers.

In an embodiment, a surfactant is an environmentally favourablesurfactant including, without limitation, dodecyl glucosides.

In an embodiment, a surfactant is a lathering surfactant. In a furtherembodiment, a lathering surfactant has a log P of less than about 2.5that produces foam when mixed with and agitated in water. In anadditional embodiment, an anionic lathering surfactant is a sulfate,wherein the sulfate is, without limitation, an alkyl sulfate or an alkylether sulfate. In a further embodiment, the sulfates include, withoutlimitation, sodium laureth sulfate and ammonium laureth sulfate. Sodiumlaureth sulfate is an article of commerce available from a number ofsources, including under the tradename Steal CS-370 from Stepan. It hasa molecular formula CH₃(CH₂)₁₀CH₂(0CH₂CH₂)₂0S0₃Na and conforms to thefollowing structure:

In an embodiment, a sunscreen composition or a bodywash, shampoo,conditioner, gel, soap, hand sanitizer, cream, lotion, spray or moussecombined with a sunscreen composition, includes, without limitation,sodium laureth sulfate at a concentration of from about 10% to about 15%or from about 7.5% to about 8.5%. In a further embodiment, ammoniumlaureth sulfate is used in combination with an alkyl glucoside, whereinthe alkyl glucoside includes, without limitation, decyl glucoside. Thecombination of ammonium laureth sulfate and decyl glucoside is soldunder the tradename Plantaren PS-100 by Cognis. In an embodiment,ammonium laureth sulfate in combination with decyl glucoside is presentin a sunscreen composition or a bodywash, shampoo, conditioner, gel,soap, hand sanitizer, cream, lotion, spray or mousse combined with asunscreen composition at a concentration of from about 5% to about 10%,or from about 7.5% to about 8.5%.

In a further embodiment, a lathering surfactant includes one, two, threeor more anionic lathering surfactants, including, without limitation,sulfates, including, without limitation, sodium laureth sulfate andammonium laureth sulfate. In an embodiment, sodium laureth sulfate andammonium laureth sulfate are combined with decyl glucoside. In anadditional embodiment, the two sulfates are present at a combinedconcentration of from about 15% to about 25%.

In a further embodiment, anionic surfactants, include, withoutlimitation, sulfated monoglycerides of the formR1CO—O—CH₂—C(OH)H—CH₂—O—SO₃M, wherein R1 is a saturated or unsaturated,branched or unbranched alkyl group from about 8 to about 24 carbonatoms, and M is a water-soluble cation such as ammonium, sodium,potassium, magnesium, triethanolamine, diethanolamine, monoethanolamineand sodium cocomonoglyceride sulfate. In a further embodiment, anionicsurfactants include, without limitation, olefin sulfonates of the formR1SO₃M, wherein R1 is a mono-olefin having from about 12 to about 24carbon atoms, and M is a water-soluble cation such as ammonium, sodium,potassium, magnesium, triethanolamine, diethanolamine andmonoethanolamine. In an embodiment, a sulfonated olefin is sodiumC14/C16 alpha olefin sulfonate. In a further embodiment, anionicsurfactants, include, without limitation, linear alkylbenzene sulfonatesof the form R₁—C₆H₄—SO₃M, wherein R1 is a saturated or unsaturated,branched or unbranched alkyl group from about 8 to about 24 carbonatoms, and M is a water-soluble cation such as ammonium, sodium,potassium, magnesium, triethanolamine, diethanolamine monoethanolamineand sodium dodecylbenzene sulfonate. In an additional embodiment,anionic surfactants include, without limitation, primary or secondaryalkane sulfonates of the form R1 SO₃M, wherein R1 is a saturated orunsaturated, branched or unbranched alkyl chain from about 8 to about 24carbon atoms, and M is a water-soluble cation such as ammonium, sodium,potassium, magnesium, triethanolamine, diethanolamine andmonoethanolamine. In a further embodiment, alkane sulfonate include,without limitation, alkali metal or ammonium C 13 C 17 paraffinsulfonates. In an additional embodiment, anionic surfactants include,without limitation, alkyl sulfosuccinates, which include disodiumN-octadecylsulfosuccinamate; diammonium lauryl sulfosuccinate;tetrasodium N-(1,2-dicarboxyethyl)-N-octadecylsulfosuccinate; diamylester of sodium sulfosuccinic acid; dihexyl ester of sodiumsulfosuccinic acid; and dioctyl esters of sodium sulfosuccinic acid.

In an embodiment, taurates include, without limitation, taurine,N-alkyltaurines such as the one prepared by reacting dodecylamine withsodium isethionate as detailed in U.S. Pat. No. 2,658,072. In a furtherembodiment, anionic surfactants include, without limitation, acylisethionates, including, without limitation, acyl isethionates includeammonium cocoyl isethionate, sodium cocoyl isethionate, sodium lauroylisethionate, alkylglyceryl ether sulfonates of the formR1-OCH₂—C(OH)H—CH₂—SO₃M, wherein R1 is a saturated or unsaturated,branched or unbranched alkyl group from about 8 to about 24 carbonatoms, and M is a water-soluble cation such as ammonium, sodium,potassium, magnesium, triethanolamine, diethanolamine andmonoethanolamine, sodium cocoglyceryl ether sulfonate, Sulfonated fattyacids of the form R1-CH(SO₄)—COOH and sulfonated methyl esters of thefrom R1-CH(SO₄)—CO—O—CH₃, where R1 is a saturated or unsaturated,branched or unbranched alkyl group from about 8 to about 24 carbon atoms(e.g., alpha sulphonated coconut fatty acid and lauryl methyl ester);phosphates such as monoalkyl, dialkyl, and trialkylphosphate saltsformed by the reaction of phosphorous pentoxide with monohydric branchedor unbranched alcohols having from about 8 to about 24 carbon atoms(e.g., sodium mono or dilaurylphosphate, ethoxylated monoalkylphosphates, etc.); acyl glutamates corresponding to the formulaR1CO—N(COOH)—CH₂CH₂—CO₂M wherein R1 is a saturated or unsaturated,branched or unbranched alkyl or alkenyl group of about 8 to about 24carbon atoms, and M is a water-soluble cation (e.g., sodium lauroylglutamate and sodium cocoyl glutamate); alkanoyl sarcosinatescorresponding to the formula R1CON(CH₃)—CH₂CH₂—CO₂M wherein R1 is asaturated or unsaturated, branched or unbranched alkyl or alkenyl groupof about 10 to about 20 carbon atoms, and M is a water-soluble cation(e.g., sodium lauroyl sarcosinate, lauroyl sarcosine, sodium cocoylsarcosinate, and ammonium lauroyl sarcosinate); alkyl ether carboxylatescorresponding to the formula R1-(OCH₂CH₂)x-OCH₂—CO₂M wherein R1 is asaturated or unsaturated, branched or unbranched alkyl or alkenyl groupof about 8 to about 24 carbon atoms, x is 1 to 10, and M is awater-soluble cation (e.g., sodium laureth carboxylate); acyl lactylatescorresponding to the formula R1CO—[O—CH(CH₃)—CO]x-CO₂M wherein R1 is asaturated or unsaturated, branched or unbranched alkyl or alkenyl groupof about 8 to about 24 carbon atoms, x is 3, and M is a water-solublecation (e.g., sodium cocoyl lactylate); carboxylates, nonlimitingexamples of which include sodium lauroyl carboxylate, sodium cocoylcarboxylate, and ammonium lauroyl carboxylate; anionicflourosurfactants; and natural soaps derived from the saponification ofvegetable and/or animal fats & oils examples of which include sodiumlaurate, sodium myristate, palmitate, stearate and tallowate, cocoate.In a further embodiment, a soap is a semi-solid. In another embodiment,a soap includes a wax to form a solid soap bar.

In an embodiment a counter cation, M, is used on the anionic surfactant.In a further embodiment, a counter cation includes, without limitation,sodium, potassium, ammonium, monoethanolamine, diethanolamine, andtriethanolamine.

In an embodiment, nonionic surfactants include, without limitation,alkyl glucosides, alkyl polyglucosides, polyhydroxy fatty acid amides,alkoxylated fatty acid esters, sucrose esters, amine oxides, andmixtures thereof. Alkyl glucosides and alkyl polyglucosides arecondensation products of long chain alcohols, including, withoutlimitation, C8 30 alcohols, with sugars or starches or sugar or starchpolymers, including, without limitation, glycosides or polyglycosidesand are represented by the formula (S)_(n)—O—R wherein S is a sugarmoiety such as glucose, fructose, mannose, and galactose; n is aninteger of from about 1 to about 1000, and R is a C8 30 alkyl group. Inan embodiment, long chain alcohols from which the alkyl group can bederived include, without limitation, decyl alcohol, cetyl alcohol,stearyl alcohol, lauryl alcohol, myristyl alcohol, oleyl alcohol, andmore. In a further embodiment, these surfactants include, withoutlimitation, those wherein S is a glucose moiety, R is a C8 20 alkylgroup, and n is an integer of from about 1 to about 9. Commerciallyavailable examples of these surfactants include decyl polyglucoside(available as APG 325 CS from Henkel) and lauryl polyglucoside(available as APG 600CS and 625 CS from Henkel). In an additionalembodiment, sucrose ester surfactants include, without limitation,sucrose cocoate and sucrose laurate.

In another embodiment, nonionic surfactants include, without limitation,polyhydroxy fatty acid amide surfactants, more specific examples ofwhich include glucosamides. In an embdodiment a process for makingcompositions containing polyhydroxy fatty acid amides are disclosed, forexample, in G.B. Pat. Specification 809,060, published Feb. 18, 1959, byThomas Hedley & Co., Ltd.; U.S. Pat. No. 2,965,576, to E. R. Wilson,issued Dec. 20, 1960; U.S. Pat. No. 2,703,798, to A. M. Schwartz, issuedMar. 8, 1955; and U.S. Pat. No. 1,985,424, to Piggott, issued Dec. 25,1934. In an embodiment, nonionic surfactants include, withoutlimitation, amine oxides, including, without limitation, thosecorresponding to the general formula R₁R₂, R₃NO, wherein R₁ contains analkyl, alkenyl or monohydroxy alkyl radical of from about 8 to about 18carbon atoms, from 0 to about 10 ethylene oxide moieties, and from 0 toabout 1 glyceryl moiety, and R₂ and R₃ contain from about 1 to about 3carbon atoms and from 0 to about 1 hydroxy group, e.g., methyl, ethyl,propyl, hydroxyethyl, or hydroxypropyl radicals. The arrow in theformula is a conventional representation of a semipolar bond. In anembodiment, amine oxides include, without limitation,dimethyl-dodecylamine oxide, oleyldi(2-hydroxyethyl) amine oxide,dimethyloctylamine oxide, dimethyl-decylamine oxide,dimethyl-tetradecylamine oxide, 3,6,9-trioxaheptadecyldiethylamineoxide, di(2-hydroxyethyl)-tetradecylamine oxide,2-dodecoxyethyldimethylamine oxide,3-dodecoxy-2-hydroxypropyldi(3-hydroxypropyl)amine oxide,dimethylhexadecylamine oxide.

The term “amphoteric surfactant,” as used herein, is also intended toencompass zwitterionic surfactants, which are well known to formulatorsskilled in the art as a subset of amphoteric surfactants.

In an embodiment, amphoteric lathering surfactants include, withoutlimitation, derivatives of aliphatic secondary and tertiary amines,including, without limitation, those wherein the nitrogen is in acationic state, in which the aliphatic radicals can be straight orbranched chain and wherein one of the radicals contains an ionizablewater solubilizing group, e.g., carboxy, sulfonate, sulfate, phosphate,or phosphonate. In an embodiment, amphoteric or zwitterionic surfactantsinclude, without limitation, betaines, sultaines, hydroxysultaines,alkyliminoacetates, iminodialkanoates, aminoalkanoates, and mixturesthereof. In an embodiment, betaines include, without limitation, thehigher alkyl betaines, such as coco dimethyl carboxymethyl betaine,lauryl dimethyl carboxymethyl betaine, lauryl dimethyl alphacarboxyethylbetaine, cetyl dimethyl carboxymethyl betaine, cetyl dimethyl betaine(available as Lonzaine 16SP from Lonza Corp.), laurylbis-(2-hydroxyethyl) carboxymethyl betaine, oleyl dimethylgamma-carboxypropyl betaine, laurylbis-(2-hydroxypropyl)alpha-carboxyethyl betaine, coco dimethylsulfopropyl betaine, lauryl dimethyl sulfoethyl betaine, laurylbis-(2-hydroxyethyl) sulfopropyl betaine, amidobetaines andamidosulfobetaines (wherein the RCONH(CH₂)₃ radical is attached to thenitrogen atom of the betaine), oleyl betaine (available as amphotericVelvetex OLB-50 from Henkel), and cocamidopropyl betaine (available asVelvetex BK-35 and BA-35 from Henkel). In a further embodiment,sultaines and hydroxysultaines include, without limitation, materialssuch as cocamidopropyl hydroxysultaine (available as Mirataine CBS fromRhone-Poulenc).

In an embodiment, amphoteric surfactants include, without limitation,the following compounds: Cetyl dimethyl betaine (this material also hasthe CTFA designation cetyl betaine); Cocamidopropylbetaine;Cocamidopropyl hydroxy sultaine. Examples of other useful amphotericsurfactants are alkyliminoacetates, and iminodialkanoates andaminoalkanoates of the formulas RN[(CH₂)—CO₂—M]₂ and RNH(CH₂)_(m)CO₂ Mwherein m is from 1 to 4, R is a C₈-C₂₂ alkyl or alkenyl, and M is H,alkali metal, alkaline earth metal ammonium, alkanolammonium orimidazolinium and ammonium derivatives. In a further embodiment,amphoteric surfactants include, without limitation, sodium3-dodecyl-aminopropionate, sodium 3-dodecylaminopropane sulfonate. In afurther embodiment, N-higher alkyl aspartic acids include, withoutlimitation, those produced according to the teaching of U.S. Pat. No.2,438,091; and the products sold under the trade name “Miranol” anddescribed in U.S. Pat. No. 2,528,378. In a further embodiment,amphoterics include, without limitation, amphoteric phosphates, such ascoamidopropyl PG-dimonium chloride phosphate (commercially available asMonaquat PTC, from Mona Corp.). In another embodiment, amphoacetatesinclude, without limitation, disodium lauroamphodiacetate, sodiumlauroamphoacetate, and mixtures thereof.

In an embodiment, a sunscreen composition or a sunscreen compositioncombined with a bodywash, shampoo, conditioner, gel, soap, handsanitizer, cream, lotion, spray or mousse include, without limitation,at least one cationic surfactant. In an embodiment, cationic surfactantsinclude, without limitation, fatty amines, di-fatty quaternary amines,tri-fatty quaternary amines, imidazolinium quaternary amines, andcombinations thereof. In a further embodiment, fatty amines include,without limitation, monalkyl quaternary amines such ascetyltrimethylammonium bromide. In an embodiment, quaternary amineinclude, without limitation, dialklamidoethyl hydroxyethylmoniummethosulfate, In an embodiment, a sunscreen composition or a sunscreencomposition combined with a bodywash, shampoo, conditioner, gel, soap,hand sanitizer, cream, lotion, spray or mousse include, withoutlimitation, stearyldimenthylbenzyl ammonium chloride;dodecyltrimethylammonium chloride; nonylbenzylethyldimethyl ammoniumnitrate; tetradecylpyridinium bromide; laurylpyridinium chloride;cetylpyridinium chloride; laurylpyridinium chloride; laurylisoquinoliumbromide; ditallow(Hydrogenated)dimethyl ammonium chloride;dilauryldimethyl ammonium chloride; and stearalkonium chloride.Additional cationic surfactants are disclosed in U.S. Pat. No. 4,303,543see column 4, lines 58 and column 5, lines 1 42, incorporated herein byreferences. Also see CTFA Cosmetic Ingredient Dictionary, 4th Edition1991, pages 509 514 for various long chain alkyl cationic surfactants;incorporated herein by reference.

In an embodiment, the total amount of surfactants, including, withoutlimitation, a cationic surfactant, is present in a sunscreen compositionor a sunscreen composition combined with a bodywash, shampoo,conditioner, gel, soap, hand sanitizer, cream, lotion, spray or mousseat about 0.1 to about 20%, or about 0.1 to about 10%, or about 0.1 toabout 5%, or about 0.5 to about 5%, or about 1 to about 10%, or about 1to about 5%, or about 0.1 to about 2%, or about 1 to about 2% or about0.01% w/v or about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%,1% or 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%,16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%,30%, 35%, 40%, 45%, 50%, 55%, 60%, 65% or more w/v. In addition tosurfactants, other ingredients, as described above for additives, may beincluded in a sunscreen composition combined with a bodywash, shampoo,conditioner, gel, soap, hand sanitizer, cream, lotion, spray or mousse.In an embodiment, soapless cleansers are used in addition to, or insteadof, soaps/surfactants, including, without limitation OILATUM™ AD(registered trademark, Stiefel Laboratories) AQUANIL™ (registeredtrademark, Person & Covey, Inc.), CETAPHIL™ (trademark, GaldermaLaboratories, Inc.) or SPECTRODERM™ (registered trademark, DraxisPharmaceutical Inc.), or their equivalents, may be utilized as asoapless component in the present invention.

In an embodiment, a bodywash is, without limitation, SUAVE Body Wash,which has the following ingredients: Water, Ammonium Lauryl Sulfate,Ammonium Laureth Sulfate, Cocamidopropyl Betaine, Fragrance, Glycerin,Hydrolyzed Milk Protein & Honey Extract, PEG-10 Sunflower Glycerides,Cocamide MEA, Guar Hydroxypropylrimonium Chloride, Acrylates Copolymer,PEG-5 Cocamide, Helianthus Annuus (Sunflower) Seed Oil or Glycine Soja(Soybean) Oil, Tetrasoidum EDTA, Propylene Glycol, Ammonium Chloride,Sodium Hydroxide, Methylchloroisothiazolinone, Methylisothiazolinone,Titanium Dioxide (CI 77891).

The additional agents and sunscreen active agent in a sunscreencomposition are selected for use in a combination product that includesa bodywash, shampoo, conditioner, gel, soap, hand sanitizer, cream,lotion, spray or mousse (a “combination product”), with a combinationproduct applied to the surface of an individual, including anindividual's skin and hair. In an embodiment, application can occurduring washing in a suitable or effective amount, with application overpart or the whole body. A shampoo or conditioner, gel, soap, handsanitizer, cream, may be applied to hair, though in an embodiment, theshampoo combination product may be rinsed over part or the whole body,with a sunscreen composition adhering to the skin and hair. A selectedamount of a combination product may be applied directly to the skin, forinstance, without limitation, a lotion, spray or bodywash or may be usedthrough intermediate application to a washcloth, pad, sponge, or otherapplicator. After lathering, dirt and sloughed-off skin may be washedaway by rinsing with water leaving behind one or more of the sunscreenactive agents, and in an embodiment, without limitation, a sunscreenactive agent encapsulated in a cellulose derived capsule.

In an embodiment, methods for protection of skin from sunlight include,applying a combination product containing a sunscreen active agent,including, without limitation, a sunscreen active agent encapsulated ina cellulose derived capsule, wherein after application of thecombination product to an individual's outer surface, including, withoutlimitation, an individual's skin, the skin is protected from sunlightwith an average SPF of at least about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,12, 1.3, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29,30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47,48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65,66, 67, 68, 69, 70, 71, 72, 73, 74, 75 or more. In a further embodiment,the skin is protected from sunlight with an average SPF of at leastabout 2. In a further embodiment, the skin is protected from sunlightwith an average SPF of at least about 5. In a further embodiment, theskin is protected from sunlight with an average SPF of at least about10. In a further embodiment, the skin is protected from sunlight with anaverage SPF of at least about 15. In a further embodiment, thecombination product is applied more than once; in these cases, the SPFmay be cumulative and can increase with the second wash to, e.g., anaverage of more than 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 1.3, 14, 15,16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33,34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51,52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69,70, 71, 72, 73, 74, 75 or more. In a further embodiment, the individualrinses off after application of a combination product, with the SPFfollowing rinsing at least about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12,1.3, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30,31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48,49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66,67, 68, 69, 70, 71, 72, 73, 74, 75 or more. In an additional embodiment,a combination product is applied once per day. In a further embodiment,a combination product is applied more than once per day, for example, 2,3, 4, or more than 4 times per day. In an additional embodiment, acombination product is applied about every other day. In a furtherembodiment, the combination product is applied about 10, 8, 7, 6, 5, 4,3, 2 or 1 time per week.

In an embodiment, a sunscreen active agent, including, withoutlimitation, a sunscreen active agent encapsulated in a cellulose derivedcapsule does not penetrate more than about 1, 2, 5, 7, 10, 15, 20, 25,30, 35, 40, 45, or 50 microns into the skin of an individual followingone application of a combination product. In an additional embodiment, asunscreen active agent, including, without limitation, a sunscreenactive agent encapsulated in a cellulose derived capsule, does notpenetrate more than about 1, 2, 5, 7, 10, 15, 20, 25, 30, 35, 40, 45,50, 60, 70, 80, 90, 100, 120, or 150 microns into the skin, even afterrepeated applications.

In a further embodiment a sunscreen active agent, including, withoutlimitation, a sunscreen active agent encapsulated in a cellulose derivedcapsule is designed to penetrate into the skin, and can penetrate to atleast about 1, 2, 5, 7, 10, 15, 20, 25, 30, 35, 40, 45, or 50 micronsinto the skin after one application with a combination product. In afurther embodiment, a sunscreen active agent, including, withoutlimitation, a sunscreen active agent encapsulated in a cellulose derivedcapsule, penetrates more than about 1, 2, 5, 7, 10, 15, 20, 25, 30, 35,40, 45, 50, 60, 70, 80, 90, 100, 120, or 150 microns into the skin. In afurther embodiment penetration occurs following a single application. Ina further embodiment, penetration occurs following a single applicationand rinsing. In a further embodiment, penetration occurs with repeatedapplications. In a further embodiment, penetration occurs with repeatedapplications and rinsings.

Any additive described herein, including, without limitation, sunscreenactive agents and/or additional agents, generally as a component of abodywash, shampoo, conditioner, gel, soap, hand sanitizer, cream,lotion, spray or mousse, may be used in the methods of the invention. Inan embodiment, the sunscreen active agents and/or additional agents isencapsulated in a cellulose derived capsule. It is understood that acombination product can be applied to an individual's surface,including, without limitation, an individual's skin and/or hair whilethe skin and/or hair is wet or while it is dry. In an embodiment, thecombination product contains one, two or more surface-treated metaloxide pigments that block ultraviolet radiation in the wavelength rangeof from about 290 nm to about 400 nm. In an additional embodiment, theone, two or more surface-treated metal oxide pigments are present at acombined concentration (based on the total weight of the compo-sition)of at least about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%,1%, 1.25%, 1.5%, 1.75%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%, 5.5%, 6%,6.5%, 7%, 7.5%, 8%, 8.5%, 9%, 9.5%, 10%, 11%, 12%, 13%, 14%, 15%, 16%,17%, 18%, 19%, 20%, 25%, 30%, 35%, 40%, 45%, 50%.

In an embodiment, a sunscreen composition has an inner refractive indexof 1.5-1.7, 1.5-1.9, 1.5-2.2, 1.5-2.4 or 1.5-2.6. In a furtherembodiment, a sunscreen composition has a non-sunscreen active agentwith an inner refractive index of 1.5-2.7. In a further embodiment, asunscreen composition has a non organic dispersed with organic sunscreenactive agent with an inner refractive index of 1.5-2.7. In a furtherembodiment, a sunscreen composition has cellulose derived capsules ofdifferent sizes with an inner refractive index of 1.5-2.7. In a furtherembodiment, a sunscreen composition has a mixture of cellulose derivedcapsules containing different cellulose derivatives with an innerrefractive index of 1.5-2.7. In an embodiment, a sunscreen compositionhas an overall refractive index of 1.4 -2.

Aspects of the present specification may also be described as follows:

-   1. A sunscreen composition comprising a sunscreen active agent    encapsulated in a cellulose derived capsule and one or more    additional agents.-   2. A sunscreen composition of embodiment 1, wherein a sunscreen    composition is combined with a bodywash, shampoo, conditioner, gel,    soap, hand sanitizer, cream, spray, mousse or lotion.-   3. A sunscreen composition of embodiment 1 or 2, wherein a sunscreen    active agent absorbs or blocks UV radiation from about 290 to about    420 nm.-   4. A sunscreen composition of any one of embodiments 1-3, wherein a    sunscreen active agent is selected from paraamino benzoates,    salicylates, cinnamates, benzophenones; and miscellaneous chemicals    including menthyl anthralinate and digalloyl trioleate.-   5. A sunscreen composition of any one of embodiments 1-3, wherein a    sunscreen active agent is selected from p-aminobenzoic acid, its    salts and its derivatives (ethyl, isobutyl, glyceryl esters;    p-dimethylaminobenzoic acid); Anthranilates (i.e., o-aminobenzoates;    methyl, menthyl, phenyl, benzyl, phenylethyl, linalyl, terpinyl, and    cyclohexenyl esters); Salicylates (amyl, phenyl, benzyl, menthyl,    glyceryl, and dipropylene glycol esters); Cinnamic acid derivatives    (methyl and benzyl esters, alpha-phenyl cinnamonitrile; butyl    cinnamoyl pyruvate); Dihydroxycinnamic acid derivatives    (umbelliferone, methylumbelliferone, methylaceto-umbelliferone);    Trihydroxycinnamic acid derivatives (esculetin, methylesculetin,    daphnetin, and the glucosides, esculin and daphnin); Hydrocarbons    (diphenylbutadiene, stilbene); Dibenzalacetone and    benzalacetophenone; Naphtholsulfonates (sodium salts of    2-naphthol-3,3-disulfonic and of 2-naphthol-6,8-disulfonic acids);    Dihydroxynaphthoic acid and its salts; o- and    p-Hydroxybiphenyldisulfonates; Coumarin derivatives (7-hydroxy,    7-methyl, 3-phenlyll); Diazoles (2-acetyl-3-bromoindazole, phenyl    benzoxazole, methyl naphthoxalole, various aryl benzothiazoles);    Quinine salts (bisulfate, sulfate, chloride, oleate, and tannate);    quinoline derivatives (8-hydroxyquinoline salts, 2-phenylquinoline);    Hydroxy- or methoxy substituted benzophenones; Uric and vilouric    acids; Tannnic acid and its derivatives (e.g., hexaethylether);    (Butyl carbityl) (6-propyl piperonyl) ether; Hydroquinone;    Benzophenones (Oxybenzene, Sulisobenzone, Dioxybenzone,    Benzoresorcinol, 2,2′,4,4′-Tetrahydroxybenzophenone,    2,2′-Dihydroxy4,4′-dimethoxybenzophenone, Octabenzone;    4-Isopropyhldibenzoylmethane; Butylmethoxydibenzoylmethane;    Etocrylene; and 4-isopropyl-di-benzoylmethane; titanium dioxide,    iron oxide, zinc oxide, and mixtures thereof. Other    cosmetically-acceptable sunscreens and concentrations (percent by    weight of the total cosmetic sunscreen composition) include    diethanolamine methoxycinnamate (10% or less),    ethyl-[bis(hydroxypropyl)]aminobenzoate (5% or less), glyceryl    aminobenzoate (3% or less), 4-isopropyl dibenzoylmethane (5% or    less), 4-methylbenzylidene camphor (6% or less), terephthalylidene    dicamphor sulfonic acid (10% or less), and sulisobenzone (also    called benzophenone-4, 10% or less).-   6. A sunscreen composition of any one of embodiments 1-3, wherein a    sunscreen active agent is a zinc oxide.-   7. A sunscreen composition of embodiment 6, wherein a zinc oxide    particle is in the range of about 2 to about 50 microns.-   8. A sunscreen composition of embodiment 6, wherein a zinc oxide    particle is in the range of at least about 2, 3, 4, 5, 6, 7, 8, 9,    10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26,    27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43,    44, 45, 46, 47, 48, 49, 50 or more microns.-   9. A sunscreen composition of any one of embodiments 6-8, wherein a    zinc oxide is surface coated to facilitate dispersion.-   10. A sunscreen composition of any one of embodiments 1-3, wherein a    sunscreen active agent included in a sunscreen composition in the    United States is selected from aminobenzoic acid (also called    para-aminobenzoic acid and PABA; 15% or less; a UVB absorbing    organic sunscreen), avobenzone (also called butyl methoxy    dibenzoylmethane; 3% or less, a UVA I absorbing organic sunscreen),    cinoxate (also called 2-ethoxyethyl p-methoxycinnamate; 3% or less,    a UVB absorbing organic sunscreen), decamsule, dioxybenzone (also    called benzophenone-8; 3% or less, a UVB and UVA II absorbing    organic sunscreen), homosalate (15% or less, a UVB absorbing organic    sunscreen), menthyl anthranilate (also called menthyl    2-aminobenzoate; 5% or less, a UVA II absorbing organic sunscreen),    octocrylene (also called 2-ethylhexyl-2-cyano-3,3 diphenylacrylate;    10% or less, a UVB absorbing organic sunscreen), octyl    methoxycinnamate (7.5% or less, a UVB absorbing organic sunscreen),    octyl salicylate (also called 2-ethylhexyl salicylate; 5% or less, a    UVB absorbing organic sunscreen), oxybenzone (also called    benzophenone-3; 6% or less, a UVB and UVA II absorbing organic    sunscreen), padimate 0 (also called octyl dimethyl PABA; 8% or less,    a UVB absorbing organic sunscreen), phenylbenzimidazole sulfonic    acid (water soluble; 4% or less, a UVB absorbing organic sunscreen),    sulisobenzone (also called benzophenone-4; 10% or less, a UVB and    UVA II absorbing organic sunscreen), titanium dioxide (25% or less,    an inorganic physical blocker of UVA and UVB), trolamine salicylate    (also called triethanolamine salicylate; 12% or less, a UVB    absorbing organic sunscreen), and zinc oxide (25% or less, an    inorganic physical blocker of UVA and UVB).-   11. A sunscreen composition of any one of embodiments 1-3, wherein a    sunscreen active agent included in a sunscreen composition in Euorpe    is selected from Cellulosic derived capsules in the 400-700 nm range    containing active sunscreen agents PABA (5% or less), camphor    benzalkonium methosulfate (6% or less), homosalate (10% or less),    benzophenone-3 (10% or less), phenylbenzimidazole sulfonic acid (8%    or less, expressed as acid), terephthalidene dicamphor sulfonic acid    (10% or less, expressed as acid), butyl methoxydibenzoylmethane (5%    or less), Mexoryl XL,Neo heliopan AP, Benzophenone-9, Uvinul T 150,    Uvinul A Plus, Uvasorb HEB, Parsol SLX, benzylidene camphor sulfonic    acid (6% or less, expressed as acid), octocrylene (10% or less,    expressed as acid), polyacrylamidomethyl benzylidene camphor (6% or    less), octyl methoxycinnamate (10% or less), PEG-25 PABA (10% or    less), isoamyl p-methoxycinnamate (10% or less), ethylhexyl triazone    (5% or less), drometrizole trielloxane (15% or less), diethylhexyl    butamido triazone (10% or less), 4-methylbenzylidene camphor (4% or    less), 3-benzylidene camphor (2% or less), ethylhexyl salicylate (5%    or less), ethylhexyl dimethyl PABA (8% or less), benzophenone-4 (5%,    expressed as acid), methylene bis-benztriazolyl    tetramethylbutylphenol (10% or less), disodium phenyl    dibenzimidazole tetrasulfonate (10% or less, expressed as acid),    bis-ethylhexyloxyphenol methoxyphenol triazine (10% or less),    methylene bisbenzotriazolyl tetramethylbutylphenol (10% or less,    also called TINOSORB M), and bisethylhexyloxyphenol methoxyphenyl    triazine. (10% or less, also called TINOSORB S).-   12. A sunscreen composition of any one of embodiments 1-3, wherein a    sunscreen active agent is selected from silicone long-chain molecule    with chromophores, e.g., PARASOL SLX (DSM Nutritional Products),    which contains benzyl malonate chromophores attached to specific    points on a polysiloxane chain. In an additional embodiment, a    sunscreen active agent comprises a silicone long-chain molecule with    chromophores. In an embodiment, sunscreen compositions include,    without limitation, octyl methoxycinnamate, octocrylene, avobenzone,    titanium dioxide, and a silicone long-chain molecule with    chromophores.-   13. A sunscreen composition of embodiment 12, wherein a silicon    long-chain molecule is included at a concentration of about 0.5 to    about 5%.-   14. A sunscreen composition of embodiment 12, wherein a silicon    long-chain molecule is included in a combination product at a    concentration of about 0.2 to about 2% (w/v).-   15. A sunscreen composition of of any one of embodiments 1-15,    wherein, a sunscreen active agent is an inorganic physical blocker    of UVA solar radiation.-   16. A sunscreen composition of any one of embodiments 1-15, wherein    a sunscreen active agent is an inorganic physical blocker of UVB    solar radiation.-   17. A sunscreen composition of any one of embodiments 1-3, wherein a    sunscreen active agent is an iron oxide or a polymer.-   18. A sunscreen composition of embodiment 17, wherein a polymer is a    polyethylene or a polyamide.-   19. A sunscreen composition of any one of embodiments 1-3, wherein a    sunscreen active agent is selected from cinnamate (e.g.,    Octylmethoxycinnamate (ethyl hexyl methoxycinnamate), (available    under the tradename PARSOL MCX), oxybenzone (e.g., benzophenone-3    (2-Hydroxy4-Methoxybenzophenone), avobenzone    (4-tert-Butyl-4′-methoxydibenzoylmethane or PARSOL 1789), octyl    salicylate (2-Ethylhexyl Salicylate), octocrylene (2-Ethylhexyl    2-Cyano-3,3-Diphenylacrylate), methyl anthranilate, and/or titanium    dioxide, Tineubin or combinations thereof.-   20. A sunscreen composition of any one of embodiments 1-3, wherein a    sunscreen active agent is a p-methoxycinnamic acid ester.-   21. A sunscreen composition of embodiment 20, wherein a sunscreen    active agent is selected from amyl p-methoxycinnamate, 2-ethylhexyl    p-methoxycinnamate, 2-ethoxyethyl p-methoxycinnamate, diethanolamine    p-methoxycinnamate, n-octyl p-methoxycinnamate and propyl    p-methoxycinnamate.-   22. A sunscreen composition of any one of embodiments 1-21, wherein    the composition comprises one, two, three, four or more sunscreen    active agents.-   23. A sunscreen composition of any one of embodiments 1-3, wherein a    second sunscreen active agent is selected from p-aminobenzoic acid,    Cinoxate, Avobenzone, digalloyl trioleate, dioxybenzone, ethyl    4-[bis(hydroxypropyl)]aminobenzoate, glyceryl aminobenzoate,    homosalate, lawsone with dihydroxyacetone, menthyl anthranilate,    octocrylene ethyl 2-cyano-3,3-diphenyl acrylate, octyl salicylate,    oxybenzone, Padimate 0, phenylbenzimidazole sulfonic acid, red    petrolatum, sulisobenzone, titanium dioxide, zinc oxide, including    regular grades and grades of such fine particle size as enable the    composition to be translucent or transparent, and triethanolamine    salicylate. Additional sunscreen compounds recognized by European    authorities include N,N,N-trimethyl-4-(2-oxoborn-3-ylidene    methyl)anilinium methyl sulfate, 3-imidazol-4-ylacrylic acid and its    ethyl ester, 2-phenylbenzimidazole-5-sulfonic acid and its salts,    ethoxylated 4-aminobenzoic acid, amyl 4-dimethylaminobenzoate,    3,3,5-trimethylcyclohexyl-2-acetamidobenzoate, potassium cinnamate,    4-methoxycinnamic acid salts, propyl 4-methoxycinnamate, salicylic    acid salts, amyl 4-methoxycinnamate, mexenone, sulisobenzone,    2-ethylhexyl 2-(4-phenylbenzoyl)-benzoate,    5-methyl-2-phenylbenzoxazole, sodium 3,4-dimethoxyphenylglyoxylate,    1,3-bis(4-methoxphenyl)propane-1,3-dione,    5-(3,3-dimethyl-2-norbornylidene)-3-penten-2-one,    alpha-(2-oxoborn-3-ylidene)-p-xylene-2-sulfonic acid,    alpha-(2-oxoborn-3-ylidene)toluene-4-sulfonic acid and its salts,    3-(4-methylbenzylidene)bornan-2-one, 3-benzylidenebornan-2-one,    alpha-cyano-4-methoxycinnamic acid and its hexyl ester,    1-p-cumenyl-3-phenylpropane-1,-3-dione, 4-isopropylbenzyl    salicylate, cyclohexyl 4-methoxycinnamate, and    1-(4-t-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-dione.-   24. A sunscreen composition of any one of embodiments 1-3, wherein a    sunscreen active agent is octyl methoxycinnamate at a concentration    of about 4.5% to about 15% (w/v).-   25. A sunscreen composition of any one of embodiments 1-3, wherein a    sunscreen active agent is Octocrylene at a concentration of about    0.5% to about 15% (w/v).

26. A sunscreen composition of any one of embodiments 1-3, wherein asunscreen active agent is Avobenzone (e.g., PARSOL 1789) at aconcentration of about 2% to about 4% (w/v),

-   27. A sunscreen composition of any one of embodiments 1-3, wherein a    sunscreen active agent is titanium dioxide at a concentration of    about 3% to about 9% (w/v).-   28. A sunscreen composition of any one of embodiments 1-3, wherein    the composition contains an active agent at about 0.1 to 7.5 weight    percent of octylmethoxy cinnamate, and/or about 0.1 to 6 parts    weight percent of octyl salicylate, and/or about 0.1 to 5 parts    weight percent of oxybenzone, and/or about 1 to 10 weight percent of    cationic surfactant, andor about 0.01 to 1 weight percent of a    quaternized compound.-   29. A sunscreen composition of any one of embodiments 1-28, wherein    the composition contains a firm former.-   30. A sunscreen composition of any one of embodiments 1-30, wherein    the composition contains a preservative.-   31. A sunscreen composition of embodiment 30, wherein the    preservative is at a concentration of about 0.01% to about 1% (w/v).-   32. A sunscreen composition of any one of embodiments 1-32, wherein    the SPF protection provided by a sunscreen active agent in the    composition is from about 1 to 70.-   33. A sunscreen composition of any one of embodiments 1-32, wherein    the SPF protection provided by a sunscreen active agent in the    composition is from about 1 to about 50, or about 2 to about 50, or    about 2 to about 40, or about 2 to about 30, or about 2 to about 20,    or about 2 to about 10, or about 2 to about 5, or about 5 to about    25, or about 5 to about 20, or about 5 to about 15, or about 5 to    about 10.-   34. A sunscreen composition of any one of embodiments 1-32, wherein    the SPF protection provided by a sunscreen composition in the    composition is at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,    14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30,    31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47,    48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64,    65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81,    82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98,    99, 100 or more.-   35. A sunscreen composition of any one of embodiments 1-32, wherein    the SPF protection provided by a sunscreen composition in the    composition remains above about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,    12, 13, 14, 15, 16, 17, 18, 19, or 20, 21, 22, 23, 24, 25, 26, 27,    28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44,    45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61,    62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78,    79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95,    96, 97, 98, 99, 100 or more-   36. A sunscreen composition of any one of embodiments 1-32, wherein    the SPF protection provided by the composition lasts at least about    0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10,11, 12, 13, 14, 15, 16, 17, 18,    19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75,    80, 85, 90, 95, 100 hours or more.-   37. A sunscreen composition of any one of embodiments 1-36, wherein    the SPF protection provided by the composition lasts for an average    of at least about about 1 day, 2 days, 3 days, 4 days, 5 days, 6    days, 7 days, 8 days, 9 days, 10 days, 11 days, 12 days, 13 days, 14    days, after rinsing.-   38. A sunscreen composition of any one of embodiments 1-37, wherein    the SPF protection provided by the composition increases after each    additional application.-   39. A sunscreen composition of embodiment 38, wherein the SPF    protection provided by the composition increases after each    additional application so that after a second, third, fourth, fifth,    sixth, seventh, eighth, ninth, tenth, eleventh or more washes, the    SPF provided can be above about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,    12, 13, 14, 15, 16, 17, 18, 19, or 20, 21, 22, 23, 24, 25, 26, 27,    28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44,    45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61,    62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78,    79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95,    96, 97, 98, 99, 100 or more.-   40. A sunscreen composition of any one of embodiments 1-40, wherein    the composition includes a cationic polymer.-   41. A sunscreen composition of embodiment 40, wherein the cationic    polymer is a quaternium or a polyquaternium.-   42. A sunscreen composition of embodiment 29, wherein the film    former is dimethicone and/or petrolatum.-   43. A sunscreen composition of embodiment 30, wherein the    preservative is BHT.-   44. A sunscreen composition of any one of embodiments 1-43, wherein    the additional agent is an antioxidant, a chelating agent, a liquid    hydrocarbon, a foaming agent, a skin nourishing substance, sunless    tanning actives, skin lightening actives, anti-acne actives,    anti-skin wrinkling and anti-skin aging actives, vitamins,    anti-inflammatory actives, anesthetic actives, analgesic actives,    anti-pruritic actives, anti-microbial actives (e.g. antifungals,    antibacterials, and antiparasitics), anti-virals, anti-allergenics,    medicinal actives (e.g., skin rash, skin disease and dermatitis    medications), anti-cellulite additives, insect repellant actives,    antioxidants, hair growth promoters, hair growth inhibitors, hair    bleaching agents, vitamins, deodorant compounds, dihydroxyacetone    (DHA); glyceryl aldehyde; tyrosine and tyrosine derivatives such as    malyltyrosine, tyrosine glucosinate, and ethyl tyrosine;    phospho-DOPA, indoles and derivatives, skin lightening actives    include, without limitation, EMBLICA (also an antioxidant),    monobenzone (a depigmenting agent), kojic acid, arbutin, ascorbic    acid and derivatives thereof (e.g., magnesium ascorbyl phosphate or    sodium ascorbyl phosphate), and extracts (e.g., mulberry extract,    placental extract).-   45. A sunscreen composition of any one of embodiments 1-44, wherein    the composition is applied topically.-   46. A sunscreen composition of embodiment 45, wherein the    composition is sprayed.-   47. A sunscreen composition of any one of embodiments 1-46, wherein    an additional agent is a surfactant.-   48. A sunscreen composition of embodiment 47, wherein the surfactant    is cationic, anionic, nonionic, zwitterionic, amphoteric, or any    combination thereof.-   49. A sunscreen composition of any one of embodiments 1-48, wherein    a sunscreen active agent is organic or inorganic.-   50. A sunscreen composition of any one of embodiments 1-49, wherein    the sunscreen composition includes an additional agent to treat a    condition suffered by an individual.-   51. A sunscreen composition of embodiment 50, wherein the    composition is used to treat Seborrheic dermatitis, eczema, xerosis,    infestation, dyschromia, keratosis pilaris, acne, anti-aging,    sensitive skin, ephilidies, solar lentigines, photo sensitive    disease, skin cancer and hx of skin cancer, melisma, auto immune,    alopecia, fungal, bacterial, and viral infections, protect colored    or treated hair, bromhidrosis, malodor, dandruff, wound healing,    insect repellant, pet shampoo/skin care, lindane or similar    conditions.-   52. A sunscreen composition of any one of embodiments 1-3, wherein a    sunscreen active agent is titanium dioxide.-   53. A sunscreen composition of embodiment 52, wherein the titanium    dioxide has an anatase, ritile or amorphous structure.-   54. A sunscreen composition of embodiment 52, wherein the titanium    dioxide is uncoated or coated.-   55. A sunscreen composition of embodiment 54, wherein the titanium    dioxide is coated with aluminum compounds.-   56. A sunscreen composition of embodiment 55, wherein the titanium    dioxide is coated with aluminum oxide, aluminum stearate or aluminum    laurate.-   57. A sunscreen composition of embodiment 54, wherein the titanium    dioxide is coated with phospholipids or silicone compounds.-   58. A sunscreen composition of embodiment 52, wherein the titanium    dioxide is micronized and has a mean primary particle size ranging    from about 10 nm to about 50 nm.-   59. A sunscreen composition of embodiment 52, wherein the titanium    dioxide has a micronized mean primary particle size of 15 nm.-   60. A sunscreen composition of embodiment 52, wherein the titanium    dioxide is uncoated.-   61. A sunscreen composition of embodiment 60, wherein the uncoated    titanium dioxide has a mean particle size of around 35 nm to about    50 nm.-   62. A sunscreen composition of embodiment 52, wherein the    composition comprises a mixture of two or more different particle    sizes of titanium dioxide.-   63. A sunscreen composition of embodiment 52, wherein the    composition comprises a mixture of coated and uncoated titanium    dioxide.-   64. A sunscreen composition of any one of embodiments 1-63, wherein    the composition comprises a sunscreen active agent is encapsulated.-   65. A sunscreen composition of any one of embodiments 1-63, wherein    the composition comprises two or more sunscreen active agents are    encapsulated.-   66. A sunscreen composition of any one of embodiments 1-65, wherein    the composition comprises one or more sunscreen active agents, each    comprising at least about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,    14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30,    31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47,    48, 49, 50% or more of the sunscreen composition (w/v).-   67. A sunscreen composition of any one of embodiments 1-65, wherein    the composition comprises one or more sunscreen active agents, each    comprising at least about , 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13,    14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30,    31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47,    48, 49, 50% or more of the sunscreen composition (w/v).-   68. A sunscreen composition of any one of embodiments 1-68, wherein    the composition absorbs at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,    12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28,    29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45,    46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62,    63, 64, 65, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80,    81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97,    98, 99, or 100% of incident radiation at wave lengths of 290 to 320    nanometers,-   69. A sunscreen composition of any one of embodiments 1-68, wherein    the composition absorbs at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,    12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28,    29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45,    46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62,    63, 64, 65, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80,    81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97,    98, 99, or 100% of incident radiation at wave lengths less than 290    or greater than 320 nanometers.-   70. A sunscreen composition of any one of embodiments 1-69, wherein    the ratio of sunscreen composition to bodywash, shampoo,    conditioner, lotion, gel, soap, cream, hand sanitizer, spray or    mousse is about 0.2, 0.5, 0.7 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6,    1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9,    3.0, 3.2, 3.5, 3.7, 4.0, 4.2, 4.5, 4.7, 5.0, 6.0, 7.0, 8.0, 9.0, 10;    12, 15, or 20 parts bodywash, shampoo, lotion, conditioner, gel,    soap, hand sanitizer, cream, spray or mousse to sunscreen active    agent as measured w/w.-   71. A sunscreen composition of any one of embodiments 1-70, wherein    the pH of the composition is from about 6 to about 8.-   72. A sunscreen composition of any one of embodiments 1-70, wherein    the pH of the composition is from about 6.7 to about 7.5. pH to 4.0    to about 10.-   73. A sunscreen composition of any one of embodiments 1-70, wherein    the pH of the composition is at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10,    11, 12, 13, or 14.-   74. A sunscreen composition according to any one of embodiments    1-73, wherein a cellulose derived capsule contains one sunscreen    active agent.-   75. A sunscreen composition according to any one of embodiments    1-73, wherein a cellulose derived capsule contains two or more    sunscreen active agents.-   76. A sunscreen composition according to any one of embodiments    1-73, wherein the cellulose derived capsule is flexible.-   77. A sunscreen composition according to any one of embodiments    1-73, wherein the cellulose derived capsule has a high load rate.-   78. A sunscreen composition according to any one of embodiments    1-77, wherein the cellulose derived capsule is comprised of    hydroxypropylcellulose, hydroxypropylmethylcellulose,    ethylcellulose, carboxymethylcellulose or any derivatives therefrom.-   79. A sunscreen composition according to any one of embodiments    1-78, wherein the cellulose derived capsule has a diameter of about    400 nm to about 700 nm. In an additional embodiment, a cellulose    derived capsule has a diameter of about 400 nm to about 650 nm,    about 400 nm to about 600 nm, about 400 nm to about 550 nm, about    400 nm to about 500 nm, about 400 nm to about 450 nm. In a further    embodiment, a cellulose derived capsule has a diameter of at least    25 nm, at least 50 nm, at least 75 nm, at least 100 nm, at least 125    nm, at least 150 nm, at least 175 nm, at least 200 nm, at least 225    nm, at least 250 nm, at least 275 nm, at least 300 nm, at least 325    nm, at least 350 nm, at least 375 nm, at least 400 nm, at least 425    nm, at least 450 nm, at least 475 nm, at least 500 nm, at least 525    nm, at least 550 nm, at least 575 nm, at least 600 nm, at least 625    nm, at least 650 nm, at least 675 nm, at least 700 nm, at least 725    nm, at least 750 nm, at least 775 nm, at least 800 nm, at least 825    nm, at least 850 nm, at least 875 nm, at least 900 nm, at least 925    nm, at least 950 nm, at least 975 nm, at least 1000 nm or more.-   80. A sunscreen composition of any one of embodiments 1-79, wherein    the composition comprises water, a chelating agent, a moisturizing    agent, a preservative, a thickening agent, a silicone containing    compound, an essential oil, a structuring agent, a vitamin, a    pharmaceutical ingredient, or an antioxidant, or any combination of    such ingredients or mixtures of such ingredients.-   81. A sunscreen composition of any one of embodiments 1-80, wherein    the composition includes, without limitation, at least two, three,    four, five, six, seven, eight, nine, ten, or more additional agents.-   82. A sunscreen composition of embodiment 81, wherein the additional    agents have a concentration that is from about 0.0001% to about    99.9% (w/v).-   83. A sunscreen composition of any one of embodiments 1-82, wherein    one or more additional agents are encapsulated.-   84. A sunscreen composition of any one of embodiments 1-82, wherein    one or more additional agents are encapsulated and one or more    additional agents are not encapsulated.-   85. A sunscreen composition of any one of embodiments 1-82, wherein    one or more additional agents are not encapsulated.-   86. A sunscreen composition of any one of embodiments 1-85, wherein    the composition increases the protection of an individual to which    the composition is applied by at least 0.1 times greater, 0.2 times    greater, 0.3 times greater, 0.4 times greater, 0.5 times greater,    0.6 times greater, 0.7 times greater, 0.8 times greater, 0.9 times    greater, 1 times greater, 1.25 times greater, 1.5 times greater,    1.75 times greater, 2 times greater, 2.25 times greater, 2.5 times    greater, 2.75 times greater, 3 times greater, 3.25 times greater,    3.5 times greater, 3.75 times greater, 4 times greater, 4.25 times    greater, 4.5 times greater, 4.75 times greater, 5 times greater,    5.25 times greater, 5.5 times greater, 5.75 times greater, 6 times    greater, 6.25 times greater, 6.5 times greater, 6.75 times greater,    7 times greater, 7.25 times greater, 7.5 times greater, 7.75 times    greater, 8 times greater, 8.25 times greater, 8.5 times greater,    8.75 times greater, 9 times greater, 9.25 times greater, 9.5 times    greater, 9.75 times greater, 10 times greater, 11 times greater, 12    times greater, 13 times greater, 14 times greater, 15 times greater,    16 times greater, 17 times greater, 18 times greater, 19 times    greater, 20 times greater, 21 times greater, 22 times greater, 23    times greater, 24 times greater, 25 times greater, 30 times greater,    35 times greater, 40 times greater, 45 times greater, 50 times    greater, 55 times greater, 60 times greater, 65 times greater, 70    times greater, 75 times greater, 80 times greater, 85 times greater,    90 times greater, 95 times greater, 100 times greater than a    sunscreen active agent is not encapsulated-   87. A sunscreen composition of any one of embodiments 1-86, wherein    the concentration of a sunscreen active agent that is a UVA absorber    is from of about 1% to about 40%, or about 2% to about 20%, or about    2% to about 10%, or about 5% to about 10%, or about 1%, 2%, 3%, 4%,    5%, 6%, 7%, 7.4%, 7.5%, 7.6%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%,    16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%,    29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39% or 40% (w/v).-   88. A sunscreen composition of any one of embodiments 1-86, wherein    the concentration of a sunscreen active agent that is a UVB absorber    is from of about 1% to about 40%, or about 2% to about 20%, or about    2% to about 10%, or about 5% to about 10%, or about 1%, 2%, 3%, 4%,    5%, 6%, 7%, 7.4%, 7.5%, 7.6%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%,    16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%,    29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39% or 40% (w/v).-   89. A sunscreen composition of any one of embodiments 1-86, wherein    the concentration of a sunscreen active agent is from of about 1% to    about 40%, or about 2% to about 20%, or about 2% to about 10%, or    about 5% to about 10%, or about 1, 2%, 3%, 4%, 5%, 6%, 7%, 7.4%,    7.5%, 7.6%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%,    19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%,    32%, 33%, 34%, 35%, 36%, 37%, 38%, 39% or 40% (w/v).-   90. A sunscreen composition of any one of embodiments 1-89, wherein    the cellulose derived capsule is prepared so as to experience    breakage in the range of about 0, 0.1, 0.5, 1, 2, 3, 4, 5, 6, 7, 8,    9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25,    30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90 or 95% to about    0.50.1, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16,    17, 18, 19, 20, 21, 22, 23, 24, 25, 30, 35, 40, 45, 50, 55, 60, 65,    70, 75, 80, 85, 90 or 95% after application.-   91. A sunscreen composition of any one of embodiments 1-89, wherein    the cellulose derived capsule is prepared so as to experience    breakage in response to conditions that occur on the skin or hair.-   92. A sunscreen composition of any one of embodiments 1-89, wherein    the cellulose derived capsule is prepared so as to experience    breakage in response to conditions that occur on the skin or hair in    a time release or controlled manner.-   93. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a vitamin.-   94. A sunscreen composition of embodiment 93, wherein the vitamin is    selected from Vitamin A and derivatives thereof (including, for    example, retinol, see anti-wrinkling actives), ascorbic acid    (Vitamin C and derivatives), Vitamin B (e.g., riboflavin, vitamin    B2), biotin, Vitamin D (all forms), Vitamin E and derivatives    thereof such as tocopheryl acetate, beta-carotene, panthothenic    acid, vitamin C, vitamin E and coenzyme Q-10 more.-   95. A sunscreen composition of embodiment 93, wherein the vitamin is    encapsulated in a cellulose derived capsule.-   96. A sunscreen composition of embodiment 93, wherein the vitamin is    not encapsulated in a cellulose derived capsule.-   97. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is an anti-acne active.-   98. A sunscreen composition of embodiment 97, wherein the anti-acne    active is selected from benzoyl peroxide, erythromycin, clindamycin    phosphate, 5,7-dichloro-8-hydroxyquinoline, resorcinol, resorcinol    acetate, salicylic acid, azaleic acid, long chain dicarboxylic    acids, sulfur, zinc, various natural agents such as those derived    from green tree, and more.-   99. A sunscreen composition of embodiment 97, wherein the anti-acne    active is encapsulated in a cellulose derived capsule.-   100. A sunscreen composition of embodiment 97, wherein the anti-acne    active is not encapsulated in a cellulose derived capsule.-   101. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is an anti-skin wrinkling active.-   102. A sunscreen composition of embodiment 101, wherein the    anti-skin wrinkling active is selected from cosmetic products that    contain hydroxy acids, retinol, retinoic, retinol palmitate, a    derivative of vitamin A, (or its stronger, prescribed version    Retin-A and Renova), bicyclic aromatic compounds with retinoid-type    activity and more.-   103. A sunscreen composition of embodiment 101 wherein the anti-skin    wrinkling active is encapsulated in a cellulose derived capsule.-   104. A sunscreen composition of embodiment 101 wherein the anti-skin    wrinkling active is not encapsulated in a cellulose derived capsule.-   105. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a botulinium toxin serotype A.-   106. A sunscreen composition of embodiment 105, wherein an anti-skin    aging or anti-wrinkling additional agents are bicyclic aromatic    compounds, compounds which have retinoid-type activity, free-radical    scavengers, hydroxy or keto acids or derivatives thereof.-   107. A sunscreen composition of embodiment 106, wherein the    free-radical scavengers are selected from α-tocopherol, superoxide    dismutase, ubiquinol or certain metal-chelating agents.-   108. A sunscreen composition of embodiment 106, wherein hydroxyl    acids are selected from α-hydroxy acids such as lactic acid and    glycolic acid or β-hydroxy acids such as salicylic acid and    salicylic acid derivatives such as the octanoyl derivative; other    hydroxy acids and keto acids include, without limitation, malic,    citric, mandelic, tartaric or glyceric acids or the salts, amides or    esters thereof.-   109. A sunscreen composition of any one of embodiments 1-104,    wherein an anti-skin aging or anti-wrinkling additional agents are    sulfur-containing D and L amino acids and their derivatives and    salts, phospholipids (e.g., distearoyl lecithin phospholipid), fatty    acids, fatty alcohols, cholesterol, plant sterols, phytic acid,    lipoic acid; lysophosphatidic acid, and skin peel agents (e.g.,    phenol and the like), and mixtures thereof.-   110. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is an anti-inflammatory active.-   111. A sunscreen composition of embodiment 110, wherein the    anti-inflammatory active is selected from corticosteroids such as    hydrocortisone, hydroxyltriamcinolone, alpha-methyl dexamethasone,    dexamethasone-phosphate, beclomethasone dipropionates, clobetasol    valerate, desonide, desoxymethasone, desoxycorticosterone acetate,    dexamethasone, dichlorisone, diflorasone diacetate, diflucortolone    valerate, fluadrenolone, fluclorolone acetonide, fludrocortisone,    flumethasone pivalate, fluosinolone acetonide, fluocinonide,    flucortine butylesters, fluocortolone, fluprednidene    (fluprednylidene) acetate, flurandrenolone, halcinonide,    hydrocortisone acetate, hydrocortisone butyrate, methylprednisolone,    triamcinolone acetonide, cortisone, cortodoxone, flucetonide,    fludrocortisone, difluorosone diacetate, fluradrenolone,    fludrocortisone, diflurosone diacetate, fluradrenolone acetonide,    medrysone, amcinafel, amcinafide, betamethasone and the balance of    its esters, chloroprednisone, chlorprednisone acetate, clocortelone,    clescinolone, dichlorisone, diflurprednate, flucloronide,    flunisolide, fluoromethalone, fluperolone, fluprednisolone,    hydrocortisone valerate, hydrocortisone cyclopentylpropionate,    hydrocortamate, meprednisone, paramethasone, prednisolone,    prednisone, beclomethasone dipropionate, triamcinolone, and mixtures    thereof.-   112. A sunscreen composition of embodiment 110, wherein the    anti-inflammatory active is selected from nonsteroidal    anti-inflammatory agents include, without limitation, oxicams (e.g.,    piroxicam, isoxicam, tenoxicam, sudoxicam, CP-14,304); salicylates    (e.g., aspirin, disalcid, benorylate, trilisate, safapryn, solprin,    diflunisal, fendosal); acetic acid derivatives (e.g., diclofenac,    fenclofenac, indomethacin, sulindac, tolmetin, isoxepac, furofenac,    tiopinac, zidometacin, acematacin, fentiazac, zomepirac, clindanac,    oxepinac, felbinac, ketorolac); fenamates (e.g., mefenamic,    meclofenamic, flufenamic, niflumic, tolfenamic acids); propionic    acid derivatives (e,g., ibuprofen, naproxen, benoxaprofen,    flurbiprofen, ketoprofen, fenoprofen, fenbufen, indopropfen,    pirprofen, carprofen, oxaprozin, pranoprofen, miroprofen,    tioxaprofen, suprofen, alminoprofen, tiaprofenic); pyrazoles (e.g.,    phenylbutazone, oxyphenbutazone, feprazone, azapropazone,    trimethazone); and combinations thereof as well as any    dermatologically acceptable salts or esters of thereof, COX-2    inhibitors incuding AZD 3582 (Astrazeneca and NicOx), Celecoxib    (Pharmacia Corp.)    (4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]    benzenesulfonamide), Meloxicam (Boehringer Ingelheim    Pharmaceuticals)    (4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2GW-406381    (Glaxosmithkline), Etoricoxib (MERCK & Co.), Rofecoxib (MERCK & Co.)    (4-[4-(methylsulfonyl) phenyl]-3-phenyl-2(5H)-furanone), Lumiracoxib    (Novartis Pharma AG), Valdecoxib (Pharmacia Corp.)    (4-(5-methyl-3-phenyl-4-isox-azolyl) benzenesulfonamide), and    Etodolac (Wyeth Ayerst Laboratories) ((±)    1,8-diethyl-1,3,4,9-tetrahydropyrano-[3,4-b]acid).-   113. A sunscreen composition of embodiment 110, wherein the    anti-inflammatory active is encapsulated in a cellulose derived    capsule.-   114. A sunscreen composition of embodiment 110, wherein the    anti-inflammatory active is not encapsulated in a cellulose derived    capsule.-   115. A sunscreen composition of embodiment 114, wherein an    additional agent is selected from candelilla wax, bisabolol (e.g.,    alpha bisabolol), aloe vera, plant sterols (e.g., phytosterol),    Manjistha (extracted from plants in the genus Rubia, particularly    Rubia Cordifolia), and Guggal (extracted from plants in the genus    Commiphora, particularly Commiphora Mukul), kola extract, chamomile,    red clover extract, sea whip extract, anise oil, garlic oil, ginger    extract, vasoconstrictors such as phenylephrine hydrochloride,    compounds of the Licorice (the plant genus/species Glycyrrhiza    glabra) family, including glycyrrhetic acid, glycyrrhizic acid, and    derivatives thereof (e.g., salts and esters). Suitable salts of the    foregoing compounds include metal and ammonium salts. Suitable    esters include C₂-C₂₄ saturated or unsaturated esters of the acids,    preferably C₁₀-C₂₄, more preferably C₁₆-C₂₄. Specific non-limiting    examples of the foregoing include oil soluble licorice extract, the    glycyrrhizic and glycyrrhetic acids themselves, mono ammonium    glycyrrhizinate, monopotassium glycyrrhizinate, dipotassium    glycyrrhizinate, 1-beta-glycyrrhetic acid, stearyl glycyrrhetinate,    and 3-stearyloxy-glycyrrhetinic acid, disodium    3-succinyloxy-beta-glycyrrhetinate, and combinations thereof.-   116. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is an anesthetic.-   117. A sunscreen composition of embodiment 116, wherein the    anesthetic is selected from butamben picrate, lidocaine, xylocalne,    benzocaine, bupivacaine, chlorprocaine, dibucaine, etidocaine,    mepivacaine, tetracaine, dyclonine, hexylcaine, procaine, cocaine,    ketamine, pramoxine, phenol, and pharmaceutically acceptable salts    thereof.-   118. A sunscreen composition of embodiment 116, wherein the    anesthetic is encapsulated in a cellulose derived capsule.-   119. A sunscreen composition of embodiment 116, wherein the    anesthetic is not encapsulated in a cellulose derived capsule.-   120. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is an analgesic.-   121. A sunscreen composition of embodiment 120, wherein the    analgesic is selected from dyclonine hydrochloride, aloe vera,    fentanyl, capsaicin, and the like. In an embodiment, anti-pruritic    actives include, without limitation, alclometasone dipropionate,    betamethasone valerate, and isopropyl myristate MSD. In an    embodiment, anti-microbial actives include, without limitation,    antifungal, antibacterial, and antiseptic compounds. Antifungal    compounds include, but are not limited to, compounds such as    imidazole antifungals. Specific antifungals include butocouazole    nitrate, miconazole, econazole, ketoconazole, oxiconizole,    haloprogin, clotrimazole, and butenafine HCI, naftifine,    terbinafine, ciclopirox, and tolnaftate. Antibacterial and    antiseptic compounds include phenol-TEA complex, mupirocin,    triclosan, chlorocresol, chlorbutol, iodine, clindamycin, CAE    (Anjinomoto Co., Inc., containing DL-pyrrolidone Carboxylic acid    salt of L-Cocoyl Arginine Ethyl Ester), povidone-iodine, polymyxin b    sulfate-bacitracin, zinc-neomycin sulfate-hydrocortisone,    chloramphenicol, methylbenzethonium chloride, and erythromycin and    antiseptics (e.g., benzalkonium chloride, benzethonium chloride,    chlorhexidine gluconate, mafenide acetate, nitrofurazone,    nitromersol, antimicrobial deodorant compounds, antiparasitics, and    lindane.-   122. A sunscreen composition of embodiment 120, wherein the    analgesic is encapsulated in a cellulose derived capsule.-   123. A sunscreen composition of embodiment 120, wherein the    analgesic is not encapsulated in a cellulose derived capsule.-   124. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is an antimicrobial and antifungal.-   125. A sunscreen composition of embodiment 124, wherein the    antimicrobial and antifungal is selected from beta.-lactam drugs,    quinolone drugs, ciprofloxacin, norfloxacin, tetracycline, amikacin,    2,4,4′-trichloro-2′-hydroxy diphenyl ether,    3,4,4′-trichlorocarbanilide, phenoxyethanol, phenoxy propanol,    phenoxyisopropanol, doxycycline, capreomycin, chlorhexidine,    chlortetracycline, oxytetracycline, ethambutol, hexamidine    isethionate, metronidazole, pentamidine, gentamicin, kanamycin,    lineomycin, methacycline, methenamine, minocycline, neomycin,    netilmicin, paromomycin, streptomycin, tobramycin, miconazole,    tetracycline hydrochloride, erythromycin, zinc erythromycin,    erythromycin estolate, erythromycin stearate, amikacin sulfate,    doxycycline hydrochloride, capreomycin sulfate, chlorhexidine    gluconate, chlorhexidine hydrochloride, chlortetracycline    hydrochloride, oxytetracycline hydrochloride, clindamycin    hydrochloride, ethambutol hydrochloride, metronidazole    hydrochloride, pentamidine hydrochloride, gentamicin sulfate,    kanamycin sulfate, lineomycin hydrochloride, methacycline    hydrochloride, methenamine hippurate, methenamine mandelate,    minocycline hydrochloride, neomycin sulfate, netilmicin sulfate,    paromomycin sulfate, streptomycin sulfate, tobramycin sulfate,    miconazole hydrochloride, amanfadine hydrochloride, amanfadine    sulfate, octopirox, parachlorometa xylenol, nystatin, tolnaftate,    zinc pyrithione and clotrimazole.-   126. A sunscreen composition of embodiment 124, wherein the    antimicrobial and antifungal is encapsulated in a cellulose derived    capsule.-   127. A sunscreen composition of embodiment 124, wherein the    antimicrobial and antifungal is not encapsulated in a cellulose    derived capsule.-   128. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is an anti-viral.-   129. A sunscreen composition of embodiment 128, wherein the    anti-viral is selected from limitatin, metal salts, silver nitrate,    copper sulfate, iron chloride, organic acids, malic acid, salicylic    acid, succinic acid and benzoic acid.-   130. A sunscreen composition of embodiment 128, wherein the    anti-viral is encapsulated in a cellulose derived capsule.-   131. A sunscreen composition of embodiment 129, wherein the    anti-viral is not encapsulated in a cellulose derived capsule.-   132. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is an anti-allergenics.-   133. A sunscreen composition of embodiment 132, wherein the    anti-allergenics is an antihistamine.-   134. A sunscreen composition of embodiment 132, wherein the    antihistamine is selected from diphenhydramine (Benadryl),    chlorpheniramine, tripelennamine, promethazine, clemastine,    doxylamine, benadryl and more. In a further embodiment,    H₁-non-sedating antihistamines include, without limitation,    astemizole, terfenadine, loratadine, cimetadine, cromolyn,    famotidine, nizatidine, and ranitidine.-   135. A sunscreen composition of embodiment 132, wherein the    anti-allergenics is encapsulated in a cellulose derived capsule.-   136. A sunscreen composition of embodiment 132, wherein the    anti-allergenics is not encapsulated in a cellulose derived capsule.-   137. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent treats dermatological conditions.-   138. A sunscreen composition of embodiment 137, wherein the    dermatological condition is selected from psoriasis, acne, eczema,    and other skin conditions due to disease, pathology, accident, and    the like.-   139. A sunscreen composition of embodiment 137, wherein the    treatment of a dermatological condition is selected from    o-amino-p-toluenesulfonamide monoacetate; dermatitis relief agents,    such as the active steroid amcinonide, diflorasone diacetate, and    hydrocortisone; diaper rash relief agents, such as    methylbenzethonium chloride and the like; herpes treatment drugs,    such as O-[(2-hydroxyethoxy)methyl]guanine; psoriasis, seborrhea and    scabicide agents, such as shale oil and derivatives thereof,    elubiol, ketoconazole, coal tar and petroleum distillates, salicylic    acid, zinc pyrithione, selenium sulfide, hydrocortisone, sulfur,    menthol, psoralen, pramoxine hydrochloride anthralin, and    methoxsalen; steroids, such as    2-(acetyloxy)-9-fluoro-1′,2′,3′,4′-tetrahydro-11-hydroxypregna-1,4-dieno    [16,17-b]naphthalene-3,20-dione and    21-chloro-9-fluoro-1′,2′,3′,4′-tetrahydro-11    b-hydroxypregna-1,4-dieno[16z, 17-b]naphthalene-3,20-dione, camphor,    menthol, benzocaine, butamben picrate, dibucaine, dibucaine    hydrochloride, dimethisoquin hydrochloride, dyclonine hydrochloride,    lidocaine, metacresol, lidocaine hydrochloride, pramoxine    hydrochloride, tetracaine, tetracaine hydrochloride, benzyl alcohol,    camphorated metacresol, juniper tar, phenol, phenolate sodium,    resorcinol, diphenhydramine hydrochloride, tripelennamine    hydrochloride, hydrocortisone, a corticosteroid, or hydrocortisone    acetate.-   140. A sunscreen composition of embodiment 137, wherein the    dermatological condition is encapsulated in a cellulose derived    capsule.-   141. A sunscreen composition of embodiment 137, wherein the    dermatological condition is not encapsulated in a cellulose derived    capsule.-   142. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is an anticellulite active.-   143. A sunscreen composition of embodiment 142, wherein the    anticellulite active is selected from isobutylmethylxanthine,    caffeine, theophylline, theobromine, aminophylline, yohimbine, and    mixtures thereof.-   144. A sunscreen composition of embodiment 142, wherein the    anti-allergenics is encapsulated in a cellulose derived capsule.-   145. A sunscreen composition of embodiment 142, wherein the    anti-allergenics is not encapsulated in a cellulose derived capsule.-   146. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent treats hair loss.-   147. A sunscreen composition of embodiment 146, wherein the hair    loss treatment active is selected from potassium channel openers or    peripheral vasodilators such as minoxidil, diazoxide, and compounds    such as N*-cyano-N-(tert-pentyl)-N′-3-pyridinyl-guanidine; vitamins,    such as vitamin E and vitamin C, and derivatives thereof such as    vitamin E acetate and vitamin C palmitate; hormones, such as    erythropoietin, prostaglandins, such as prostaglandin EI and    prostaglandin F2-alpha; fatty acids, such as oleic acid; diruretics    such as spironolactone; heat shock proteins (“HSP”), HSP 27,d HSP    72; calcium channel blockers, such as verapamil HCL, nifedipine, and    diltiazemamiloride; cyclosporin and Fk-506; 5 alpha-reductase    inhibitors such as finasteride; EGF, IGF and FGF; transforming    growth factor beta; tumor necrosis factor; non-steroidal    anti-inflammatory agents such as benoxaprofen; retinoids such as    tretinoin; cytokines, such as IL-6, IL-1 alpha, and IL-1 beta; cell    adhesion molecules such as ICAM; glucorcorticoids such as    betametasone; botanical extracts such as aloe, clove, ginseng,    rehmannia, swertia, sweet orange, zanthoxylum, Serenoa repens (saw    palmetto), Hypoxis rooperi, stinging nettle, pumpkin seeds, and rye    pollen; other botanical extracts including sandlewood, red beet    root, chrysanthemum, rosemary, burdock root, Kalium Phosphoricum D2,    Azadirachta indica D2, and Joborandi DI; ketoconazole and elubiol;    streptomycin; cycloheximide; acetazolamide; benoxaprofen; cortisone;    diltiazem; hexachlorobenzene; hydantoin; nifedipine; penicillamine;    phenothaiazines; pinacidil; psoralens, verapamil; zidovudine;    alpha-glucosylated rutin: quercetin, isoquercitrin, hespeddin,    naringin, and methylhesperidin, and flavonoids and transglycosidated    derivatives, minoxidil, piperidinyl)-2,4-pyrimidinediamine-3-oxide,    N′-cyano-N-(tert-pentyl)-N′-3-pyridinyl-guanidine, finasteride,    retinoids and derivatives thereof, ketoconazole, elubiol, trypsin;    vitamins such as alpha-tocophenol (vitamin E) and derivatives    thereof such as tocophenol acetate and tocophenol palmitate;    antineoplastic agents, such as doxorubicin, cyclophosphamide,    chlormethine, methotrexate, fluorouracil, vincristine, daunorubicin,    bleomycin and hydroxycarbamide; anticoagulants, such as heparin,    heparinoids, coumaerins, detran and indandiones; antithyroid drugs,    such as iodine, thiouracils and carbimazole; lithium and lithium    carbonate; interferons, such as interferon alpha, interferon    alpha-2a and interferon alpha-2b; retinoids, such as retinol    (vitamin A), isotretinoin: glucocorticoids such as betamethasone,    and dexamethosone; antihyperlipidaemic drugs, such as triparanol and    clofibrate; thallium; mercury; albendazole; allopurinol; amiodarone;    amphetamines; androgens; bromocriptine; butyrophenones;    carbamazepine; cholestyramine; cimetidine; clofibrate; danazol;    desipramine; dixyrazine; ethambutol; etionamide; fluoxetine;    gentamicin, gold salts; hydantoins; ibuprofen; impramine;    immunoglobulins; indandiones; indomethacin; intraconazole; levadopa;    maprotiline; methysergide; metoprolol; metyrapone; nadolol;    nicotinic acid; potassium thiocyanate; propranolol; pyridostimine;    salicylates; sulfasalazine; terfenadine; thiamphenicol; thiouracils;    trimethadione; troparanol; valproic acid; and mixtures thereof.    Preferred hair growth inhibitory agents include serine proteases,    retinol, isotretinoin, betamethoisone, alpha-tocophenol or mixtures    thereof.-   148. A sunscreen composition of embodiment 146, wherein the hair    growth stimulant is encapsulated in a cellulose derived capsule.-   149. A sunscreen composition of embodiment 146, wherein the hair    growth stimulant is not encapsulated in a cellulose derived capsule.-   150. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a hair bleaching agent.-   151. A sunscreen composition of embodiment 150, wherein the hair    bleaching agent is selected from perborate or persulfate salts.-   152. A sunscreen composition of embodiment 150, wherein the hair    bleaching agent is encapsulated in a cellulose derived capsule.-   153. A sunscreen composition of embodiment 150, wherein the hair    bleaching agent is not encapsulated in a cellulose derived capsule.-   154. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a deodorant.-   155. A sunscreen composition of embodiment 154, wherein the    deodorant is selected from astringent salts and bioactive compounds.-   156. A sunscreen composition of embodiment 155, wherein the    astringent salts are selected from organic and inorganic salts of    aluminum, zirconium, zinc, sulfate, chloride, chlorohydroxide, alum,    formate, lactate, benzyl sulfonate or phenyl sulfonate, sluminum    chloride, aluminum halides, aluminum hydroxyhalides, zirconyl    oxyhalides, zirconyl hydroxyhalides, aluminum bromohydrate,    potassium alum, sodium aluminum chlorohydroxy lactate, aluminum    sulfate, aluminum chlorohydrate, aluminum-zirconium    tetrachlorohydrate, an aluminum-zirconium polychlorohydrate    complexed with glycine, aluminum-zirconium trichlorohydrate,    aluminum-zirconium octachlorohydrate, aluminum sesquichlorohydrate,    aluminum sesquichlorohydrex PG, aluminum chlorohydrex PEG, aluminum    zirconium octachlorohydrex glycine complex, aluminum zirconium    pentachlorohydrex glycine complex, aluminum zirconium    tetrachlorohydrex glycine complex, aluminum zirconium    trichlorohydrex glycine complex, aluminum chlorohydrex PG, zirconium    chlorohydrate, aluminum dichlorohydrate, aluminum dichlorohydrex    PEG, aluminum dichlorohydrex PG, aluminum sesquichlorohydrex PG,    aluminum chloride, aluminum zirconium pentachlorohydrate,    chlorophyllin copper complex, aluminum chloride, aluminum chloride    hexahydrate, and methylbenzethonium and mixtures thereof.-   157. A sunscreen composition of embodiment 154, wherein the    deodorant is a bacteriostatic quaternary aluminum compound.-   158. A sunscreen composition of embodiment 156, wherein the aluminum    compound is selected from cetyl trimethyl ammonium bromide, cetyl    pyridinium chloride, benzethonium chloride,    diisobutylbenzoxyethoxyethyldimethylbenzyl ammonium chloride, sodium    N-lauryl sarcosine, sodium N-polymethyl sarcosine, lauroyl    sarcosine, N-myristolyl glycine, potassium N-lauroyl sarcosine, and    stearyl trimethyl ammonium chloride; alkali metal carbonates and    bicarbonates, and ammonium and tetralkylammonium carbonates and    bicarbonates.-   159. A sunscreen composition of embodiment 154, wherein the    deodorant is encapsulated in a cellulose derived capsule.-   160. A sunscreen composition of embodiment 154, wherein the    deodorant agent is not encapsulated in a cellulose derived capsule.-   161. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is an antioxidant.-   162. A sunscreen composition of embodiment 161, wherein the    antioxidants is selected from propyl, octyl and dodecyl esters of    gallic acid, butylated hydroxyanisole, butylated hydroxytoluene    (BHT), nordihydroguaiaretic acid, Vitamin A, ascorbic acid and its    salts, ascorbyl esters of fatty acids, ascorbic acid derivatives,    magnesium ascorbyl phosphate, sodium ascorbyl phosphate, ascorbyl    sorbate, tocopherol, tocopherol acetate, other esters of tocopherol,    tocotrienols and their esters,    6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, uric acid    and its salts and alkyl esters, sorbic acid and its salts, lipoic    acid, amines, N,N-diethylhydroxylamine, amino-guanidine, sulfhydryl    compounds, glutathione, N-acetyl cysteine, dihydroxy fumaric acid    and its salts, lycine pidolate, arginine pilolate,    nordihydroguaiaretic acid, bioflavonoids, curcumin, lysine,    methionine, proline, superoxide dismutase, silymarin, tea extracts,    grape skin/seed extracts, melanin, and rosemary extracts.-   163. A sunscreen composition of embodiment 161, wherein the    antioxidants is encapsulated in a cellulose derived capsule.-   164. A sunscreen composition of embodiment 161, wherein the    antioxidants is not encapsulated in a cellulose derived capsule.-   165. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a photostable antioxidant.-   166. A sunscreen composition of embodiment 165, wherein the    photostable antioxidant is encapsulated in a cellulose derived    capsule.-   167. A sunscreen composition of embodiment 165, wherein the    photostable antioxidant is not encapsulated in a cellulose derived    capsule.-   168. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is an insect repellent.-   169. A sunscreen composition of embodiment 168, wherein the insect    repellent is selected from N,N-Diethyl-m-toluamide, dimethyl    phthalate, ethyl hexanediol, indalone, citronella oil, lemon grass    oil, limonene, rosemary oil and eucalyptus oil,    di-n-propylisocinchoronat-e, bicycloheptene, dicarboximide and    tetrahydrofuraldehyde.-   170. A sunscreen composition of embodiment 168, wherein the insect    repellent is encapsulated in a cellulose derived capsule.-   171. A sunscreen composition of embodiment 168, wherein the insect    repellent is not encapsulated in a cellulose derived capsule.-   172. A sunscreen composition of embodiment 41, wherein a    polyquaternium is polyquaternium -4, -7, -11, -22, -37, -44, -5, and    -64.-   173. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a cationic agent.-   174. A sunscreen composition of embodiment 173, wherein the cationic    agent is comprises about 0.1 to about 20%, or about 0.1 to about    10%, or about 0.5 to about 10%, or about 1 to about 10%, or about    0.5 to about 5%, or about 0.5 to about 3% or about 1 to about 5%, or    about 1 to about 3% of the sunscreen composition (w/v).-   175. A sunscreen composition of embodiment 173, wherein the cationic    agent comprises about about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%,    0.7%, 0.8%, 0.9%, 1% or 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%,    11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%,    24%, 25%, 26%, 27%, 28%, 29%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%    or more of the sunscreen composition (w/v).-   176. A sunscreen composition of any of embodiments 1-2, wherein the    additional agent is a film barrier system.-   177. A sunscreen composition of embodiment 176, wherein the film    barrier system is selected from petrolatum, silicon derivatives and    polymers with carboxylic ends.-   178. A sunscreen composition of embodiment 176, wherein the film    barrier system is encapsulated in a cellulose derived capsule.-   179. A sunscreen composition of embodiment 176, wherein the film    barrier system is not encapsulated in a cellulose derived capsule.-   180. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a film former.-   181. A sunscreen composition of embodiment 180, wherein the film    former is selected from emollient esters, lanolin derivatives,    acetylated lanolins, dimethicone, stearamidopropyl dimethylamine    stearate tocopheryl acetate, superfatted oils, synthetic wax, acacia    gum, cellulose derivatives, guar derivatives acrylamides copolymer,    acrylamide/sodium aciylate copolymer, acrylate/acrylamide copolymer,    acrylate/ammonium methacrylate copolymer, acrylates copolymer,    acrylates/diacetoneacrylamide copolymer, acrylic/acrylate copolymer,    adipic acid/d imethylaminohydroxypropyl diethlenetnamine copolymer,    adipic acid/epoxypropyl/diethlenetriamine copolymer, albumen, allyl    stearate/VA copolymer, aminoethylacrylate phosphate/acrylate    copolymer, ammonium acrylates copolymer, ammonium alginate, ammonium    vinyl acetate/acrylates copolymer, AMP acrylates/diacetoneacrylamide    copolymer, balsam canada, balsam oregon, balsam peru, balsam tolu,    benzoi acid/phthalic anhydride/pentaerythritol/neopentyl g    lycol/palmitic acid copolymer, benzoin extract,    butadiene/acrylonitrile copolymer, butylated urea-formaldehyde    resin, butyl benzoic acid/phthalic anhydride trimethylolethane    copolymer, butyl ester of ethylene maleic anhydride copolymer, butyl    ester of PVM/MA copolymer, calcium carrageenean, calcium/sodium    PVM/MA copolymer, carboxymethyl hydroxyethyl cellulose, cellulose    gum, collodion, copal, corn starch/aciylainide/sodium acrylate    copolymer, damar, diethylene glycolamine/epichlorohydrin/piperazine    copolymer, DMJ-IF, dodecanedoic acid/cetearyl alcoholglycol    copolymer, ethylcellulose, ethylene/acrylate copolymer,    ethylene/maleic anhydride copolymer, ethylene/vinyl acetate    copolymer, ethyl ester of PVM/fvIA copolymer, flexible collodian,    gum benzoin, gutta percha, hydroxybutyl methylceflulose,    hydroxyethylcellulose, hydroxyethyl ethyl cellulose,    hydroxypropylceilulose, hydroxypropyl guar, hydroxypropyl    methylcellulose, isopropyl ester of PVM/MA copolymer, maltodextrin,    melamine/formaldehyde resin, methacryloyl ethyl    betainelmethacrylates copolymer, nitrocellulose,    octylacrylamide/acrylates/butylaminoethylmethaciylate copolymer,    octylacrylamide/acrylates copolymer, phthalic    anhydride/glycerin/gycidyl decanoate copolymer,    phthalic/trimellitic/glycols copolymer, polyacrylamide,    polyaciylamidomethylpropane sulfone acid, polyacrylic acid,    polybutylene terephthalate, polychlorotrifluoroethylene,    polyethylacrylate, polyethylene, polyethylene terephthalate,    polyisobutene, Polyquaternium-1, Polyquaternium-2, Polyquaternium-4,    Polyquaternium-5, Polyquaternium-6, Polyquaternium-7,    Polyquaternium-8, Polyquaternium-9, Polyquaternium-10,    Polyquaternium-11, Polyquaternium-12, Polyquaternium-13,    Polyquaternium-14, Polyquaternium-15, polystyrene, polyvinyl    acetate, polyvinyl alcohol, polyvinyl butyral, polyvinyl    imidazolinium acetate, polyvinyl laurate, polyvinyl methyl ether,    potassium carrageenan, PVM/MA copolymer, PVP,    PVP/dimethylaminoethymethacrylate copolymer, PVP/eicosene copolymer,    PVP/ethyl methacrylate/methacrylic acid copolyerm, PVP/hexadecene    copolymer, PVP/VA copolymer, PVP/vinyl acetate/itaconic acid    copolymer, rosin, serum albumin, shellac, sodium acrylate/vinyl    alcohol, copolymer, sodium carrageen, sodium polymethacrylate,    sodium polystyrene sulfonate, starch/acrylates/acrylamide copolymer,    starch diethylaminoethyl ether, steaxyvinyl ether/maleic anhydride    copolymer, styrene/acrylate/acrylonitrile copolymer,    styrene/acrylate/ammonium methacrylate copolymer, styrene/maleic    anhydride copolymer, styrene/PVP copolymer, sucrose benzoate/sucrose    acetate isobutyrate/butyl benzyl phthalate copolymer, sucrose    benzoate/sucrose acetate isobutyrate/butyl benzyl phthalate/methyl    methaciylate copolymer, sucrose benzoate/sucrose acetate isobutyrate    copolymer, toluenesulfonamide/formaldehyde resin, tragacath gum,    vinyl acetate/crotonates copolymer, vinyl acetate/crotonic acid    copolymer, vinyl acetate/crotonic acid/methacryloxybenzophenon-1    copolymer, vinyl acetate/crotonic aid/vinyl neodecanoate copolymer,    zein.-   182. A sunscreen composition of embodiment 180, wherein the film    former is a liquid acrylic copolymer.-   183. A sunscreen composition of embodiment 182, wherein a sunscreen    composition includes a liquid acrylic copolymer at a concentration    of about 0.05%, 0.1%, 0.2%, 0.3%, 0.4%, or 0.5% or about 0.1%, 0.2%,    0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1% or 1%, 2%, 3%, 4%, 5%,    6%, 7%, 8%, 9%, 10% or more.-   184. A sunscreen composition of embodiment 180, wherein the film    former is encapsulated in a cellulose derived capsule.-   185. A sunscreen composition of embodiment 180, wherein the film    former is not encapsulated in a cellulose derived capsule.-   186. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a secondary film former.-   187. A sunscreen composition of embodiment 186, wherein the    secondary film former is selected from keratin or other protein    derivative in an amino acid complex such as cysteine.-   188. A sunscreen composition of embodiment 187, wherein a sunscreen    composition includes a secondary film former at a concentration of    about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1% or    1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%,    16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%,    29%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65% or more.-   189. A sunscreen composition of embodiment 186, wherein the    secondary film former is encapsulated in a cellulose derived    capsule.-   190. A sunscreen composition of embodiment 186, wherein the    secondary film former is not encapsulated in a cellulose derived    capsule.-   191. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a preservative.-   192. A sunscreen composition of embodiment 191, wherein the    preservative is selected from citric acid, tartaric acid, phosphoric    acid, iminodiacetic acid, nitrilotriacetic acid,    hydroxyethyleneaminodiacetic acid and ethylenediaminetetraacetic    acid and salts thereof; parα-hydroxybenzoates such as butyl paraben,    methyl paraben and propyl paraben; imidazolines, imidiazolinylurea,    triclosan, hydantoins, dimethyloldimethylhydantoin,    isothiazolidinone compounds and mixtures thereof,    methylchloroisothiazolinone and methylisothiazolinone.-   193. A sunscreen composition of embodiment 191, wherein the    concentration of preservative in a sunscreen composition is about    about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1% or    1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%,    16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%,    29%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65% or more (w/v).-   194. A sunscreen composition of embodiment 191, wherein the    preservative is encapsulated in a cellulose derived capsule.-   195. A sunscreen composition of embodiment 191, wherein the    preservative is not encapsulated in a cellulose derived capsule.-   196. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a chelating agent.-   197. A sunscreen composition of embodiment 196, wherein the    chelating agent is selected from heterocyclic ring structures,    ethylene diaminetetraacetic acid (EDTA), EDTA disodium, calcium    disodium edetate, EDTA trisodium, EDTA tetrasodium and EDTA    dipotassium.-   198. A sunscreen composition of embodiment 196, wherein the    concentration of chelating agent in a sunscreen composition is about    about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%, 0.9%, 1% or    1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%,    16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%,    29%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65% or more (w/v).-   199. A sunscreen composition of embodiment 196, wherein the    chelating agent is encapsulated in a cellulose derived capsule.-   200. A sunscreen composition of embodiment 196, wherein the    chelating agent is not encapsulated in a cellulose derived capsule.-   201. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a thickening agent or gellant.-   202. A sunscreen composition of embodiment 201, wherein the    thickening agent or gellant system is selected from CARBOPOL™ resins    [e.g., 934, 971, 974, 980, 981] and PEMULEN™ [TR-1 and TR-2] [both    CARBOPOL™ and PEMULEN™ are registered trademarks of BF Goodrich],    Noveon AA-1, ETD resins, and ULTREZ™ resins [registered trademark,    BF Goodrich] or carbomers.-   203. A sunscreen composition of embodiment 201, wherein the    thickening agent or gellant is encapsulated in a cellulose derived    capsule.-   204. A sunscreen composition of embodiment 201, wherein the    thickening agent or gellant is not encapsulated in a cellulose    derived capsule.-   205. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a fragrance, dye or antimicrobial material.-   206. A sunscreen composition of embodiment 205, wherein the    antimicrobial material is selected from triclocarban, triclosan,    iodophors, iodine formulations, phenolic compounds, e.g.    hexachlorophene, and bisbiguanides, e.g. chlorhexidene gluconate.-   207. A sunscreen composition of embodiment 205, wherein fragrance,    dye or antimicrobial material is encapsulated in a cellulose derived    capsule.-   208. A sunscreen composition of embodiment 205, wherein the    fragrance, dye or antimicrobial material is not encapsulated in a    cellulose derived capsule.-   209. A sunscreen composition of any one of embodiments 1-208,    wherein the composition is mixed together in a water or an oil.-   210. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a surfactant.-   211. A sunscreen composition of embodiment 210, wherein the    surfactant is selected from cationic, anionic, nonionic,    zwitterionic, amphoteric, or any combination of surfactants thereof.    In a further embodiment, surfactants include, without limitation,    alkyl and alkyl ether sulfates, sulfated monoglycerides, sulfonated    olefins, alkyl aryl sulfonates, primary or secondary alkane    sulfonates, alkyl sulfosuccinates, acyl taurates, acyl isethionates,    alkyl glycerylether sulfonate, sulfonated methyl esters, sulfonated    fatty acids, alkyl phosphates, ethoxylated alkyl phosphates, acyl    glutamates, acyl sarcosinates, alkyl sulfoacetates, acylated    peptides, alkyl ether carboxylates, acyl lactylates, anionic    fluorosurfactants, sodium, ammonium, potassium, magnesium, or TEA    salts of lauryl or myristyl sulfate or ammonium, sodium, magnesium,    or TEA laureth-3 sulfate and combinations thereof.-   212. A sunscreen composition of embodiment 201, wherein the    concentration of surfactant included in a sunscreen composition is    at least 0.01%, at least 0.02%, at least 0.03%, at least 0.04%, at    least 0.05%, at least 0.06%, at least 0.07%, at least 0.08%, at    least 0.09%, at least 0.1%, at least 0.25%, at least 0.5%, at least    0.75%, at least 1%, at least 1.25%, at least 1.5%, at least 1.75%,    at least 2%, at least 2.25%, at least 2.5%, at least 2.75%, at least    3%, at least 3.25%, at least 3.5%, at least 3.75%, at least 4%, at    least 4.25%, at least 4.5%, at least 4.75%, at least 5%, at least    5.25%, at least 5.5%, at least 5.75%, at least 6%, at least 6.25%,    at least 6.5%, at least 6.75%, at least 7%, at least 7.25%, at least    7.5%, at least 7.75%, at least 8%, at least 8.25%, at least 8.5%, at    least 8.75%, at least 9%, at least 9.25%, at least 9.5%, at least    9.75%, at least 10%, at least 11%, at least 12%, at least 13%, at    least 14%, at least 15%, at least 16%, at least 17%, at least 18%,    at least 19%, at least 20%, at least 21%, at least 22%, at least    23%, at least 24%, at least 25% (w/v).-   213. A sunscreen composition of embodiment 210, wherein the    concentration of surfactant included in a sunscreen composition is    about 0.01% to about 5%.-   214. A sunscreen composition of embodiment 210, wherein the    concentration of surfactant included in a sunscreen composition is    about 3% to about 5%.-   215. A sunscreen composition of embodiment 213, wherein the    concentration of surfactant results in reduced lathering.-   216. A sunscreen composition of embodiment 210, wherein the    conctration of surfactant included in a sunscreen composition is    about 7.5% to 15%.-   217. A sunscreen composition of embodiment 216, wherein the    concentration of surfactant results in lathering.-   218. A sunscreen composition of embodiment 210, wherein the    surfactant is an anionic surfactant.-   219. A sunscreen composition of embodiment 218, wherein the anionic    surfactant is selected from sulfated monoglycerides of the form    R1CO—O—CH₂—C(OH)H—CH₂—O—SO₃M, wherein R1 is a saturated or    unsaturated, branched or unbranched alkyl group from about 8 to    about 24 carbon atoms, and M is a water-soluble cation such as    ammonium, sodium, potassium, magnesium, triethanolamine,    diethanolamine, monoethanolamine and sodium cocomonoglyceride    sulfate, olefin sulfonates of the form R1SO₃M, wherein R1 is a    mono-olefin having from about 12 to about 24 carbon atoms, and M is    a water-soluble cation such as ammonium, sodium, potassium,    magnesium, triethanolamine, diethanolamine and monoethanolamine,    sodium C14/C16 alpha olefin sulfonate, linear alkylbenzene    sulfonates of the form R₁—C₆H₄—SO₃M, wherein R1 is a saturated or    unsaturated, branched or unbranched alkyl group from about 8 to    about 24 carbon atoms, and M is a water-soluble cation such as    ammonium, sodium, potassium, magnesium, triethanolamine,    diethanolamine monoethanolamine and sodium dodecylbenzene sulfonate.    In an additional embodiment, anionic surfactants include, without    limitation, primary or secondary alkane sulfonates of the form R1    SO₃M, wherein R1 is a saturated or unsaturated, branched or    unbranched alkyl chain from about 8 to about 24 carbon atoms, and M    is a water-soluble cation such as ammonium, sodium, potassium,    magnesium, triethanolamine, diethanolamine and monoethanolamine,    alkane sulfonate, alkali metal or ammonium C 13 C 17 paraffin    sulfonates, alkyl sulfosuccinates, which include disodium    N-octadecylsulfosuccinamate; diammonium lauryl sulfosuccinate;    tetrasodium N-(1,2-dicarboxyethyl)-N-octadecylsulfosuccinate; diamyl    ester of sodium sulfosuccinic acid; dihexyl ester of sodium    sulfosuccinic acid; dioctyl esters of sodium sulfosuccinic acid,    acyl isethionates, including, without limitation, acyl isethionates    include ammonium cocoyl isethionate, sodium cocoyl isethionate,    sodium lauroyl isethionate, alkylglyceryl ether sulfonates of the    form R1-OCH₂—C(OH)H—CH₂—SO₃M, wherein R1 is a saturated or    unsaturated, branched or unbranched alkyl group from about 8 to    about 24 carbon atoms, and M is a water-soluble cation such as    ammonium, sodium, potassium, magnesium, triethanolamine,    diethanolamine and monoethanolamine, sodium cocoglyceryl ether    sulfonate, Sulfonated fatty acids of the form R1-CH(SO₄)—COOH and    sulfonated methyl esters of the from R1-CH(SO₄)—CO—O—CH₃, where R1    is a saturated or unsaturated, branched or unbranched alkyl group    from about 8 to about 24 carbon atoms, alpha sulphonated coconut    fatty acid and lauryl methyl ester; phosphates such as monoalkyl,    dialkyl, and trialkylphosphate salts formed by the reaction of    phosphorous pentoxide with monohydric branched or unbranched    alcohols having from about 8 to about 24 carbon atoms, sodium mono    or dilaurylphosphate, ethoxylated monoalkyl phosphates, acyl    glutamates corresponding to the formula R1CO—N(COOH)—CH₂CH2—CO₂M    wherein R1 is a saturated or unsaturated, branched or unbranched    alkyl or alkenyl group of about 8 to about 24 carbon atoms, and M is    a water-soluble cation, sodium lauroyl glutamate and sodium cocoyl    glutamate, alkanoyl sarcosinates corresponding to the formula    R1CON(CH₃)—CH₂CH₂—CO₂M wherein R1 is a saturated or unsaturated,    branched or unbranched alkyl or alkenyl group of about 10 to about    20 carbon atoms, and M is a water-soluble cation, sodium lauroyl    sarcosinate, lauroyl sarcosine, sodium cocoyl sarcosinate, and    ammonium lauroyl sarcosinate, alkyl ether carboxylates corresponding    to the formula R1-(OCH₂CH₂)x-OCH₂—CO₂M wherein R1 is a saturated or    unsaturated, branched or unbranched alkyl or alkenyl group of about    8 to about 24 carbon atoms, x is 1 to 10, and M is a water-soluble    cation (e.g., sodium laureth carboxylate); acyl lactylates    corresponding to the formula R1CO—[O—CH(CH₃)—CO]x-CO₂M wherein R1 is    a saturated or unsaturated, branched or unbranched alkyl or alkenyl    group of about 8 to about 24 carbon atoms, x is 3, and M is a    water-soluble cation, sodium cocoyl lactylate, carboxylates,    nonlimiting examples of which include sodium lauroyl carboxylate,    sodium cocoyl carboxylate, and ammonium lauroyl carboxylate; anionic    flourosurfactants; natural soaps derived from the saponification of    vegetable and/or animal fats & oils examples of which include sodium    laurate, sodium myristate, palmitate, stearate and tallowate    cocoate.-   220. A sunscreen composition of embodiment 210, wherein the    surfactant is a taurate.-   221. A sunscreen composition of embodiment 218, wherein the taurate    is selected from taurine, N-alkyltaurines.-   222. A sunscreen composition of embodiment 210, wherein the    surfactant is a nonionic surfactant.-   223. A sunscreen composition of embodiment 218, wherein the nonionic    surfactant is selected from alkyl glucosides, alkyl polyglucosides,    polyhydroxy fatty acid amides, alkoxylated fatty acid esters,    sucrose esters, amine oxides, glycosides or polyglycosides and are    represented by the formula (S)_(n)—O—R wherein S is a sugar moiety    such as glucose, fructose, mannose, and galactose; n is an integer    of from about 1 to about 1000, and R is a C₈₋₃₀ alkyl groupdecyl    alcohol, cetyl alcohol, stearyl alcohol, lauryl alcohol, myristyl    alcohol, oleyl alcohol, decyl polyglucoside, sucrose cocoate,    polyhydroxy fatty acid amide, glucosamides and sucrose laurate.-   224. A sunscreen composition of embodiment 210, wherein the    surfactant is an ampohoteric lathering surfactant.-   225. A sunscreen composition of embodiment 218, wherein the    ampohoteric lathering surfactant is selected from carboxy,    sulfonate, sulfate, phosphate, or phosphonate. In an embodiment,    amphoteric or zwitterionic surfactants include, without limitation,    betaines, sultaines, hydroxysultaines, alkyliminoacetates,    iminodialkanoates, aminoalkanoates, coco dimethyl carboxymethyl    betaine, lauryl dimethyl carboxymethyl betaine, lauryl dimethyl    alphacarboxyethyl betaine, cetyl dimethyl carboxymethyl betaine,    cetyl dimethyl betaine (available as Lonzaine 16SP from Lonza    Corp.), lauryl bis-(2-hydroxyethyl) carboxymethyl betaine, oleyl    dimethyl gamma-carboxypropyl betaine, lauryl    bis-(2-hydroxypropyl)alpha-carboxyethyl betaine, coco dimethyl    sulfopropyl betaine, lauryl dimethyl sulfoethyl betaine, lauryl    bis-(2-hydroxyethyl) sulfopropyl betaine, amidobetaines and    amidosulfobetaines (wherein the RCONH(CH₂)₃ radical is attached to    the nitrogen atom of the betaine), oleyl, and cocamidopropyl    betaine, sultaines, hydroxysultaines and cocamidopropyl    hydroxysultaine.-   226. A sunscreen composition of embodiment 210, wherein the    surfactant is an amphoteric surfactant.-   227. A sunscreen composition of embodiment 218, wherein the    amphoteric surfactant is selected from taurine, Cetyl dimethyl    betaine, Cocamidopropylbetaine; Cocamidopropyl hydroxy sultaine,    alkyliminoacetates, and iminodialkanoates and aminoalkanoates of the    formulas RN[(CH₂)CO₂M]₂ and RNH(CH₂)_(m)CO₂M wherein m is from 1 to    4, R is a C₈-C₂₂ alkyl or alkenyl, and M is H, alkali metal,    alkaline earth metal ammonium, alkanolammonium or imidazolinium and    ammonium derivatives, sodium 3-dodecyl-aminopropionate, sodium    3-dodecylaminopropane sulfonate, N-higher alkyl aspartic acids,    amphoteric phosphates, such as coamidopropyl PG-dimonium chloride    phosphate, disodium lauroamphodiacetate, sodium lauroamphoacetate,    and mixtures thereof.-   228. A sunscreen composition of embodiment 210, wherein the    surfactant is a cationic surfactant.-   229. A sunscreen composition of embodiment 218, wherein the cationic    surfactant is selected from fatty amines, di-fatty quaternary    amines, tri-fatty quaternary amines, imidazolinium quaternary    amines, monalkyl quaternary amines such as cetyltrimethylammonium    bromide, dialklamidoethyl hydroxyethylmonium meth osulfate    stearyldimenthylbenzyl ammonium chloride; dodecyltrimethylammonium    chloride; nonylbenzylethyldimethyl ammonium nitrate;    tetradecylpyridinium bromide; laurylpyridinium chloride;    cetylpyridinium chloride; laurylpyridinium chloride;    laurylisoquinolium bromide; ditallow(Hydrogenated)dimethyl ammonium    chloride; dilauryldimethyl ammonium chloride and stearalkonium    chloride.-   230. A sunscreen composition of embodiment 210, wherein the    concentration of a cationic surfactant included in a sunscreen    composition is about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%,    0.9%, 1% or 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%,    14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%,    27%, 28%, 29%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65% or more (w/v).-   231. A sunscreen composition of embodiment 210, wherein the    surfactant is encapsulated in a cellulose derived capsule.-   232. A sunscreen composition of embodiment 210, wherein the    surfactant is not encapsulated in a cellulose derived capsule.-   233. A sunscreen composition of any one of embodiments 1-232,    wherein the composition provides an SPF protection that is at least    about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 1.3, 14, 15, 16, 17,    18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34,    35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51,    52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68,    69, 70, 71, 72, 73, 74, 75 or more.-   234. A sunscreen composition of any one of embodiments 1-234,    wherein the composition is applied two or more times to an    individual and the cumulative SPF protection following the two or    more applications is at least about at least about 1, 2, 3, 4, 5, 6,    7, 8, 9, 10, 11, 12, 1.3, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23,    24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40,    41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57,    58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74,    75 or more.-   235. A sunscreen composition of any one of embodiments 1-234,    wherein the composition is applied once per day.-   236. A sunscreen composition of any one of embodiments 1-234,    wherein the composition is applied two, three, four or more times    per day.-   237. A sunscreen composition of any one of embodiments 1-234,    wherein the composition is applied every other day.-   238. A sunscreen composition of any one of embodiments 1-234,    wherein the composition is applied about 10, 8, 7, 6, 5, 4, 3, 2 or    1 time per week.-   239. A sunscreen composition of any one of embodiments 1-238,    wherein the composition is applied to wet skin and/or hair.-   240. A sunscreen composition of any one of embodiments 1-238,    wherein the composition is applied to dry skin and/or hair.-   241. A sunscreen composition of any one of embodiments 1-240,    wherein the composition contains one, two or more surface-treated    metal oxide pigments that block UV radiation.-   242. A sunscreen composition of embodiment 241, wherein the    surface-treated metal oxide blocks UV radiation in the wavelength    range of from about 290 nm to about 400 nm.-   243. A sunscreen composition of embodiment 241, wherein the combined    concentration of the one, two or three surface-metal oxide pigments    is at least about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.6%, 0.7%, 0.8%,    0.9%, 1%, 1.25%, 1.5%, 1.75%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, 5%,    5.5%, 6%, 6.5%, 7%, 7.5%, 8%, 8.5%, 9%, 9.5%, 10%, 11%, 12%, 13%,    14%, 15%, 16%, 17%, 18%, 19%, 20%, 25%, 30%, 35%, 40%, 45%, 50%.-   244. A sunscreen composition of any one of embodiments 1-243,    wherein the cellulose derived capsules containing sunscreen active    agents are in the 400-450 nm range.-   245. A sunscreen composition of any one of embodiments 1-243,    wherein the cellulose derived capsules containing sunscreen active    agents are in the 400-500 nm range.-   246. A sunscreen composition of any one of embodiments 1-243,    wherein the cellulose derived capsules containing sunscreen active    agents are in the 400-550 nm range.-   247. A sunscreen composition of any one of embodiments 1-243,    wherein the cellulose derived capsules containing sunscreen active    agents are in the 400-600 nm range.-   248. A sunscreen composition of any one of embodiments 1-243,    wherein the cellulose derived capsules containing sunscreen active    agents are in the 400-650 nm range.-   249. A sunscreen composition of any one of embodiments 1-248,    wherein the cellulose derived capsules containan active coating on    the exterior of the cellulose derived capsule membrane which has    absorption properties.-   250. A sunscreen composition of any one of embodiments 1-249,    wherein the cellulose derived capsules, further wherein, the    cellulose derived capsules are of different sizes.-   251. A sunscreen composition of any one of embodiments 1-250,    wherein the cellulose derived capsule is comprised of 0.1%-5% wt/wt    of cellulosic material.-   252. A sunscreen composition of any one of embodiments 1-250,    wherein the cellulose derived capsule is comprised of 5%-20% wt/wt    of cellulosic material.-   253. A sunscreen composition of any one of embodiments 1-250,    wherein the cellulose derived capsule is comprised of 20%-50% wt/wt    of cellulosic material.-   254. A sunscreen composition of any one of embodiments 1-250,    wherein the cellulose derived capsule is comprised of 50%-70% wt/wt    of cellulosic material.-   255. A sunscreen composition of any one of embodiments 1-254,    wherein the cellulose derived capsule is comprised of two or more    layers.-   256. A sunscreen composition of embodiment 255, wherein each layer    contains a different sunscreen active agent.-   257. A sunscreen composition of embodiment 255, wherein each layer    contains the same sunscreen active agent.-   258. A sunscreen composition of embodiment 255, wherein each layer    contains a different sunscreen active agent.-   259. A sunscreen composition of embodiment 255, wherein at least one    layer contains a different sunscreen active agent than at least one    other layer.-   260. A sunscreen composition of embodiment 255, wherein at least one    layer contains a sunscreen active agent and at least one layer    contains an antioxidant.-   261. A sunscreen composition of embodiment 255, wherein at least one    layer contains a sunscreen active agent and at least one layer    contains a vitamin.-   262. A sunscreen composition of embodiment 255, wherein at least one    layer contains a sunscreen active agent and at least one layer    contains an anti-inflammatory.-   263. A sunscreen composition of embodiment 255, wherein at least one    layer contains a sunscreen active agent and at least one layer    contains an astringent.-   264. A sunscreen composition of any one of embodiments 1-263,    wherein the composition is comprised of a cationic surfactant, a    cellulose derived capsule and a polymer.-   265. A sunscreen composition of any one of embodiments 1-263,    wherein the composition is comprised of an anionic surfactant,    cellulose derived encapsulate, and a polymer.-   266. A sunscreen composition of any one of embodiments 1-263,    wherein the composition is comprised of a nonionic surfactant,    cellulose derived encapsulate, and a polymer.-   267. A sunscreen composition of any one of embodiments 1-263,    wherein the composition is comprised of an amphoteric surfactant,    cellulose derived encapsulate, and a polymer.-   268. A sunscreen composition of any one of embodiments 1-263,    wherein the composition is comprised of a surfactant containing a    quat group, wherein said quat group is capable of absorbing UV    radiation.-   269. A sunscreen composition of any one of embodiments 1-263,    wherein the composition is comprised of a surfactant metal complex    to enhance reflective properties.-   270. A sunscreen composition of any one of embodiments 1-263,    wherein the composition is comprised of more than one surfactant, a    cellulose derived capsule and a polymer.-   271. A sunscreen composition of any one of embodiments 1-270,    wherein the composition is comprised of a cellulose derived capsule    comprising ethyl cellulose and a surfactant base containing one or    more polymers.-   272. A sunscreen composition of any one of embodiments 1-270,    wherein the composition is comprised of a cellulose derived capsule    comprising carboxymethyl cellulose and a surfactant base containing    one or more polymers.-   273. A sunscreen composition of any one of embodiments 1-272,    wherein the sunscreen active agent is an organic or non-polar highly    refractive sunscreen active agent.-   274. A sunscreen composition of any one of embodiments 1-273,    wherein the sunscreen active agent is an organic sunscreen active    agent and wherein, the composition contains inorganic metals.-   275. A sunscreen composition of any one of embodiments 1-274,    wherein the sunscreen composition comprises a surfactant, apolymer    and a cellulose derived capsule, further wherein, the composition is    comprised of one or more different cellulose derived capsules, each    comprised of a different cellulose derivative.-   276. A sunscreen composition of any one of embodiments 1-275,    wherein the inner refractive index of the composition is 1.5-1.7.-   277. A sunscreen composition of any one of embodiments 1-275,    wherein the inner refractive index of the composition is 1.5-1.7.-   278. A sunscreen composition of any one of embodiments 1-275,    wherein the inner refractive index of the composition is 1.5-1.9.-   279. A sunscreen composition of any one of embodiments 1-275,    wherein the inner refractive index of the composition is 1.5-2.2.-   280. A sunscreen composition of any one of embodiments 1-275,    wherein the inner refractive index of the composition is 1.5-2.4.-   281. A sunscreen composition of any one of embodiments 1-275,    wherein the inner refractive index of the composition is 1.5-2.6.-   282. A sunscreen composition of any one of embodiments 1-275,    wherein the inner refractive index of a non-sunscreen active agent    in the composition is 1.5-2.7.-   283. A sunscreen composition of any one of embodiments 1-275,    wherein the inner refractive index of a non organic dispersed with    organic sunscreen active agent in the composition is 1.5-2.7.-   284. A sunscreen composition of any one of embodiments 1-283,    wherein the composition contains cellulose derived capsules of    different sizes and the inner refractive index of the composition is    greater than 1.5.-   285. A sunscreen composition of any one of embodiments 1-283,    wherein the composition contains cellulose derived capsules, further    wherein, the mixture of cellulose derived capsules contains capsules    containing different cellulose derivatives and the inner refractive    index of the composition is greater than 1.5.-   286. A sunscreen compositon of any one of embodiments 1-285, wherein    the composition has an overall refractive index of 1.4-2.-   287. A sunscreen composition of any one of embodiments 1-286,    wherein the cellulose derived capsule wherein 75% or more of the    cellulose derived capsules have a diameter of about 300 nm to about    600 nm.-   288. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a skin whitening active.-   289. A sunscreen composition of embodiment 288, wherein the skin    whitening agent is a skin lightener and/or a skin bleaching agent.-   290. A sunscreen composition of embodiment 288, wherein the skin    whitening agent is encapsulated in a cellulose derived capsule.-   291. A sunscreen composition of embodiment 288, wherein the skin    whitening agent is not encapsulated in a cellulose derived capsule.-   292. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a cascading antioxidant agent.-   293. A sunscreen composition of embodiment 292, wherein the    cascading antioxidant agent is emblica or synovia.-   294. A sunscreen composition of embodiment 292, wherein the    cascading antioxidant agent is encapsulated in a cellulose derived    capsule.-   295. A sunscreen composition of embodiment 292, wherein the    cascading antioxidant agent is not encapsulated in a cellulose    derived capsule.-   296. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is a quencher active.-   297. A sunscreen composition of embodiment 288, wherein the quencher    is Polycrylene.-   298. A sunscreen composition of embodiment 288, wherein the quencher    is encapsulated in a cellulose derived capsule.-   299. A sunscreen composition of embodiment 288, wherein the quencher    is not encapsulated in a cellulose derived capsule.-   300. A sunscreen composition of any one of embodiments 1-92, wherein    the additional agent is an infrared reflective coating.-   301. A sunscreen composition of embodiment 288, wherein the infrared    reflective coating is encapsulated in a cellulose derived capsule.-   302. A sunscreen composition of embodiment 288, wherein the infrared    reflective coating is not encapsulated in a cellulose derived    capsule.-   303. A sunscreen composition of any one of embodiments 2-302,    wherein the soap includes a surfactant.-   304. A sunscreen composition of any one of embodiments 2-302,    wherein the soap does not include a surfactant.-   305. A sunscreen composition of any one of embodiments 2-302,    wherein the soap is a melt and pour soap.-   306. A sunscreen composition of any one of embodiments 2-302,    wherein the soap is Castile soap.-   307. A sunscreen composition of any of embodiments 1-92, wherein the    additional agent is a hindered amine light stabilizer.-   308. A sunscreen composition of embodiment 288, wherein the hindered    amine light stabilizer is encapsulated in a cellulose derived    capsule.-   309. A sunscreen composition of embodiment 288, wherein the hindered    amine light stabilizer is not encapsulated in a cellulose derived    capsule.-   310. A sunscreen composition of any one of embodiments 1-309,    wherein the sunscreen composition is encapsulated in a cellulose    derived capsule and, further wherein, the composition is included in    a paint.-   311. A sunscreen composition of any one of embodiments 1-309,    wherein the sunscreen composition is encapsulated in a cellulose    derived capsule and, further wherein, the encapsulated composition    is included in a plastic.-   312. A sunscreen composition of embodiment 311, wherein the plastic    is selected from natural, synthetic or semi-synthetic organic solids    that are moldable.-   313. A sunscreen composition of embodiment 311, wherein the plastic    is selected from thermoplastics and thermosetting plastics.-   314. A sunscreen composition of embodiment 313, wherein the    thermoplastics and thermosetting plastic are selected from    polyethylene, polyamides, polyethylene terephthalate, polyesters,    acrylonitrile butadiene styrene, polycarbonate, polyurethane,    polypropylene, melamine formadehyde, phenolics,    polyetheretherketone, polyetherimide, polylactic acid, polymethyl    methacrylate, polytetrafluoroethylene, urea-formaldehyde,    polystyrene, polyvinyl chloride and polytetrafluoroethylene.-   315. A sunscreen composition of embodiment 311, wherein the plastic    is biodegradable.-   316. A sunscreen composition of embodiment 311, wherein the plastic    is used in a consumer product.-   317. A sunscreen composition of embodiment 316, wherein the consumer    product is an automobile.-   318. A sunscreen composition of embodiment 317, wherein the plastic    in the automobile includes vinyl.-   319. A sunscreen composition of any one of embodiments 1-318,    wherein the sunscreen composition is encapsulated in a cellulose    derived capsule and further, wherein, the encapsulated composition    is used in a paint.-   320. A sunscreen composition of any one of embodiments 1-319,    wherein the composition is used in a military, police or other    governmental or non-governmental force product.-   321. A sunscreen composition of embodiment 320 wherein the military,    police or other governmental or non-governmental force product is    selected from, sunscreen, paint, clothes, weapons, including,    without limitation, weapons containing composite or other synthetic    parts, and other military products.-   322. A sunscreen composition of embodiment 320 wherein the military,    police or other governmental or non-governmental force product    includes a reflective agent.-   323. A sunscreen composition of embodiment 320 wherein the military,    police or other governmental or non-governmental force product    includes an agent capable of preventing the detection of infrared    radiation by an individual or equipment.

EXAMPLES Example 1: SPF Testing of Sunscreen Composition

Various sunscreen compositions were tested to determine their SPF value.The test consisted of applying the sunscreen composition by wetting theapplication site on an individual with 10 ml of water delivered via asyringe followed by application of the test material monograph amount.The lather was then worked in for two minutes. After 30 seconds, thesite was rinsed with 20 ml of water and patted dry. The test site wasthen rubbed using moderate pressure for 20 seconds. The material wasallowed to dry for 15 minutes.

TABLE 1 Evaluation of Sun Protection by SPF Determination (FDA)-Static(Rinse/Lather/Rinse/Rub) Subject I^(a) Skin MED I MED II SPF Values No.Gender MED/Hr (Amps) Type (J/M²) (J/M²) STD^(b) Static RLR/RUB 62-0539 F127.3 6.0 I 30.33 30.33 16.30 39.60 34.50 48-9212 F 129.2 6.0 II 46.2046.20 18.75 39.60 34.50 78-4159 M 127.1 6.0 II 46.20 46.20 16.30 34.5030.00 78-4237 M 128.4 6.0 II 46.20 46.20 18.75 39.60 34.50 72-7479 M128.1 6.0 II 46.20 46.20 18.75 34.50 30.00 76-0164 M 125.9 6.0 II 46.2046.20 18.75 39.60 34.50 54-1578 F 127.1 5.4 II 46.20 46.20 16.30 39.6034.50 58-3948 M 128.4 6.0 II 46.20 46.20 16.30 34.50 30.00 70-8402 F126.9 5.9 III 46.20 46.20 18.75 39.60 34.50 56-5529 F 125.4 6.0 II 30.3330.33 16.30 39.60 34.50 Mean (x) 17.53 38.07 33.15 Standard Deviation(s)1.29 2.46 2.17 Standard Error 0.41 0.78 0.69 Standard Error % of Mean2.34 2.05 2.08 N 10 10 10 Upper 5% t Dist. 2.2622 1.8331 1.8331 A Values0.9228 1.4260 1.2579 Label SPF 16 36 31 ^(a)I is Intensity of LightSource. ^(b)7% PadO/3% Oxyb.

TABLE 2 Evaluation of Sun Protection by SPF Determination (FDA)-80Minute Water Immersion Subject I^(a) Skin MED I MED II WR SPF Values No.Gender MED/Hr (Amps) Type (J/M²) (J/M²) STD^(b) Control Static WR78-4159 M 127.1 6.0 II 46.20 46.20 16.30 15.00 34.50 34.50 72-7479 M128.1 6.0 II 46.20 46.20 18.75 18.00 34.50 34.50 Mean (x) 17.53 16.5034.50 34.50 Standard Deviation(s) 1.73 2.12 0.00 0.00 Standard Error1.23 1.50 0.00 0.00 Standard Error % of Mean 7.02 9.09 0.00 0.00 N 2 2 22 ^(a)I is Intensity of Light Source. ^(b)7% PadO/3% Oxyb.

TABLE 3 Evaluation of Sun Protection by SPF Determination(FDA)-Rinse/Lather/Rinse/Rub-Water Resistant-80 Minute Water ImmersionSubject I^(a) Skin MED I MED II WR SPF Values No. Gender MED/Hr (Amps)Type (J/M²) (J/M²) STD^(b) Control Static WR 78-4159 M 126.7 5.8 II46.20 46.20 16.30 18.00 34.50 34.50 48-1671 F 126.2 6.0 II 30.33 30.3318.75 15.00 34.50 30.00 Mean (x) 17.53 16.50 34.50 32.25 StandardDeviation(s) 1.73 2.12 0.00 3.18 Standard Error 1.23 1.50 0.00 2.25Standard Error % of Mean 7.02 9.09 0.00 6.98 N 2 2 2 2 ^(a)I isIntensity of Light Source. ^(b)7% PadO/3% Oxyb.

TABLE 4 Evaluation of Sun Protection by SPF Determination (FDA)-Static(Rinse/Lather/Rinse/Rub) Subject I^(a) Skin MED I MED II SPF Values No.Gender MED/Hr (Amps) Type (J/M²) (J/M²) STD^(b) Static RLR/RUB 62-0539 F127.3 6.0 I 30.33 30.33 16.30 34.50 34.50 48-9212 F 129.2 6.0 II 46.2046.20 18.75 34.50 34.50 78-4159 M 127.1 6.0 II 46.20 46.20 16.30 34.5030.00 78-4237 M 128.4 6.0 II 46.20 46.20 18.75 39.60 34.50 72-7479 M128.1 6.0 II 46.20 46.20 18.75 34.50 34.50 76-0164 M 125.9 6.0 II 46.2046.20 18.75 39.50 34.50 54-1578 F 127.1 5.4 II 46.20 46.20 16.30 34.5034.50 58-3948 M 128.4 6.0 II 46.20 46.20 16.30 34.50 30.00 70-8402 F126.9 5.9 III 46.20 46.20 18.75 39.60 34.50 56-5529 F 125.4 6.0 II 30.3330.33 16.30 39.60 34.50 Mean (x) 17.53 36.54 33.60 Standard Deviation(s)1.29 2.63 1.90 Standard Error 0.41 0.83 0.60 Standard Error % of Mean2.34 2.27 1.79 N 10 10 10 Upper 5% t Dist. 2.2622 1.8331 1.8331 A Values0.9228 1.5246 1.1014 Label SPF 16 35 32 ^(a)I is Intensity of LightSource. ^(b)7% PadO/3% Oxyb.

TABLE 5 Evaluation of Sun Protection by SPF Determination (FDA)-80Minute Water Immersion Subject I^(a) Skin MED I MED II WR SPF Values No.Gender MED/Hr (Amps) Type (J/M²) (J/M²) STD^(b) Control Static WR78-4159 M 127.1 6.0 II 46.20 46.20 16.30 15.00 34.50 30.00 72-7479 M128.1 6.0 II 46.20 46.20 18.75 18.00 34.50 30.00 Mean (x) 17.53 16.5034.50 30.00 Standard Deviation(s) 1.73 2.12 0.00 0.00 Standard Error1.23 1.50 0.00 0.00 Standard Error % of Mean 7.02 9.09 0.00 0.00 N 2 2 22 ^(a)I is Intensity of Light Source. ^(b)7% PadO/3% Oxyb.

TABLE 6 Evaluation of Sun Protection by SPF Determination(FDA)-Rinse/Lather/Rinse/Rub-Water Resistant-80 Minute Water ImmersionSubject I^(a) Skin MED I MED II WR SPF Values No. Gender MED/Hr (Amps)Type (J/M²) (J/M²) STD^(b) Control Static WR 78-4159 M 126.7 5.8 II46.20 46.20 16.30 18.00 34.50 30.00 48-1671 F 126.2 6.0 II 30.33 30.3318.75 15.00 34.50 30.00 Mean (x) 17.53 16.50 34.50 30.00 StandardDeviation(s) 1.73 2.12 0.00 0.00 Standard Error 1.23 1.50 0.00 0.00Standard Error % of Mean 7.02 9.09 0.00 0.00 N 2 2 2 2 ^(a)I isIntensity of Light Source. ^(b)7% PadO/3% Oxyb.

Table 1 through Table 3 show that following administration of asunscreen composition to a spot on an adult individual and thesubsequent washing and patting dry of the spot on the individual withwater, the mean residual SPF from the sunscreen composition applied tothe spot on the individual was 38.07 (Table 1), 34.50 (Table 2) and34.50 (Table 3).

Table 4 through Table 6 show that following administration of asunscreen composition to a spot on a child and the subsequent washingand patting dry of the spot on the individual with water, the meanresidual SPF from the sunscreen composition applied to the spot on theindividual was 36.54 (Table 4), 34.50 (Table 5) and 34.50 (Table 6).

Certain embodiments of the present invention are described herein,including the best mode known to the inventors for carrying out theinvention. Of course, variations on these described embodiments willbecome apparent to those of ordinary skill in the art upon reading theforegoing description. The inventor expects skilled artisans to employsuch variations as appropriate, and the inventors intend for the presentinvention to be practiced otherwise than specifically described herein.Accordingly, this invention includes all modifications and equivalentsof the subject matter recited in the claims appended hereto as permittedby applicable law. Moreover, any combination of the above-describedembodiments in all possible variations thereof is encompassed by theinvention unless otherwise indicated herein or otherwise clearlycontradicted by context.

Groupings of alternative embodiments, elements, or steps of the presentinvention are not to be construed as limitations. Each group member maybe referred to and claimed individually or in any combination with othergroup members disclosed herein. It is anticipated that one or moremembers of a group may be included in, or deleted from, a group forreasons of convenience and/or patentability. When any such inclusion ordeletion occurs, the specification is deemed to contain the group asmodified thus fulfilling the written description of all Markush groupsused in the appended claims.

Unless otherwise indicated, all numbers expressing a characteristic,item, quantity, parameter, property, term, and so forth used in thepresent specification and claims are to be understood as being modifiedin all instances by the term “about.” As used herein, the term “about”means that the characteristic, item, quantity, parameter, property, orterm so qualified encompasses a range of plus or minus ten percent aboveand below the value of the stated characteristic, item, quantity,parameter, property, or term. Accordingly, unless indicated to thecontrary, the numerical parameters set forth in the specification andattached claims are approximations that may vary. At the very least, andnot as an attempt to limit the application of the doctrine ofequivalents to the scope of the claims, each numerical indication shouldat least be construed in light of the number of reported significantdigits and by applying ordinary rounding techniques. Notwithstandingthat the numerical ranges and values setting forth the broad scope ofthe invention are approximations, the numerical ranges and values setforth in the specific examples are reported as precisely as possible.Any numerical range or value, however, inherently contains certainerrors necessarily resulting from the standard deviation found in theirrespective testing measurements. Recitation of numerical ranges ofvalues herein is merely intended to serve as a shorthand method ofreferring individually to each separate numerical value falling withinthe range. Unless otherwise indicated herein, each individual value of anumerical range is incorporated into the present specification as if itwere individually recited herein.

The terms “a,” “an,” “the” and similar referents used in the context ofdescribing the present invention (especially in the context of thefollowing claims) are to be construed to cover both the singular and theplural, unless otherwise indicated herein or clearly contradicted bycontext. All methods described herein can be performed in any suitableorder unless otherwise indicated herein or otherwise clearlycontradicted by context. The use of any and all examples, or exemplarylanguage (e.g., “such as”) provided herein is intended merely to betterilluminate the present invention and does not pose a limitation on thescope of the invention otherwise claimed. No language in the presentspecification should be construed as indicating any non-claimed elementessential to the practice of the invention.

Specific embodiments disclosed herein may be further limited in theclaims using consisting of or consisting essentially of language. Whenused in the claims, whether as filed or added per amendment, thetransition term “consisting of” excludes any element, step, oringredient not specified in the claims. The transition term “consistingessentially of” limits the scope of a claim to the specified materialsor steps and those that do not materially affect the basic and novelcharacteristic(s). Embodiments of the present invention so claimed areinherently or expressly described and enabled herein.

All patents, patent publications, and other publications referenced andidentified in the present specification are individually and expresslyincorporated herein by reference in their entirety for the purpose ofdescribing and disclosing, for example, the compositions andmethodologies described in such publications that might be used inconnection with the present invention. These publications are providedsolely for their disclosure prior to the filing date of the presentapplication. Nothing in this regard should be construed as an admissionthat the inventors are not entitled to antedate such disclosure byvirtue of prior invention or for any other reason. All statements as tothe date or representation as to the contents of these documents isbased on the information available to the applicants and does notconstitute any admission as to the correctness of the dates or contentsof these documents.

1. A sunscreen composition comprises: a first cellulose derived capsule,the first flexible cellulose derived capsule comprising one or more UVAsunscreen active agents, each of the one or more UVA sunscreen activeagents being present at a final percentage of 3% or less of the totalweight of the sunscreen composition and one or more UVB sunscreen activeagents, each of the one or more UVB sunscreen active agents beingpresent at a final percentage of 15% or less of the total weight of thesunscreen composition; wherein the first cellulose derived capsulescomprise a flexible shell consisting essentially of a cellulosicmaterial.
 2. The sunscreen composition according to claim 1, wherein theone or more UVA sunscreen active agent includes a dibenzoylmethane. 3.The sunscreen composition according to claim 2, wherein thedibenzoylmethane includes Avobenzone.
 4. The sunscreen compositionaccording to claim 1, wherein the one or more UVB sunscreen activeagents includes a salicylate.
 5. The sunscreen composition according toclaim 4, wherein the salicylate includes Homosalate and/or OctylSalicylate.
 6. The sunscreen composition according to claim 1, whereinthe first flexible cellulose derived capsule further comprises apolyamide polymer.
 7. The sunscreen composition according to claim 6,wherein the polyamide polymer includes a Polyamide-3.
 8. The sunscreencomposition according to claim 1, wherein the cellulosic materialincludes cellulose, methyl cellulose, ethylmethyl cellulose,hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxyethylmethylcellulose, hydroxypropylmethyl cellulose, ethyl hydroxyethyl cellulose,carboxymethyl cellulose, or any salt therefrom, or any derivative ofcellulose, methyl cellulose, ethylmethyl cellulose, hydroxyethylcellulose, hydroxypropyl cellulose, hydroxyethylmethyl cellulose,hydroxypropylmethyl cellulose, ethyl hydroxyethyl cellulose, orcarboxymethyl cellulose.
 9. The sunscreen composition according to claim1, further comprising a second cellulose derived capsule comprising ashea oil, the second flexible cellulose derived capsule being present ata final percentage of about 0.01% to about 7% of the total weight of thecomposition.
 10. The sunscreen composition according to claim 1, furthercomprising a second cellulose derived capsule comprising a silicone oil,the second flexible cellulose derived capsule being present at a finalpercentage of about 0.01% to about 7% of the total weight of thecomposition.
 11. The sunscreen composition according to claim 1, furthercomprising a second cellulose derived capsule comprising a shea oil, thesecond flexible cellulose derived capsule being present at a finalpercentage of about 0.01% to about 7% of the total weight of thecomposition and a third cellulose derived capsule comprising a siliconeoil, the third flexible cellulose derived capsule being present at afinal percentage of about 0.01% to about 7% of the total weight of thecomposition.
 12. The sunscreen composition according to claim 1, furthercomprising a film former, the film former being present at a finalpercentage of about 1% to about 6% of the total weight of thecomposition.
 13. The sunscreen composition according to claim 13,wherein the film former includes a polyquaternium.
 14. The sunscreencomposition according to claim 14, wherein the polyquaternium includes aPolyquaternium-1, a Polyquaternium-2, a Polyquaternium-4, aPolyquaternium-5, a Polyquaternium-6, a Polyquaternium-7, aPolyquaternium-8, a Polyquaternium-9, a Polyquaternium-10, aPolyquaternium-11, a Polyquaternium-12, a Polyquaternium-13, aPolyquaternium-14, or a Polyquaternium-15.
 15. The sunscreen compositionaccording to claim 1, further comprising one or more emollients, each ofthe one or more emollients being present at a final percentage of about0.25% to about 10% of the total weight of the composition.
 16. Thesunscreen composition according to claim 1, further comprising one ormore antioxidant agents.
 17. The sunscreen composition according toclaim 1, further comprising one or more thickening agents, each of theone or more thickening agents being present at a final percentage ofabout 0.5% to about 12% of the total weight of the composition.
 18. Thesunscreen composition according to claim 1, further comprising one ormore non-polar waxes.
 19. The sunscreen composition according to claim1, further comprising one or more broad-spectrum UVA/UVB sunscreenactive agents, each of the one or more broad-spectrum UVA/UVB sunscreenactive agents being present at a final percentage of 25% or less of thetotal weight of the sunscreen composition.
 20. The sunscreen compositionaccording to claim 1, wherein the sunscreen composition is a solid or aliquid.
 21. The sunscreen composition according to claim 1, wherein thesunscreen composition is a lotion, a lip balm, a bodywash, a shampoo, aconditioner, a soap, a gel, a hand sanitizer, a cream, a spray, a mouse,a make-up or a hair spray.